Palladium-catalyzed and electrophilic cyclization approaches to important heterocycles and carbocycles by Mehta, Saurabh
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2009
Palladium-catalyzed and electrophilic cyclization
approaches to important heterocycles and
carbocycles
Saurabh Mehta
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Chemistry Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Mehta, Saurabh, "Palladium-catalyzed and electrophilic cyclization approaches to important heterocycles and carbocycles" (2009).
Graduate Theses and Dissertations. 10951.
https://lib.dr.iastate.edu/etd/10951
Palladium-catalyzed and electrophilic cyclization approaches to important heterocycles 
and carbocycles 
 
 
by 
 
 
Saurabh Mehta 
 
 
 
 
A dissertation submitted to the graduate faculty 
 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
Major:  Organic Chemistry  
 
Program of Study Committee: 
Richard C. Larock, Major Professor 
George A. Kraus 
Nicola L. Pohl 
Klaus Schmidt-Rohr 
John G. Verkade 
 
 
 
 
 
 
 
 
Iowa State University 
 
Ames, Iowa 
 
2009 
 
Copyright © Saurabh Mehta, 2009.  All rights reserved. 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
To my parents, my family and my teachers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
TABLE OF CONTENTS 
LIST OF ABBREVIATIONS vi 
GENERAL INTRODUCTION 1 
 Dissertation Organization 1 
CHAPTER 1.  COMPETITION STUDIES IN ALKYNE ELECTROPHILIC 
CYCLIZATION REACTIONS 
 Abstract 4 
 Introduction 4 
 Results and Discussion 6 
 Conclusions 22 
 Experimental Section 23 
 Acknowledgments 51 
 References 51 
 
CHAPTER 2.  IODINE/PALLADIUM APPROACHES TO THE SYNTHESIS OF 
POLYHETEROCYCLIC COMPOUNDS 
 Abstract 57 
 Introduction 58 
 Results and Discussion 59 
 Conclusions 69 
 Experimental Section 70 
 Acknowledgements 115 
 References 115 
iv 
 
CHAPTER 3.  A SIMPLE AND MILD SYNTHESIS OF 1H-ISOCHROMENES AND 
(Z)-1-ALKYLIDENE-1,3-DIHYDROISOBENZOFURANS BY THE 
IODOCYCLIZATION OF 2-(1-ALKYNYL)BENZYLIC ALCOHOLS 
 Abstract 123 
 Introduction 124 
 Results and Discussion 126 
 Conclusions 133 
 Experimental Section 134 
 Acknowledgements 185 
 References 186 
 
CHAPTER 4.  SOLUTION PHASE PARALLEL SYNTHESIS OF A MULTI-
SUBSTITUTED CYCLIC IMIDATE LIBRARY 
 Abstract 194 
 Introduction 195 
 Results and Discussion 197 
 Conclusions 211 
 Experimental Section 211 
 Acknowledgments 243 
 References 244 
 
GENERAL CONCLUSIONS 247 
ACKNOWLEDGEMENTS 249 
v 
 
APPENDIX A. CHAPTER 1 1H AND 13C NMR SPECTRA 251 
APPENDIX B. CHAPTER 2 1H AND 13C NMR SPECTRA 332 
APPENDIX C. CHAPTER 3 1H AND 13C NMR SPECTRA 416 
APPENDIX D. CHAPTER 4 1H AND 13C NMR SPECTRA    459 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
LIST OF ABBREVATIONS 
  
Ac acetyl 
aq aqueous 
Ar argon 
Bn benzyl 
Bu butyl 
t-Bu tert-butyl 
oC degrees celsius 
calcd  calculated 
cat. catalytic 
CO carbon monoxide 
δ  chemical shift 
d doublet 
dba dibenzylideneacetone 
DCM dichloromethane  
dd doublet of doublets 
DIPA diisopropylamine 
DME 1,2-dimethoxyethane 
DMF N,N-dimethylformamide 
DMSO dimethyl sulfoxide 
dt doublet of triplets 
eq equation 
vii 
 
equiv equivalent 
E electrophile 
EtOAc ethyl acetate 
GC gas chromatography 
h hour(s) 
HMBC heteronuclear multiple bond correlation 
HRMS high resolution mass spectroscopy 
Hz hertz 
HPLC high performance liquid chromatography 
IR infrared 
LAH lithium aluminum hydride 
m  multiplet 
m meta 
Me methyl 
mg milligram   
mL milliliter(s) 
mol mole(s) 
mmol millimole(s) 
mp melting point 
MS mass spectrometry 
NBS    N-bromosuccinimide 
NMR nuclear magnetic resonance 
o ortho 
viii 
 
OTf trifluoromethanesulfonate 
p para 
Ph phenyl 
q quartet 
s singlet 
satd saturated 
t triplet 
TBAF tetra-n-butylammonium fluoride 
td triplet of doublets 
tert tertiary 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMS trimethylsilyl 
UV    ultraviolet
1 
 
 
GENERAL INTRODUCTION 
Heterocyclic and carbocyclic compounds are of immense importance and find 
applications in a variety of areas, e.g. agricultural chemicals, materials, pharmaceuticals, etc. 
The establishment of innovative and efficient synthetic methods for obtaining important 
heterocycles and carbocycles is an area of active research in synthetic organic chemistry. 
Over the years, the Larock group has investigated several palladium-catalyzed 
transformations and electrophilic cyclization reactions for the synthesis of these important 
classes of compounds. This thesis describes the development of several new and useful 
approaches for the synthesis of important heterocyclic and carbocyclic ring systems, which 
take advantage of very efficient and versatile palladium-catalyzed and electrophilic 
cyclization reactions. 
Dissertation organization 
This dissertation is organized into four chapters. Each of the first three chapters 
presented herein is written following the American Chemical Society guidelines for a full 
paper in the Journal of Organic Chemistry, while the fourth chapter is written following the 
guidelines for a full paper in the Journal of Combinatorial Chemistry. Each chapter is 
composed of an abstract, introduction, results and discussion, conclusions, experimental 
section, acknowledgments, and references. 
Chapter 1 describes the results of competitive electrophilic cyclizations where the 
relative reactivity of various functional groups towards alkyne electrophilic cyclization 
reactions has been studied. The required diarylalkynes have been prepared by consecutive 
Sonogashira reactions of appropriately substituted aryl halides and the competitive 
cyclizations have been performed using I2, ICl, NBS and PhSeCl as electrophiles. The results 
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of these competition studies indicate that various factors, e.g. the nucleophilicity of the 
competing functional groups, polarization of the alkyne triple bond, and the cationic nature 
of the intermediate, influence the outcome of these reactions. 
Chapter 2 describes various strategies for the synthesis of linear and fused 
polyheterocyclic compounds (PHCs). The general method to prepare linked polyheterocyclic 
compounds involves iterative cycles of palladium-catalyzed Sonogashira coupling, followed 
by iodocyclization using I2 or ICl. A variety of heterocyclic units, including benzofurans, 
benzothiophenes, indoles and isocoumarins, can be efficiently incorporated under mild 
reaction conditions. Several variations of this methodology have been combined with other 
efficient transformations, e.g. click chemistry, palladium-catalyzed Ullmann reaction, alkyne 
annulation reaction etc., to generate interesting linked and fused ring polyheterocyclic 
systems. 
A simple and mild method for the preparation of a variety of iodoheterocyclic ethers, 
e.g. isochromenes, dihydroisobenzofurans, etc., by the iodocyclization of easily accessible 2-
(1-alkynyl)benzylic alcohols is described in Chapter 3. The regiochemistry of the reaction 
products has been studied and it has been found to be dependent upon the substitution pattern 
of the starting material. 
Synthesis of a good sized library of potential pharmacophores is desirable for their 
biological evaluation. Chapter 4 describes the solution-phase parallel synthesis of a 71-
member library of highly-substituted cyclic imidates with four diversity points. The 3-
iodomethylene cyclic imidates are readily prepared in good to excellent yields by the 
palladium/copper-catalyzed cross-coupling of various o-iodobenzamides and terminal 
alkynes, followed by electrophilic cyclization with I2. Diversification of these 3-
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iodomethylene cyclic imidates has been accomplished by palladium-catalyzed Sonogashira, 
Suzuki, carbonylative amidation and Heck coupling reactions using commercially available 
building block sublibraries. 
Finally, all of the 1H and 13C NMR spectra for all previously unknown starting 
materials and products are compiled in appendices A-D, following a general conclusion for 
this dissertation. 
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CHAPTER 1. Competition Studies in Alkyne Electrophilic Cyclization Reactions 
Based on a paper published in the Journal of Organic Chemistry41  
Saurabh Mehta, Jesse P. Waldo and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, Iowa 50011 
larock@iastate.edu 
Abstract 
 
The relative reactivity of various functional groups towards alkyne electrophilic 
cyclization reactions has been studied. The required diarylalkynes have been prepared by 
consecutive Sonogashira reactions of appropriately substituted aryl halides and competitive 
cyclizations have been performed using I2, ICl, NBS and PhSeCl as electrophiles. The results 
indicate that the nucleophilicity of the competing functional groups, polarization of the 
alkyne triple bond, and the cationic nature of the intermediate are the most important factors 
in determining the outcome of these reactions. 
 
Introduction 
Alkynes are versatile building blocks in organic synthesis. A wide range of 
carbocycles and heterocycles have been prepared by the electrophilic cyclization of 
functionally-substituted alkynes1 and by transition metal-catalyzed annulations.2 Recently, 
we and others have reported that the electrophilic cyclization of alkynes using halogen, sulfur 
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and selenium electrophiles can be a very powerful tool for the preparation of a wide variety 
of interesting carbocyclic and heterocyclic compounds (Scheme 1), including benzofurans,3 
furans,4 benzothiophenes,5 thiophenes,6 benzopyrans,7 benzoselenophenes,8 selenophenes,9 
naphthols,10 indoles,11 quinolines,12 isoquinolines,13 α-pyrones,14 isocoumarins,14 
isochromenes,15 cyclic imidates,16 naphthalenes17 and
 
polycyclic aromatics,18 isoxazoles,19 
chromones,20 bicyclic β-lactams,21 cyclic carbonates,22 pyrroles,23 furopyridines,24 
spiro[4.5]trienones,25 coumestrol and coumestans,26 furanones,27 benzothiazine-1,1-
dioxides,28  etc.29 
 
Scheme 1. Electrophilic Cyclization 
 
 
In general, these electrophilic cyclization reactions are very efficient, afford clean 
reactions, proceed under very mild reaction conditions in short reaction times, and tolerate 
almost all important functional groups. Furthermore, the iodine-containing products can be 
further elaborated to a wide range of functionally-substituted derivatives using subsequent 
palladium-catalyzed processes. These reactions are generally believed to proceed by a 
stepwise mechanism involving electrophilic activation of the alkyne carbon-carbon triple 
bond, intramolecular nucleophilic attack on the cationic intermediate, and subsequent 
dealkylation (Scheme 2). 
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Scheme 2. General Mechanism 
 
 
The success of this reaction prompted us to establish the relative reactivity of various 
functional groups towards cyclization. This has been accomplished by studying competitive 
cyclizations using halogen and selenium electrophiles. 
 
Results and Discussion 
This electrophilic cyclization methodology has been applied to a variety of 
unsymmetrical functionally-substituted diarylalkynes and the resulting products 
characterized in order to determine the relative reactivities of various functional groups 
towards electrophilic cyclization. The required diarylalkynes are readily prepared by 
consecutive Sonogashira reactions30 of appropriately substituted aryl halides. Thus, 
Sonogashira substitution with trimethylsilyl acetylene, removal of the TMS group, followed 
by a second Sonogashira reaction, generally affords moderate to excellent yields of the 
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desired diarylalkynes. The results for the preparation of the intermediate terminal alkynes 
and the subsequent diarylalkynes are summarized in Tables 1 and 2 respectively.  
 
Table 1. Preparation of the Requisite Terminal Alkynesa 
 
 
 
 
 
 
entry XR1 coupling 
conditionsb 
TMS-alkyne 
(% yield) 
deprotection 
conditionsc 
terminal 
alkyne  
(% overall 
yield) 
1 SMe A 1 (97) aq KOH/MeOH 
0.5 h/25 oC 
5 (83) 
2 CO2Me A 2 (100) KF·2H2O/MeOH 
36 h/25 oC 
6 (82) 
3 Ph A -d - - 
4 CONHPh B 3 (80) KF·2H2O/MeOH 
0.5 h/25 oC 
7 (71) 
5 NMe2 C 4 (74) aq NaOH/MeOH/ether 
0.16 h/25 oC 
8 (48) 
aAll reactions have been run with 5 mmol of o-iodoarene. bReaction conditions: (A) 1.2 equiv of alkyne, 
2 mol % PdCl2(PPh3)2, 1 mol % CuI, 20 mL of Et3N, 25 oC. (B) 1.3 equiv of alkyne, 3 mol % PdCl2(PPh3)2, 
2 mol % CuI, 4 equiv of DIPA, DMF, 65 oC. (C) 1.2 equiv. of alkyne, 1 mol % PdCl2(PPh3)2, 3 mol % CuI, 
0.9 equiv of Et3N, DMF, 25 oC. cSee the Experimental Section for the experimental details. dA complex 
reaction mixture was obtained. 
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Table 2. Preparation of the Diarylalkynesa 
 
entry XR1 YR2 time (h) temp (oC) product yield (%) 
1 SMe SeMe 24 25 9 80 
2 SMe OMe 6 60 10 90 
3 SMe CO2Me 14 25 11 98 
4 SMe CONHPh 1 25 - -b 
5 SMe NMe2 24 25 - -c 
6 CO2Me SeMe 10 60 12 87 
7 CO2Me CONH2 2 25 13 83 
8 CO2Me CONHPh 4 60 14 62d 
9 CO2Me NMe2 8 25 15 78 
10 CO2Me OMe 4 25 16 74 
11 CO2Me CHO 14 25 17 84 
12 CO2Me COMe 4 25 18 88 
13 CO2Me Ph 2 25 19 70 
14 CONHPh SMe 3 65 - -b,e 
15 CONHPh SeMe 18 65 - -c,e 
16 NMe2 Ph 3 75 20 35 
17 NMe2 Ph 2 110 20 74f 
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18 OMe NMe2 24 25 21 70 
19 OMe CHO 7 25 22 80 
20 OMe OBn 8 60 23 72 
21 OMe Ph 2 25 24 94 
22 CHO NMe2 6 60 - -b 
aAll reactions were run using 1 mmol of iodoarene and 1.2 equiv of alkyne, 2 mol % PdCl2(PPh3)2, 1 mol 
% CuI, and 5 mL of Et3N. bAn inseparable mixture was obtained. cThe desired compound was not 
observed. dFour mol % of CuI was used. eTwo mililiters of DMF were used to dissolve the alkyne. fThe 
reaction was carried out in toluene using a modified procedure; see the Experimental Section. 
 
The diarylalkyne 25 containing t-butyl imine functionality was prepared by further 
derivatization of diarylalkyne 22 using a known procedure13 (Scheme 3). However, similar 
derivatization starting with the diarylalkyne 17 resulted in a complex reaction mixture. 
 
Scheme 3. Imine formation 
 
 
In addition to the above substrates, a different type of diarylalkyne 26 bearing both of 
the competing groups (OMe and Ph) on the same aromatic ring has been prepared as shown 
in Scheme 4. The requisite iodoarene was prepared using a previously reported procedure.31 
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Scheme 4. Preparation of diarylalkyne 26 with both competing groups on the same ring 
 
After preparing the desired diarylalkynes, we subjected these compounds to the 
previously established and already optimized electrophilic cyclization conditions for each 
class of heterocycle being prepared (Table 3). In most cases, reaction conditions that are 
appropriate for both of the competing functional groups present in the diarylalkyne in 
question have been used (entries 1-3). In those cases where common reaction conditions for 
both functional groups have not been previously reported, more than one set of reaction 
conditions has been tried in order to allow the functional groups to react under supposedly 
“optimal” conditions. For example, entries 4 and 5 in Table 3 involve the same diarylalkyne 
12, yet each entry uses varying amounts of different electrophiles in compliance with the 
previously reported reaction conditions for methylseleno and carbomethoxy functional 
groups, respectively.8a,14 
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Table 3. Results of the competitive cyclizationsa 
entry substrate electrophile 
time 
(h) 
product(s) 
yield 
(%) 
1 
 
1.1 I2 0.16 
 
82b 
2 
 
1.2 I2 1 
 
96 
3 
 
1.1 I2 0.5 
 
91c 
4 
 
1.2 I2 1 
 
98d 
5 12 1.2 ICl  29 93d 
12 
 
 
6 
 
 
1.2 I2 
 
1 
 
93 
 
 
 
7 
7 11 1.2 ICl 0.5 30 
+ 
31 
93 
 
7 
 
8 
 
11 
 
1.5 PhSeCl 
 
1 
 
56e 
 
 
 
44e 
9 
 
1.2 I2 1 
 
95 
10 
 
2 PhSeCl 3 
 
70 
13 
 
 
11 
 
1.2 I2 1 - -f 
12 13 3 I2 1 - -f,g 
 
 
13 
 
 
 
1.2 I2 
 
 
1 
 
 
45 
 
 
 
18 
14 14 1.2 ICl 1 36 
+ 
37 
35 
 
30 
15 
 
1.2 I2 1.5 
 
57h 
16 
 
1.2 I2 1 
 
E = I 
98 
14 
 
 
17 16 2 ICl 0.5 39 96 
18 16 1.5 PhSeCl 0.5 E = SePh  
40 
95 
19 
 
1.2 I2 2 - -i 
20 17 1.2 ICl 0.5 
 
25j 
 
21 
 
17 
 
1.2 I2, 1.2 
MeOH/1.0 
K2CO3 
 
10 
 
+ 
41 
 
82k 
 
 
12 
22 
 
1.2 I2 1 - -f 
23 18 1.2 ICl 0.5 - -f 
24 18 1.2 I2, 1.2 
MeOH/1.0 
K2CO3 
2 - -f 
15 
 
 
 
25 
 
 
2 I2 
 
3 
 
 
4:1l 
26 23 1.2 ICl 3 43 + 44 6:1l 
27 
 
2 I2 3 
 
95m 
28 
 
2 I2 2 
 
78 
29 20 1.2 ICl 0.5 - -f 
30 20 1.2 NBS 1 - -f 
31 
 
2 ICl 3 
 
90 
32 
 
2 I2 3 - -f 
16 
 
 
 
 
33 
 
 
24 
 
 
1.2 ICl 
 
 
0.5 
 
 
 
49e 
 
 
33e 
34 
 
6 I2 2 
 
89d 
35 26 1.2 ICl 1 - -d,n 
aUnless otherwise stated, all reactions have been carried out on a 0.25 mmol scale in 5 ml of methylene 
chloride at room temperature. All yields are isolated yields after column chromatography. bA small amount 
of the corresponding benzothiophene product (~7%) was observed by GC-MS analysis; however, it could 
not be isolated. cThis result has previously been reported in the literature (see reference 8a). dThis reaction 
hasf been carried out on a 0.10 mmol scale. eThe reported yield is the average of two runs. fThis reaction 
resulted in a complex mixture of unidentifiable products. gMeCN was used as the reaction solvent and 3 
equiv of NaHCO3 were added as a base. hThe corresponding indole (~8%) was also observed by GC-MS 
analysis. However, it could not be isolated. iNo reaction occurred; the starting material was recovered. A 
complex mixture was obtained upon longer reaction. jThis was the only isolated product. The rest of the 
product mixture was complex and inseparable. kThis product decomposed quickly; see the Experimental 
Section for details. lAn inseparable complex mixture was obtained. This ratio is based on GC-MS data. 
mThis result has previously been reported in the literature (see reference 3b).  nAn alkyne ICl addition 
product whose structure is similar to compound 49 in entry 34 was obtained. 
 
The results of the competition studies are summarized in Table 3. Before discussing 
individual results, it should be noted that a close examination of the results suggests that a 
number of factors affect the cyclization. These include electronic (relative nucleophilicity of 
the functional groups, polarization of the carbon-carbon triple bond, and the cationic nature 
of the intermediate) and steric factors (hindrance and geometrical alignment of the functional 
groups), as well as the nature of the electrophile. Three kinds of results have been observed 
for these competitive cyclizations. (1) Only one of the two possible products has been 
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obtained. This is most common, indicating that there is a hierarchy of functional group 
reactivity toward the electrophilic cyclizations. Assuming that the various factors mentioned 
above may affect the cyclization, the dominance of one functional group over another can be 
attributed to any one or a combination of two or more factors operating in favor of the one 
functional group over the other. (2) A mixture of both possible products has been observed. 
This occurs less commonly, but even in these cases, one product is often obtained in a 
significantly higher yield than the other, indicating that one group is usually significantly 
more reactive towards cyclization. (3) A complex reaction mixture is obtained. Although this 
does not provide any substantial information about the relative reactivity, it points to the fact 
that either the more reactive functional group is not compatible with the particular reaction 
conditions or neither of the two functional groups involved has a dominant reactivity, thus 
resulting in a complex reaction mixture.  
It also should be noted that since these reactions are very fast in general, and may 
involve multiple steps and intermediates, it is quite difficult to strictly assign the reactivity of 
any particular functional group to any one factor mentioned above. Indeed, we assume that in 
some cases one or more factors are operating in opposition to each other, resulting in a 
mixture of products. However, in the following discussion, we will attempt to ascribe the 
relative reactivity of various functional groups to what we believe to be the most important 
factors. 
With regard to the results of individual experiments, entry 1 (Table 3) demonstrates 
the competitive cyclization of a methylsulfanyl group versus a methylseleno group. 
Benzoselenophene 27 was isolated as the major product of the reaction using I2 as the 
electrophile. In another experiment (not shown in Table 3 as the product could not be 
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purified completely), when PhSeCl was used as the electrophile, the corresponding 
benzoselenophene was again formed as the major product in high yield. These results can be 
attributed to the higher nucleophilicity of selenium compared to sulfur, due to its lower 
electronegativity and higher polarizability. Similarly, in entry 2, when diarylalkyne 10 
(containing methylsulfanyl and methoxy as competing functional groups) was subjected to 
electrophilic cyclization, benzothiophene 28 was formed exclusively in an excellent yield. It 
is a general observation that the nucleophilicity increases as one descends a column in the 
periodic table.32 This trend is also observed when examining the results of entries 3-14, 
where the nucleophilicity of the competing functional groups governs the resulting 
cyclization. Thus, methylseleno is more reactive than methoxy (entry 3) and carbomethoxy 
functional groups (entries 4 and 5).  
Entries 6-8 involve the competition between a methylsulfanyl group and a 
carbomethoxy group under different conditions. In all three cases, benzothiophene 
derivatives are the major but not exclusive products, again suggesting that the greater 
nucleophilicity of sulfur over oxygen controls the reaction. It is noteworthy, however, that 
changing the electrophile to PhSeCl in entry 8 significantly affects the product distribution, 
presumably because of the nature of the electrophile. 
When competing nucleophilic atoms are in the same row in the periodic table, the 
results show that the nucleophilicity still governs the outcome of the cyclization. Thus, 
nitrogen nucleophiles are more reactive than oxygen nucleophiles. This is exemplified by the 
cyclization of diarylalkyne 21 bearing an NMe2 group and a methoxy group (entry 9), which 
leads to exclusive formation of the corresponding indole 34 in an excellent yield. Similarly, a 
t-butyl imine group was found to be more reactive than a methoxy functional group (entry 
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10). Cyclization reactions involving diarylalkyne 13 (entries 11 and 12) resulted in complex 
reaction mixtures. It has been observed previously by us that a primary amide does not afford 
the desired cyclized product and generally results in a complex reaction mixture.16 On the 
other hand, the related diarylalkyne 14 containing an N-phenyl amide undergoes cyclization 
cleanly with I2, affording two regioisomeric products, both resulting from cyclization by the 
CONHPh group (entry 13). Using ICl (entry 14) also resulted in the same set of products, 
although with reduced regioselectivity in accordance to our previously reported results.16 
Entry 15 involving a competition between a carbomethoxy group and an N,N-
dimethylamino group represents a special case where the corresponding isocoumarin 38 was 
isolated as the major product of  the cyclization. Formation of the isocoumarin product is 
presumably the result of one (or a combination) of the two factors working in favor of the 
carbomethoxy group: (1) The electronics of the two substituents polarize33 the carbon-carbon 
triple bond in a way that leads to a more cationic C2 and anionic C1, thus facilitating 
nucleophilic attack at the more electrophilic C2 position (Figure 1), and/or (2) there seems to 
be a more favorable geometrical alignment of the ester functionality when compared to the 
N,N-dimethylamino group.  
 
Figure 1. Carbomethoxy versus an N,N-dimethylamino group 
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Entries 16-27 involve competitions among various oxygen nucleophiles. In a 
competition between a methoxy group and a carbomethoxy group (entries 16-18) using I2, 
ICl and PhSeCl as the electrophiles, the corresponding isocoumarin derivatives are formed 
exclusively in excellent yields. Analogous to the previous case (entry 15 and Figure 1), 
formation of the isocoumarin products is again presumably due to the electronic polarization 
of the triple bond, which increases the electrophilicity of the carbon being attacked by the 
carbomethoxy group, and also a more favorable geometrical alignment of the ester 
functionality when compared to the methoxy group. 
Entries 19-21 involve the competitive cyclization of an aldehyde and an ester group 
under different reaction conditions. When iodine is used as the electrophile (entry 19), the 
starting material was recovered after 2 h. If the reaction was allowed to stir for a longer time, 
a complex reaction mixture was obtained. Using ICl as the electrophile (entry 20), a complex 
mixture was obtained and only isocoumarin derivative 41 was isolable in a 25% yield. It 
should be noted that the aldehyde group after nucleophilic attack becomes cationic and needs 
an external nucleophile to neutralize the positive charge. Thus, the same reaction was 
performed with methanol as an external nucleophile (entry 21). This time, isochromene 
derivative 42 was isolated as the major product, indicating the impact of an external 
nucleophile on the cyclization. Similar reactions involving a methyl ketone and a 
carbomethoxy group as competing entities resulted in complex mixtures of unidentifiable 
products (entries 22-24). 
The cyclizations reported in entries 25 and 26 involving methoxy and benzyloxy 
functional groups resulted in inseparable complex mixtures. However, the GC-MS analyses 
of the product mixtures indicated the presence of two benzofuran products 43 and 44 in 
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varying ratios, the major product resulting from cyclization by the OMe group. These results 
are presumably a consequence of the greater steric hindrance of the benzyloxy group. 
Entry 27 involves a competition between a methoxy group and a relatively electron-
poor acetoxy group. As the reaction outcome, the methoxy cyclization product is formed 
exclusively in high yield. The result of this reaction again suggests that electronic factors 
play a crucial role in these cyclization reactions. We have taken advantage of this high 
selectivity and subsequent palladium-catalyzed carbonylation to prepare coumestrol and a 
variety of related coumestans.26 
Entries 28-35 involve competition of an aryl ring versus nitrogen and different 
oxygen nucleophiles. In the cyclization of diarylalkyne 20 containing an NMe2 group and a 
phenyl ring (entries 28-30), the corresponding indole 45 is obtained when I2 is used as the 
electrophile, presumably due to the more nucleophilic NMe2 group. The reaction of 
diarylalkyne 20 with ICl or NBS resulted in complex reaction mixtures. However, mass 
spectral analysis of the mixture resulting from the NBS cyclization (entry 30) indicated the 
presence of the corresponding indole, an observation that is in accord with that of entry 28. In 
a competition between a carbomethoxy group and a phenyl group (entry 31), the exclusive 
formation of isocoumarin derivative 46 can be explained based on the greater nucleophilicity 
of the carbomethoxy group when compared to the electron-poor phenyl ring. 
The cyclization of diarylalkyne 24 bearing a phenyl ring and an o-methoxy group has 
also been studied (entries 32 and 33). Using iodine as the electrophile resulted in a complex 
mixture of inseparable products, but analysis of the crude 1H NMR and mass spectral data 
suggested preferential cyclization on the phenyl ring. Aromatic rings have previously been 
observed by us to give complex reaction mixtures upon reaction with iodine.17 Using ICl as 
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the electrophile (entry 33) resulted in a mixture of products resulting from participation by 
both the phenyl ring and the methoxy group, with the phenyl cyclized phenanthrene 
derivative 47 being the major product. Presumably, the cationic character of the intermediate 
and/or the higher nucleophilicity of the phenyl ring when compared to the methoxy group 
account for this observation. In competition studies employing diarylalkyne substrate 26 
containing both of the competing functional groups (Ph and methoxy) on the same phenyl 
ring (entries 34 and 35), the only products observed using either I2 or ICl were products of 
addition of the iodine-containing reagent to the carbon-carbon triple bond. These results can 
again be rationalized by assuming the cationic nature and the electronics of the intermediates 
involved in these reactions. 
 
Conclusions 
The results of competitive electrophilic cyclizations using halogen and selenium 
electrophiles on a wide variety of functionally-substituted diarylalkynes have been reported. 
The results suggest that a number of factors affect the cyclization. These include electronic 
(the relative nucleophilicity of the functional groups, and the cationic nature of the 
intermediate) and steric factors (hindrance and geometrical alignment of the functional 
groups), and the nature of the electrophile. It should be noted that although the 
nucleophilicity of the participating functional groups, the polarization of the carbon-carbon 
triple bond, and the cationic nature of the intermediate seem to be the crucial factors 
determining the outcome of these reactions, the possibility of some reactions being reversible 
(Figure 2) before the loss of R1 or R2 cannot be ruled out. Thus in such cases, the selectivity 
might also be controlled by the relative stability of the cyclized intermediate ions (A and B).  
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Figure 2. Possible equilibrium among reaction intermediates 
 
 
The following pattern has been observed for the relative reactivity of various functional 
groups (Figure 3). 
 
Figure 3. Relative reactivity of the functional groups towards cyclization 
 
 
 
Experimental Section 
 
General. The 1H and 13C NMR spectra were recorded at 300 and 75.5 MHz or 400 and 100 
MHz respectively. Thin layer chromatography was performed using commercially prepared 
60-mesh silica gel plates and visualization was effected with short wavelength UV light (254 
nm). DCM was distilled over CaH2. Anhydrous MeCN was used as received. Purification of 
the compounds has been performed by column chromatography. All melting points are 
uncorrected.  
Reagents. All reagents were used directly as obtained commercially unless otherwise 
noted. 
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Preparation of the non-commercial aryl iodides. 2-Iodophenyl methyl selenide was 
prepared using a modified literature procedure.8a In a 100 ml round bottom flask, 8.0 
mmol of the 2-iodoaniline was dissolved in 5 ml of HBF4 (48% solution) and the mixture 
was stirred for 15 min and then allowed to cool to 0 oC. To this solution, an aqueous solution 
of NaNO2 (8.0 mmol in 3 mL of water) was added dropwise to the reaction mixture. The 
mixture was allowed to warm to room temperature, filtered and washed with cold ethanol. 
The diazonium salt was dried under vacuum and used for the next step without purification. 
A suspension of 8.0 mmol of the crude diazonium salt in 25 mL of CHCl3 containing 10 mol 
% of 18-crown-6 and 9.0 mmol of dimethyl diselenide was stirred at 0 oC. To this mixture, 
16 mmol of KOAc was added in small portions over a period of 10 min and the resulting 
solution was allowed to stir for 4 h and then filtered. The solid residue was washed with 
chloroform and the resulting filtrate was washed with water (2 x 5 mL), dried over anhydrous 
MgSO4, and concentrated under vacuum. The crude product obtained was then purified by 
flash chromatography on silica gel using ethyl acetate/hexanes as the eluent. The product was 
obtained as a yellow oil (yield = 35%) with spectral properties identical to those previously 
reported.8a
 
N-Phenyl-2-iodobenzamide34 and N,N-dimethyl-2-iodoaniline35 were 
prepared according to literature procedures. 
 
Preparation of the TMS-protected alkynes. 
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o-(Trimethylsilylethynyl)thioanisole (1). This compound was prepared according to a 
modified literature procedure.5b To a solution of o-iodothioanisole (5.0 mmol), PdCl2(PPh3)2 
(0.07 g, 2 mol %), and CuI (0.01 g, 1 mol %) in TEA (20 mL) (stirring for 5 min 
beforehand), 6.0 mmol of trimethylsilylacetylene (1.2 equiv) in 5 mL of TEA was added 
dropwise over 15 min. The reaction flask was flushed with argon and the mixture was stirred 
at room temperature for 20 h. The resulting solution was filtered, washed with brine, and 
extracted with diethyl ether (2 x 10 mL). The combined ether fractions were dried over 
Na2SO4 and concentrated under vacuum to yield the crude product. Purification by flash 
chromatography afforded the product (yield = 97%) as a yellow oil with spectral properties 
identical to those previously reported.5b 
 
 
Methyl 2-(trimethylsilylethynyl)benzoate (2). This compound was prepared using the 
procedure (reaction time: 15 h) used for compound 1. After flash chromatography, the 
compound was isolated as a colorless oil (yield = 100%) with spectral properties identical to 
those previously reported.36 
 
TMS
NHPh
O
3
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N-Phenyl 2-(trimethylsilylethynyl)benzamide (3). To a solution of the iodobenzamide (5.0 
mmol) in DMF (20 ml) were added PdCl2(PPh3)2 (3 mol %), CuI (2 mol%) and DIPA (4 
equiv). A solution of trimethylsilylacetylene (1.3 equiv) in 5 ml of DMF was added dropwise 
and the resulting mixture was then heated under an N2 atm at 65 oC. After 4 h of stirring, the 
mixture was allowed to cool to room temperature and 25 ml of satd aq NH4Cl and 25 ml of 
ethyl acetate were added. The organic layer was separated and the aqueous layer was back 
extracted with ethyl acetate. The combined organic layers were washed with brine and water 
and dried over anhydrous MgSO4. The solvent was removed under reduced pressure and the 
residue was purified by column chromatography on silica gel to afford the product (80%) as 
a colorless solid with spectral properties identical to those previously reported:37 mp 96-97 ºC 
(lit. mp37 95-96 ºC). 
 
 
N,N-Dimethyl-2-(trimethylsilylethynyl)aniline (4). This compound was prepared according 
to a literature procedure.38 Purification by flash chromatography afforded the product as a 
yellow oil (yield = 74%) with spectral properties identical to those previously reported.38 
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Preparation of the terminal alkynes. 
 
2-Ethynylthioanisole (5). A modified literature procedure39 was used to prepare this 
compound. A solution of KOH (0.45 g, 8.0 mmol, 2 equiv) in 2 mL of water was added 
dropwise to o-(trimethylsilylethynyl)thioanisole (0.88 g, 4.0 mmol) in 20 mL of CH3OH 
under an argon atmosphere at 25 oC. The mixture was stirred for another 0.5 h at 25 oC, and 
the CH3OH was removed under vacuum. The residue was added to 20 mL of brine, and the 
mixture was extracted with EtOAc (3 x 20 mL), dried (Na2SO4), filtered, and the solvent 
removed under vacuum. Purification by flash chromatography afforded the product (yield = 
86%) as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 2.49 (s, 3H), 3.47 (s, 1H), 7.08 (td, J = 
0.8, 7.2 Hz, 1H), 7.16 (d, J = 7.6 Hz, 1H), 7.31 (td, J = 1.2, 7.6 Hz, 1H), 7.46 (dd, J = 1.2, 7.6 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 15.3, 81.2, 83.7, 120.3, 124.38, 124.41, 129.5, 
133.3, 142.0; IR (in CH2Cl2, cm-1) 3288, 3049, 2922, 2102, 1436; HRMS Calcd for C9H8S: 
148.0347. Found: 148.0334. 
 
 
Methyl 2-ethynylbenzoate (6). A modified literature procedure was used.36 To a solution of 
compound 2 (4.0 mmol) in methanol (20 mL), KF·2H2O (2.26 g, 24 mmol, 6 equiv) was 
added and the reaction mixture was stirred for 36 h at 25 oC. After the reaction was over, 
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methanol was removed under vacuum and the residue was extracted with EtOAc (3 x 20 
mL), washed with 0.1M HCl and brine, dried (Na2SO4), filtered, and the solvent removed 
under vacuum. Purification by flash chromatography afforded the product (yield = 82%) as a 
colorless oil with spectral properties identical to those previously reported.36 
 
 
N-Phenyl-2-ethynylbenzamide (7). This compound was prepared according to the modified 
literature procedure used for compound 6 above, except that the reaction time was 0.5 h.36 
Purification by flash chromatography afforded the product (yield = 89%) as a yellow solid: 
mp 95-98 oC; 1H NMR (300 MHz, CDCl3) δ 3.57 (s, 1H), 7.11-7.16 (t, J = 7.2 Hz, 1H), 7.24-
7.46 (m, 4H), 7.55-7.58 (m, 1H), 7.66 (d, J = 7.8 Hz, 2H), 7.96-7.99 (m, 1H), 9.02 (br s, 1H); 
13C NMR (75 MHz, CDCl3) δ 82.0, 84.4, 118.6, 120.1, 124.7, 129.2, 129.7, 130.0, 130.9, 
134.2, 136.9, 138.1, 164.4; IR (in CH2Cl2, cm-1) 3295, 3054, 2305, 1672, 1265; HRMS Calcd 
for C15H11NO: 221.08406. Found: 221.08437. 
 
 
N,N-Dimethyl-2-ethynylaniline (8). This compound was prepared according to a literature 
procedure.38 Purification by flash chromatography afforded the product as a yellow oil (yield 
= 65%) with spectral properties identical to those previously reported.38 
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Preparation of the diarylalkynes. 
General procedure used for the Sonogashira Coupling. The following procedure has been 
used for the preparation of all of the diarylalkynes. Slight modifications were made wherever 
required (Table 2). To a solution of iodoarene (1.0 mmol), PdCl2(PPh3)2 (0.014 g, 2 mol %), 
and CuI (0.002 g, 1 mol %) in TEA (4 mL) (stirring for 5 min beforehand), 1.2 mmol of 
trimethylsilylacetylene (1.2 equiv) in 1 mL of TEA was added dropwise over 10 min. The 
reaction flask was flushed with argon and the mixture was stirred at the indicated temperature 
for the indicated time (Table 2). After the reaction was over, the resulting solution was 
filtered, washed with brine, and extracted with EtOAc (2 x 10 mL). The combined extracts 
were dried over MgSO4 and concentrated under vacuum to yield the crude product. 
Purification was performed by flash chromatography. 
 
 
2-[(2-(Methylselenyl)phenyl)ethynyl]thioanisole (9). The product was obtained as a white 
solid: mp 105-107 oC; 1H NMR (400 MHz, CDCl3) δ 2.37 (s, 3H), 2.52 (s, 3H), 7.10-7.19 
(m, 3H), 7.24-7.33 (m, 3H), 7.54 (t, J = 6.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 6.5, 
15.5, 92.6, 94.2, 121.4, 123.7, 124.3, 124.4, 125.3, 127.5, 129.10, 129.11, 132.77, 132.81, 
136.5, 141.8; IR (in CH2Cl2, cm-1) 3053, 2986, 2305, 1266; HRMS Calcd for C16H14SSe: 
317.99814. Found: 317.99874. 
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2-[(2-Methoxyphenyl)ethynyl]thioanisole (10). The product was obtained as a white solid: 
mp 117-119 oC; 1H NMR (400 MHz, CDCl3) δ 2.52 (s, 3H), 3.93 (s, 3H), 6.89-6.96 (m, 2H), 
7.11 (t, J = 7.5 Hz, 1H), 7.18 (d, J = 8.0 Hz, 1H), 7.26-7.33 (m, 2H), 7.51-7.56 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 15.4, 56.1, 91.1, 92.5, 110.9, 112.6, 120.6, 122.0, 124.41, 124.43, 
128.7, 130.1, 132.5, 133.8, 141.7, 160.1; IR (in CH2Cl2, cm-1) 3053, 2986, 2305, 1265; 
HRMS Calcd for C16H14OS: 254.07654. Found: 254.07689. 
 
 
Methyl 2-[(2-(methylthio)phenyl)ethynyl]benzoate (11). The product was obtained as a 
colorless solid: mp 73-75 oC; 1H NMR (400 MHz, CDCl3) δ 2.49 (s, 3H), 3.96 (s, 3H), 7.11 
(t, J = 7.2 Hz, 1H), 7.16 (d, J = 7.6 Hz, 1H), 7.30 (t, J = 7.6 Hz, 1H), 7.37 (t, J = 7.6 Hz, 1H), 
7.48 (t, J = 7.8 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.72 (d, J = 7.6 Hz, 1H), 7.97 (d, J = 8.0 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 15.2, 52.4, 91.9, 94.6, 121.4, 123.6, 124.1, 124.3, 
128.1, 129.1, 130.5, 131.6, 131.8, 132.8, 134.4, 141.9, 166.8; IR (in CH2Cl2, cm-1) 3054, 
2986, 2305, 1727, 1265; HRMS Calcd for C17H14O2S: 282.07145. Found: 282.07178. 
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SeMe
MeO2C
12
 
Methyl 2-[(2-(methylselenyl)phenyl)ethynyl]benzoate (12). The product was obtained as a 
yellow gel: 1H NMR (300 MHz, CDCl3) δ 2.37 (s, 3H), 3.97 (s, 3H), 7.14-7.20 (m, 1H), 
7.24-7.32 (m, 2H), 7.36-7.42 (m, 1H), 7.48-7.55 (m, 2H), 7.73 (dd, J = 0.9, 7.8 Hz, 1H), 7.98 
(dd, J = 0.9, 7.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 6.3, 52.5, 92.9, 93.9, 123.7, 123.9, 
125.4, 127.6, 128.3, 129.3, 130.6, 131.8, 131.9, 132.9, 134.5, 136.7, 166.9; IR (in CH2Cl2, 
cm-1) 3053, 2928, 2305, 1729, 1262; HRMS Calcd for C17H14O2Se: 330.01590. Found: 
330.01629. 
 
Methyl 2-[(2-carbamoylphenyl)ethynyl]benzoate (13). The product was obtained as a 
colorless solid: mp 122-124 oC; 1H NMR (300 MHz, CDCl3) δ 3.93 (s, 3H), 6.48 (br s, 1H), 
7.39-7.57 (m, 4H), 7.65-7.70 (m, 2H), 8.03 (dt, J = 0.9, 8.1 Hz, 1H), 8.21-8.24 (m, 1H), 8.37 
(br s, 1H); 13C NMR (75 MHz, CDCl3) δ 52.6, 92.7, 94.6, 120.3, 123.2, 128.8, 129.2, 130.75, 
130.82, 130.9, 131.0, 132.3, 134.2, 134.3, 134.7, 166.3, 167.8; IR (in CH2Cl2, cm-1) 3486, 
3370, 3054, 2987, 2305, 1722, 1670; HRMS Calcd for C17H13NO3: 279.08954. Found: 
279.08994. 
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Methyl 2-[(2-(phenylcarbamoyl)phenyl)ethynyl]benzoate (14). The product was obtained 
as a yellow solid: mp 117-119 oC; 1H NMR (400 MHz, CDCl3) δ 3.78 (s, 3H), 7.10-7.14 (m, 
1H), 7.28-7.32 (m, 2H), 7.44 (td, J = 1.2, 7.6 Hz, 1H), 7.49-7.53 (m, 3H), 7.60-7.63 (m, 3H), 
7.69-7.71 (m, 1H), 8.03-8.05 (m, 1H), 8.16-8.19 (m, 1H), 9.45 (br s, 1H); 13C NMR (100 
MHz, CDCl3) δ  52.5, 92.1, 95.2, 119.8, 121.4, 123.0, 124.7, 128.96, 129.03, 129.4, 130.8, 
131.0, 131.1, 131.5, 132.4, 133.9, 134.3, 135.9, 138.2, 164.7, 166.2; IR (in CH2Cl2, cm-1) 
3350, 3053, 2985, 2306, 1719, 1665, 1265; HRMS Calcd for C23H17NO3: 355.12084. Found: 
355.12145. 
CO2Me
Me2N
15
 
Methyl 2-[(2-(dimethylamino)phenyl)ethynyl]benzoate (15). The product was obtained as 
a yellow oil (strongly fluorescent under UV): 1H NMR (300 MHz, CDCl3) δ 3.00 (s, 6H), 
3.93 (s, 3H), 6.86-6.91 (m, 2H), 7.21-7.27 (m, 1H), 7.32 (td, J = 1.5, 7.8 Hz, 1H), 7.45 (td, J 
= 1.5, 7.5 Hz, 1H), 7.55 (dd, J = 1.8, 6.9 Hz, 1H), 7.64 (dt, J = 0.6, 7.8 Hz, 1H), 7.95 (dd, J = 
1.5, 7.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 43.6, 52.2, 93.6, 94.1, 114.9, 116.8, 120.4, 
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124.4, 127.6, 129.6, 130.5, 131.5, 131.7, 133.7, 134.9, 154.7, 166.9; IR (in CH2Cl2, cm-1) 
2948, 2835, 2207, 1728, 1251; HRMS Calcd for C18H17NO2: 279.12593. Found: 279.12658. 
 
CO2Me
MeO
16
 
Methyl 2-[(2-methoxyphenyl)ethynyl]benzoate (16). The product was obtained as a light 
brown solid: mp 62-64 oC; 1H NMR (300 MHz, CDCl3) δ 3.89 (s, 3H), 3.94 (s, 3H), 6.86-
6.96 (m, 2H), 7.26-7.36 (m, 2H), 7.45 (t, J = 7.5 Hz, 1H), 7.55 (d, J = 7.5 Hz, 1H), 7.67 (d, J 
= 7.5 Hz, 1H), 7.96 (d, J = 7.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ  52.3, 56.0, 91.2, 
92.5, 111.0, 112.8, 120.7, 124.2, 128.0, 130.3, 130.6, 131.8, 131.9, 134.1, 134.3, 160.3, 
167.1; IR (in CH2Cl2, cm-1) 3054, 2951, 2838, 2306, 2216, 1716, 1270; HRMS Calcd for 
C17H14O3: 266.09429. Found: 266.09468. 
 
 
Methyl 2-[(2-formylphenyl)ethynyl]benzoate (17). The product was obtained as a white 
solid that turned gray upon exposure to air: mp 87-89 oC;  1H NMR (300 MHz, CDCl3) δ 
3.95 (s, 3H), 7.40-7.61 (m, 4H), 7.67-7.71 (m, 2H), 7.95-8.03 (m, 2H), 10.76 (s, 1H); 13C 
NMR (75 MHz, CDCl3) δ 52.6, 90.1, 95.1, 123.1, 127.16, 127.24, 128.9, 129.0, 130.9, 131.9, 
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132.1, 133.6, 133.9, 134.5, 136.5, 166.4, 192.6; IR (in CH2Cl2, cm-1) 3054, 2987, 2306, 1727, 
1696, 1264; HRMS Calcd for C17H12O3: 264.07864. Found: 264.07909. 
 
 
Methyl 2-[(2-acetylphenyl)ethynyl]benzoate (18). The product was obtained as an orange 
solid: mp 68-70 oC; 1H NMR (400 MHz, CDCl3) δ 2.79 (s, 3H), 3.93 (s, 3H), 7.36-7.40 (m, 
2H), 7.46-7.49 (m, 2H), 7.66-7.76 (m, 3H), 7.96 (dd, J = 1.2, 7.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 29.8, 52.1, 93.2, 93.7, 121.6, 123.3, 128.2, 128.4, 128.6, 130.4, 131.2, 131.5, 
131.7, 133.9, 134.1, 140.3, 166.2, 199.9; IR (in CH2Cl2, cm-1) 3055, 2952, 2305, 1730, 1678, 
1270; HRMS Calcd for C18H14O3: 278.09429. Found: 278.09473. 
 
 
Methyl 2-(biphenyl-2-ylethynyl)benzoate (19). The product was obtained as a colorless 
solid: mp 67-69 oC; 1H NMR (300 MHz, CDCl3) δ 3.82 (s, 3H), 7.29-7.47 (m, 9H), 7.68-7.74 
(m, 3H), 7.92 (d, J = 7.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 52.3, 91.2, 94.5, 121.8, 
124.1, 127.3, 127.7, 128.0, 128.2, 129.1, 129.67, 129.73, 130.6, 131.77, 131.82, 133.7, 134.1, 
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140.7, 144.0, 166.9; IR (in CH2Cl2, cm-1) 3053, 2987, 2303, 2212, 1727, 1268; HRMS Calcd 
for C22H16O2: 312.11503. Found: 312.11564. 
 
 
N,N-Dimethyl-2-(biphenyl-2-ylethynyl)aniline (20). This compound was obtained in a 35% 
yield following the general procedure mentioned above. The following slightly modified 
literature procedure resulted in a significantly increased yield.40 N,N-Dimethyl-2-iodoaniline 
(2.0 mmol), 42 mg of PdCl2(PPh3)2 (0.06 mmol, 3.0 mol %), and 12 mg of CuI (0.06 mmol, 
3.0 mol %) were placed in a dry reaction flask. Next, 5 mL of toluene and 0.6 mL of 
diisopropylamine were added to the flask, followed by 0.22 g of 2-methyl-3-butyn-2-ol (2.6 
mmol, 1.3 equiv). The reaction mixture was stirred at 80 oC under argon for 1 h. As 
monitored by TLC, the first acetylene coupling was complete. The reaction temperature of 
the oil bath was increased to 110 oC, and 96 mg of NaH (120 mg of 80% dispersion, 4.0 
mmol, 2.0 equiv) was added slowly to the mixture. After 5 min of stirring, 0.560 g (2.0 
mmol, 1.0 equiv) of 2-iodobiphenyl was added to the reaction mixture, and the stirring was 
continued. After 25 min, 48 mg of NaH (another 60 mg portion of 80% dispersion) (2.0 
mmol, 1.0 equiv) was added carefully, and the solution was stirred at 110 oC for 1 h. After 
cooling to room temperature, the suspension was filtered, and the separated amine-
hydrochloride was washed with toluene. Evaporation of the combined toluene solution gave 
a crude product, which was purified by column chromatography using hexane-ethyl acetate 
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mixtures to afford the product as a yellow oil: 1H NMR (300 MHz, CDCl3) δ 2.79 (s, 6H), 
6.78-6.85 (m, 2H), 7.16-7.45 (m, 9H), 7.66 (d, J = 6.9 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ  43.4, 91.8, 94.6, 115.4, 116.9, 120.4, 122.4, 127.2, 127.5, 128.1, 128.4, 129.3, 
129.6, 129.7, 132.9, 134.4, 140.9, 143.6, 154.6; IR (in CH2Cl2, cm-1) 3051, 2984, 2304, 2207, 
1269; HRMS Calcd for C22H19N: 297.15175. Found: 297.15210. 
 
NMe2
MeO
21
 
N,N-Dimethyl-2-[(2-methoxyphenyl)ethynyl]aniline (21). The product was obtained as a 
green liquid (fluorescent under UV): 1H NMR (300 MHz, CDCl3) δ 3.01 (s, 6H), 3.88 (s, 
3H), 6.86-6.94 (m, 4H), 7.20-7.30 (m, 2H), 7.48-7.53 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 43.8, 55.9, 91.5, 93.1, 110.8, 113.4, 115.7, 117.1, 120.59, 120.64, 129.3, 129.6, 
133.3, 134.6, 154.8, 160.2; IR (in CH2Cl2, cm-1) 3054, 2986, 2305, 1265; HRMS Calcd for 
C17H17NO: 251.13101. Found: 251.13138. 
 
 
2-[(2-Methoxyphenyl)ethynyl]benzaldehyde (22). The product was obtained as a colorless 
solid: mp 82-84 oC; 1H NMR (300 MHz, CDCl3) δ 3.91 (s, 3H), 6.90-6.98 (m, 2H), 7.31-7.44 
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(m, 2H), 7.49-7.58 (m, 2H), 7.62-7.65 (m, 1H),  7.94 (dd, J = 1.2, 7.8 Hz, 1H), 10.74 (s, 1H); 
13C NMR (75 MHz, CDCl3) δ 55.9, 89.2, 93.2, 110.8, 111.7, 120.7, 127.1, 127.5, 128.5, 
130.7, 133.1, 133.4, 133.8, 136.0, 160.5, 192.7; IR (in CH2Cl2, cm-1) 3053, 2987, 2305, 2215, 
1694, 1271; HRMS Calcd for C16H12O2: 236.08373. Found: 236.08409. 
 
 
1-Benzyloxy-2-[(2-methoxyphenyl)ethynyl]benzene (23). The product was obtained as a 
white solid: mp 77-79 oC; 1H NMR (400 MHz, CDCl3) δ 3.80 (s, 3H), 5.18 (s, 2H), 6.85-6.95 
(m, 4H), 7.22-7.30 (m, 3H), 7.35 (t, J = 7.2 Hz, 2H), 7.49 (d, J = 7.2 Hz, 1H), 7.54-7.55 (m, 
3H); 13C NMR (100 MHz, CDCl3) δ  56.0, 70.6, 90.1, 90.3, 110.9, 113.0, 113.1, 113.9, 
120.6, 121.0, 127.2, 127.8, 128.5, 129.6, 129.7, 133.6, 133.7, 137.3, 159.3, 160.0; IR (in 
CH2Cl2, cm-1) 3052, 2984, 2306, 1266; HRMS Calcd for C22H18O2: 314.13068. Found: 
314.13110. 
 
 
2-[(2-Methoxyphenyl)ethynyl]biphenyl (24). The product was obtained as a white solid: 
mp 69-71 oC; 1H NMR (300 MHz, CDCl3) δ 3.78 (s, 3H), 6.78-6.86 (m, 2H), 7.18-7.45 (m, 
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8H), 7.66-7.72 (m, 3H); 13C NMR (75 MHz, CDCl3) δ  56.0, 89.1, 93.6, 111.0, 113.0, 120.7, 
122.2, 127.2, 127.6, 128.1, 128.6, 129.7, 129.8, 129.9, 133.4, 133.6, 140.8, 143.9, 160.2; IR 
(in CH2Cl2, cm-1) 3052, 2965, 2304, 2212, 1263; HRMS Calcd for C21H16O: 284.12012. 
Found: 284.12065. 
 
 
N-[2-((2-Methoxyphenyl)ethynyl)benzylidene]-2-methylpropan-2-amine (25). The 
compound was prepared according to the literature procedure as a yellow oil and the spectral 
properties were found to be identical to those previously reported.39 
 
 
3-Methoxy-2-(phenylethynyl)biphenyl (26). The product was obtained as yellow gel: 1H 
NMR (400 MHz, CDCl3) δ 3.97 (s, 3H), 6.91 (d, J = 8.8 Hz, 1H), 7.03 (d, J = 7.6 Hz, 1H), 
7.25-7.26 (m, 3H), 7.31-7.46 (m, 6H), 7.65 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ  56.4, 85.6, 97.1, 109.4, 111.3, 122.1, 124.0, 127.7, 128.0, 128.1, 128.3, 129.3, 
129.7, 131.5, 140.7, 146.1, 160.6; IR (in CH2Cl2, cm-1) 3052, 2986, 2305, 1265; HRMS 
Calcd for C21H16O: 284.12012. Found: 284.12053. 
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Electrophilic cyclization of the diarylalkynes. 
General procedure for iodocyclization. To a solution of 0.25 mmol of the diarylalkyne in 3 
mL of CH2Cl2 was added gradually the I2/ICl (amounts as indicated in Table 3) in 2 mL of 
CH2Cl2. The reaction mixture was flushed with argon and allowed to stir at 25 °C for the 
indicated time (the reaction was monitored by TLC for completion). The excess I2/ICl was 
removed by washing with satd aq Na2S2O3. The mixture was then extracted by EtOAc or 
diethyl ether (2 x 10 mL). The combined organic layers were dried over anhydrous MgSO4 
and concentrated under vacuum to yield the crude product, which was purified by flash 
chromatography on silica gel with ethyl acetate/hexanes as the eluent. 
 
General procedure for the PhSeCl cyclizations. To a solution of 0.25 mmol of the 
diarylalkyne in CH2Cl2 (3 mL) was added the PhSeCl (amount as indicated in Table 3) in 2 
mL of CH2Cl2. The mixture was flushed with argon and allowed to stir at 25 °C for the 
indicated time. The reaction mixture was washed with 20 mL of water and extracted with 
EtOAc or diethyl ether. The combined organic layers were dried over anhydrous MgSO4 and 
concentrated under vacuum to yield the crude product, which was further purified by flash 
chromatography on silica gel with ethyl acetate/hexanes as the eluent. 
 
General procedure for bromocyclization. To a solution of 0.25 mmol of the diarylalkyne 
in 3 mL of CH2Cl2 was added gradually 1.2 equiv of NBS dissolved in 2 mL of CH2Cl2. The 
reaction mixture was allowed to stir at 25 °C for 1-4 h. The excess NBS was removed by 
washing with satd aq Na2S2O3. The mixture was then extracted by diethyl ether (2 x 10 mL). 
The combined ether layers were dried over anhydrous MgSO4 and concentrated under 
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vacuum to yield the crude product, which was purified by flash chromatography on silica gel 
using ethyl acetate/hexanes as the eluent. 
 
 
3-Iodo-2-(2-methylsulfanylphenyl)benzo[b]selenophene (27). The product was obtained as 
a white solid: mp 116-118 oC; 1H NMR (400 MHz, CDCl3) δ 2.43 (s, 3H), 7.24-7.38 (m, 4H), 
7.42-7.50 (m, 2H), 7.85-7.90 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 16.0, 87.2, 124.7, 
125.2, 125.6, 125.9, 126.1, 128.8, 129.8, 131.0, 135.6, 139.3, 141.4, 142.9, 143.1; IR (in 
CH2Cl2, cm-1) 3054, 2986, 2925, 1264; HRMS Calcd for C15H11ISSe: 429.87914. Found: 
429.88004. 
 
 
3-Iodo-2-(2-methoxyphenyl)benzo[b]thiophene (28). The product was obtained as a yellow 
solid: mp 104-106 oC; 1H NMR (400 MHz, CDCl3) δ 3.83 (s, 3H), 7.00-7.08 (m, 2H), 7.35-
7.40 (m, 2H), 7.45 (t, J = 8.0 Hz, 2H), 7.79 (t, J = 7.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) 
δ 55.8, 82.9, 111.6, 120.6, 122.3, 123.7, 125.3, 125.4, 126.1, 130.9, 132.7, 139.6, 139.8, 
141.4, 157.3; IR (in CH2Cl2, cm-1) 3052, 2980, 1432, 1264; HRMS Calcd for C15H11IOS: 
365.95764. Found: 365.95825. 
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Methyl 2-(3-iodobenzo[b]selenophen-2-yl)benzoate (29). The product was obtained as a 
white solid: mp 113-115 oC; 1H NMR (400 MHz, CDCl3) δ 3.69 (s, 3H), 7.32-7.35 (m, 1H), 
7.42-7.55 (m, 3H), 7.60 (td, J = 1.2, 7.6 Hz, 1H), 7.85 (t, J = 7.2 Hz, 2H), 8.04 (dd, J = 1.2, 
7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 52.6, 85.3, 125.3, 125.8, 125.9, 128.6, 129.1, 
130.7, 131.2, 131.9, 132.2, 138.2, 140.9, 142.8, 144.2, 167.1; IR (in CH2Cl2, cm-1) 3054, 
2984, 1727, 1266; HRMS Calcd for C16H11IO2Se: 441.89690. Found: 441.89743. 
 
 
Methyl 2-(3-iodobenzo[b]thiophen-2-yl)benzoate (30). The product was obtained as a 
colorless solid: mp 111-115 oC; 1H NMR (400 MHz, CDCl3) δ 3.68 (s, 3H), 7.38-7.39 (m, 
3H), 7.53-7.64 (m, 2H), 7.76-7.81 (m, 2H), 8.05 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 52.6, 82.2, 122.3, 125.5, 125.6, 126.0, 129.4, 130.8, 131.7, 132.0, 132.6, 135.9, 
139.4, 141.1, 142.2, 167.1; IR (in CH2Cl2, cm-1) 3053, 2952, 1729, 1264; HRMS Calcd for 
C16H11IO2S: 393.95245. Found: 393.95324. 
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4-Iodo-3-[2-(methylthio)phenyl]isocoumarin (31). The product was obtained as a colorless 
solid: mp 128-130 oC; 1H NMR (400 MHz, CDCl3) δ 2.48 (s, 3H), 7.28 (t, J = 7.6 Hz, 1H), 
7.34-7.40 (m, 2H), 7.46 (t, J = 7.2 Hz, 1H), 7.60-7.63 (m, 1H), 7.82-7.85 (m, 2H), 7.33 (d, J 
= 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 16.7, 80.1, 120.7, 125.4, 127.1, 129.7, 130.1, 
130.5, 130.8, 131.3, 135.5, 135.9, 137.8, 138.9, 154.6, 161.9; IR (in CH2Cl2, cm-1) 3054, 
2987, 1735, 1264; HRMS Calcd for C16H11IO2S: 393.95245. Found: 393.95324. 
 
 
Methyl 2-[3-(phenylselenyl)benzo[b]thiophen-2-yl]benzoate (32). The product was 
obtained as a yellow gel: 1H NMR (300 MHz, CDCl3) δ 3.59 (s, 3H), 7.07-7.12 (m, 5H), 
7.36-7.39 (m, 3H), 7.48-7.53 (m, 2H), 7.80-7.87 (m, 2H), 7.97-8.00 (m, 1H); 13C NMR (75 
MHz, CDCl3) δ 52.3, 118.0, 122.3, 125.0, 125.16, 125.19, 126.2, 129.07, 129.11, 130.0, 
130.05, 131.5, 131.8, 132.2, 132.8, 135.2, 139.7, 141.1, 147.9, 167.2; IR (in CH2Cl2, cm-1) 
3055, 2987, 1727, 1263; HRMS Calcd for C22H16O2SSe: 424.00362. Found: 424.00442. 
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3-[2-(Methylthio)phenyl]-4-(phenylselenyl)isocoumarin (33). The product was obtained as 
a white solid: mp 111-113 oC; 1H NMR (400 MHz, CDCl3) δ 2.43 (s, 3H), 7.13-7.23 (m, 6H), 
7.29-7.35 (m, 2H), 7.39-7.43 (m, 1H), 7.52-7.56 (m, 1H), 7.68-7.72 (m, 1H), 8.00 (d, J = 8.0 
Hz, 1H), 8.37 (dd, J = 0.8, 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ  16.8, 108.0, 121.4, 
125.1, 126.7, 126.9, 128.2, 129.1, 129.4, 129.9, 130.0, 130.2, 130.5, 131.5, 134.2, 135.5, 
137.9, 139.1, 158.3, 162.1; IR (in CH2Cl2, cm-1) 3056, 2987, 1743, 1262; HRMS Calcd for 
C22H16O2SSe: 424.00362. Found: 424.00442. 
 
 
3-Iodo-2-(2-methoxyphenyl)-1-methylindole (34). The product was obtained as a white oil: 
1H NMR (400 MHz, CDCl3) δ 3.60 (s, 3H), 3.79 (s, 3H), 7.04 (d, J = 8.4 Hz, 1H), 7.10 (t, J = 
7.6 Hz, 1H), 7.19-7.36 (m, 4H), 7.46-7.50 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 31.8, 
55.8, 59.4, 109.8, 111.4, 120.4, 120.77, 120.79, 121.5, 122.7, 130.4, 131.1, 133.6, 137.6, 
139.5, 158.0; IR (in CH2Cl2, cm-1) 3053, 2939, 1465, 1265; HRMS Calcd for C16H14INO: 
363.01202. Found: 363.01255. 
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3-(2-Methoxyphenyl)-4-(phenylselenyl)isoquinoline (35). The product was obtained as a 
yellow gel: 1H NMR (400 MHz, CDCl3) δ 3.66 (s, 3H), 6.94 (d, J = 8.0 Hz, 1H), 7.02-7.05 
(m, 6H), 7.35-7.40 (m, 2H), 7.60 (t, J = 7.6 Hz, 1H), 7.67 (td, J = 1.2, 8.0 Hz, 1H), 8.00 (d, J 
= 8.0 Hz, 1H), 8.36 (d, J  = 8.4 Hz, 1H), 9.36 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 55.4, 
110.6, 120.6, 124.0, 126.1, 127.5, 128.3, 128.46, 128.49, 129.1, 129.8, 130.2, 130.8, 131.6, 
131.7, 133.3, 138.1, 153.5, 156.1, 156.9; IR (in CH2Cl2, cm-1) 3053, 2985, 1265; HRMS 
Calcd for C22H17NOSe: 391.04753. Found: 391.04826. 
 
 
Methyl 2-((1E)-iodo(3-(phenylimino)isobenzofuran-1(3H)-ylidene)methyl)benzoate (36). 
The product was obtained as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 3.76 (s, 3H), 7.02 
(t, J = 7.1 Hz, 1H), 7.10-7.18 (m, 4H), 7.37-7.43 (m, 2H), 7.54-7.62 (m, 2H), 7.70 (t, J = 7.5 
Hz, 1H), 7.97-8.02 (m, 2H), 8.81 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 52.4, 
71.2, 124.0, 124.7, 125.1, 125.2, 128.5, 128.6, 129.3, 130.7, 130.8, 131.0, 132.0, 132.2, 
132.9, 135.1, 141.8, 144.7, 147.5, 151.9, 166.8; IR (in CH2Cl2, cm-1) 3054, 2986, 1726, 1689, 
1265; HRMS Calcd for C23H16INO3: 481.01750. Found: 481.01876. 
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methyl 2-(4-iodo-1-(phenylimino)-1H-isochromen-3-yl)benzoate (37). The product was 
obtained as a white solid: mp 112-114 oC; 1H NMR (400 MHz, CDCl3) δ 3.79 (s, 3H), 6.98 
(t, J = 7.3 Hz, 1H), 7.09-7.11 (m, 2H), 7.21 (t, J = 7.7 Hz, 2H), 7.46-7.52 (m, 3H), 7.57-7.68 
(m, 3H), 8.04 (d, J = 7.7 Hz, 1H), 8.39 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ 52.7, 76.6, 123.0, 123.9, 124.1, 127.8, 128.7, 129.2, 130.0, 130.1, 130.7, 130.9, 132.1, 
132.4, 133.1, 134.5, 137.1, 145.9, 148.7, 153.8, 166.1; IR (in CH2Cl2, cm-1) 3052, 2985, 
1725, 1664, 1263; HRMS Calcd for C23H16INO3: 481.01750. Found: 481.01876. 
 
 
3-[2-(Dimethylamino)phenyl]-4-iodoisocoumarin (38). The product was obtained as a light 
green solid: mp 103-105 oC; 1H NMR (400 MHz, CDCl3) δ 2.78 (s, 6H), 6.95-7.02 (m, 2H), 
7.32-7.40 (m, 2H), 7.58 (t, J = 7.2 Hz, 1H), 7.79-7.87 (m, 2H), 8.31 (d, J = 7.6 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 43.4, 79.5, 117.8, 120.0, 120.2, 126.7, 129.2, 129.9, 131.16, 
131.21, 132.2, 135.8, 138.6, 152.0, 156.2, 162.3; IR (in CH2Cl2, cm-1) 3056, 2989, 1731, 
1265; HRMS Calcd for C17H14INO2: 391.00693. Found: 391.00772. 
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4-Iodo-3-(2-methoxyphenyl)isocoumarin (39). The product was obtained as a white solid: 
mp 166-168 oC; 1H NMR (400 MHz, CDCl3) δ 3.85 (s, 3H), 6.96-6.98 (m, 1H), 7.05 (t, J = 
7.6 Hz, 1H), 7.37 (d, J = 7.2 Hz, 1H), 7.46 (t, J = 7.2 Hz, 1H), 7.56-7.60 (m, 1H), 7.79-7.85 
(m, 2H), 8.31 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.8, 79.8, 111.5, 120.5, 
120.6, 125.1, 129.3, 129.9, 131.2, 131.4, 132.0, 135.7, 138.2, 153.8, 157.2, 162.2; IR (in 
CH2Cl2, cm-1) 3054, 2928, 1735, 1265; HRMS Calcd for C16H11IO3: 377.97530. Found: 
377.97601. 
 
 
3-(2-Methoxyphenyl)-4-(phenylselenyl)isocoumarin (40). The product was obtained as a 
yellow solid: mp 113-116 oC; 1H NMR (400 MHz, CDCl3) δ 3.71 (s, 3H), 6.92 (d, J = 8.0 
Hz, 1H), 6.99 (t, J = 7.6 Hz, 1H), 7.12-7.15 (m, 3H), 7.19-7.21 (m, 2H), 7.35-7.43 (m, 2H), 
7.51 (t, J = 7.6 Hz, 1H), 7.67 (t, J = 7.6 Hz, 1H), 7.96 (d, J = 8.0 Hz, 1H), 8.35 (d, J = 8.0 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ 55.5, 107.7, 111.0, 120.2, 121.2, 123.9, 126.5, 128.0, 
128.7, 129.3, 129.6, 129.9, 131.0, 131.6, 131.8, 135.3, 138.2, 157.27, 157.35, 162.4; IR (in 
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CH2Cl2, cm-1) 3057, 2985, 1735, 1265; HRMS Calcd for C22H16O3Se: 408.02647. Found: 
408.02699. 
 
 
3-(2-Formylphenyl)-4-iodoisocoumarin (41). The product was obtained as a white solid: 
mp 146-148 oC; 1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 7.2 Hz, 1H), 7.62-7.77 (m, 3H), 
7.82-7.88 (m, 2H), 8.04 (dd, J = 1.2, 7.6 Hz, 1H), 8.34 (d, J = 7.6 Hz, 1H), 10.08 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 79.6, 120.7, 129.9, 130.2, 130.4, 131.0, 131.3, 131.6, 134.1, 
134.2, 136.1, 137.3, 137.5, 152.9, 161.3, 190.2; IR (in CH2Cl2, cm-1) 3054, 2985, 1740, 1706, 
1265; HRMS Calcd for C16H9IO3: 375.95965. Found: 375.96067. 
 
 
Methyl 2-(4-iodo-1-methoxy-1H-isochromen-3-yl)benzoate (42).  
A modified literature procedure was used to prepare this compound.15c To a solution of the 
diarylalkyne 15 (0.25 mmol), K2CO3 (0.25 mmol, 1.0 equiv) and methanol (0.3 mmol, 1.2 
equiv) in CH2Cl2 (5.0 mL), iodine (0.3 mmol, 1.2 equiv) was added and the solution was 
stirred at room temperature for 10 h. The reaction mixture was then quenched with satd aq 
Na2S2O3, extracted using EtOAc and washed with water. The combined organic extracts 
48 
 
 
were dried over anhydrous MgSO4 and concentrated under vacuum. Following flash column 
chromatography, compound 36 was isolated as the major product. The compound was 
unstable and decomposed during rotary evaporation (in order to remove the trace amounts of 
solvent). The NMR data showing the presence of the compound (note that the attached 
spectrum shows extra peaks because of the solvent and a slight impurity) is provided here: 1H 
NMR (400 MHz, CDCl3) δ 3.56 (s, 3H), 3.80 (s, 3H), 6.06 (s, 1H), 7.21 (dt, J = 0.8, 7.2 Hz, 
1H), 7.31 (td, J = 1.2, 7.2 Hz, 1H), 7.40-7.45 (m, 2H), 7.48-7.52 (m, 2H), 7.61 (td, J = 1.6, 
7.6 Hz, 1H), 8.05 (dt, J = 0.8, 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 52.5, 56.0, 74.9, 
100.5, 125.7, 127.1, 127.8, 129.0, 129.4, 130.0, 130.4, 130.5, 131.0, 131.3, 132.4, 138.8, 
152.3, 166.7. 
 
and  
2-[2-(Benzyloxy)phenyl]-3-iodobenzofuran (43) and 3-iodo-2-(2-
methoxyphenyl)benzofuran (44). The reaction resulted in a complex inseparable mixture. 
However, these two products were observed by GC-MS analysis. 
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2-(Biphenyl-2-yl)-3-iodo-1-methylindole (45). The product was obtained as a yellow gel: 
1H NMR (400 MHz, CDCl3) δ 3.15 (s, 3H), 7.07-7.09 (m, 1H), 7.13-7.23 (m, 7H), 7.46-7.48 
(m, 3H), 7.55-7.58 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 31.6, 60.4, 109.8, 120.6, 121.3, 
122.6, 127.3, 127.5, 128.4, 128.8, 130.0, 130.2, 130.3, 130.4, 133.4, 137.1, 140.6, 141.7, 
142.8; IR (in CH2Cl2, cm-1) 3052, 2984, 1463, 1265; HRMS Calcd for C21H16IN: 409.03275. 
Found: 409.03326. 
 
 
3-(Biphenyl-2-yl)-4-iodoisocoumarin (46). The product was obtained as a white solid: mp 
132-134 oC; 1H NMR (400 MHz, CDCl3) δ 7.22-7.28 (m, 3H), 7.38-7.39 (m, 2H), 7.44-7.57 
(m, 5H), 7.67-7.75 (m, 2H), 8.22 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 79.8, 
120.2, 127.4, 127.6, 128.4, 128.8, 129.4, 129.9, 130.3, 130.5, 130.8, 131.0, 134.6, 135.8, 
137.8, 140.2, 142.2, 155.7, 161.5; IR (in CH2Cl2, cm-1) 3055, 2985, 1736, 1266; HRMS 
Calcd for C21H13IO2: 423.99603. Found: 423.99687. 
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9-Iodo-10-(2-methoxyphenyl)phenanthrene (47). The product was obtained as a colorless 
solid: mp 135-137 oC; 1H NMR (400 MHz, CDCl3) δ 3.69 (s, 3H), 7.09 (d, J = 8.4 Hz, 1H), 
7.14-7.15 (m, 2H), 7.40-7.42 (m, 2H), 7.49-7.53 (m, 1H), 7.62-7.70 (m, 3H), 8.44-8.46 (m, 
1H), 8.66-8.72 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 55.9, 107.5, 111.6, 121.0, 122.8, 
122.9, 127.2, 127.3, 127.5, 128.0, 128.3, 129.8, 130.5, 130.8, 131.6, 132.4, 132.8, 134.3, 
134.7, 142.8, 157.0; IR (in CH2Cl2, cm-1) 3052, 2985, 1492, 1266; HRMS Calcd for 
C21H15IO: 410.01677. Found: 410.01757. 
 
 
2-(Biphenyl-2-yl)-3-iodobenzofuran (48). The product was obtained as a yellow gel: 1H 
NMR (400 MHz, CDCl3) δ 7.31-7.39 (m, 8H), 7.48-7.51 (m, 1H), 7.54-7.58 (m, 1H), 7.64-
7.66 (m, 2H), 7.82 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 65.7, 111.4, 121.6, 
123.4, 125.4, 127.17, 127.21, 128.3, 128.5, 128.8, 130.3, 130.6, 131.5, 132.0, 140.9, 142.7, 
154.3, 156.0; IR (in CH2Cl2, cm-1) 3053, 2984, 1449, 1263; HRMS Calcd for C20H13IO: 
396.00112. Found: 396.00172. 
 
 
2-(1,2-Diiodo-2-phenylvinyl)-3-methoxybiphenyl (49). The product was obtained as a dark 
yellow solid: mp 102-104 oC; 1H NMR (CD2Cl2, 400 MHz) δ 4.00 (s, 3H), 6.98-7.01 (m, 
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2H), 7.10 (d, J = 7.2 Hz, 2H), 7.28-7.35 (m, 3H), 7.43-7.50 (m, 4H), 7.63 (d, J = 6.4 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 56.4, 95.5, 101.2, 110.7, 123.0, 127.7, 127.9, 128.0, 128.3, 
128.5, 129.7, 130.1, 140.5, 141.6, 147.4, 155.6; IR (in CH2Cl2, cm-1) 3053, 2986, 1422, 
1265; HRMS Calcd for C21H16I2O: 537.92907. Found: 537.92995.  
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CHAPTER 2. Iodine/Palladium Approaches to the Synthesis of Polyheterocyclic 
Compounds 
Based on a paper to be published in the Journal of Organic Chemistry49 
Saurabh Mehta and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, Iowa 50011 
larock@iastate.edu 
Abstract 
 
A simple, straightforward strategy for the synthesis of polyheterocyclic compounds 
(PHCs) is reported, which involves iterative cycles of palladium-catalyzed Sonogashira 
coupling, followed by iodocyclization using I2 or ICl. A variety of heterocyclic units, 
including benzofurans, benzothiophenes, indoles and isocoumarins, can be efficiently 
incorporated under mild reaction conditions. In addition, variations of this strategy afford a 
variety of linked and fused PHCs. 
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Introduction 
The iodocyclization of alkynes has emerged as an efficient tool for the synthesis of 
important heterocycles and carbocycles.1 We and others have utilized this methodology 
(Scheme 1) for the synthesis of benzofurans,2 furans,3 benzothiophenes,4 thiophenes,5 
benzopyrans,6 benzoselenophenes,7 selenophenes,8 naphthols,9 indoles,10 quinolines,11 
isoquinolines,12 α-pyrones,13 isocoumarins,13 naphthalenes14 and polycyclic aromatics,15 
isoxazoles,16 chromones,17 bicyclic β-lactams,18 cyclic carbonates,19 pyrroles,20 
furopyridines,21 spiro[4.5]trienones,22 coumestrol and coumestans,23 furanones,24 
benzothiazine-1,1-dioxides,25 isochromenes,26 etc.27 
 
SCHEME 1. Iodocyclization Reaction 
 
 
In general, iodocyclization is a very efficient reaction, proceeds under very mild 
reaction conditions and exhibits a very broad scope in terms of the functional 
group/substituent compatibility. As iodine is known to be an excellent handle for further 
elaboration through transition metal-catalyzed cross-couplings, especially palladium-
catalyzed transformations,28 the iodocyclization products are ideal substrates for further 
functionalization and a rapid increase in molecular diversity. These features prompted us to 
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test the applicability of this strategy for building more complex systems containing multiple 
heterocyclic units. Polyheterocyclic compounds (PHCs) of this type have found applications 
in biological,29 as well as materials chemistry.30 We here present several versatile synthetic 
strategies involving iodocyclization and subsequent palladium-catalyzed transformations for 
the synthesis of PHCs. 
 
Results and Discussion 
The general scheme employed by us for polyheterocycle synthesis involves the 
Sonogashira coupling31 of a functionally-substituted haloarene with a functionalized alkyne 
(Scheme 2). The alkyne is then subjected to iodocyclization and the resulting 3-
iodoheterocycle is generally isolated in good to excellent yields as reported previously. The 
resulting iodine-containing heterocycle is then used as the starting material for further 
iterative cycles of Sonogashira coupling and iodocyclization to generate the desired 
polyheterocyclic molecule.  
Repetitive cycles of Sonogashira coupling, followed by iodocyclization, have proven 
quite efficient and lead to PHCs bearing 2 or 3 linked heterocycles in moderate to good 
yields. Representative heterocycles and the corresponding intermediates prepared by this 
general strategy are listed in Scheme 2. For preparation of the intermediate alkynes, the usual 
Sonogashira coupling conditions have been somewhat modified, as they have generally been 
performed in DMF (see the Experimental Section). The intermediate alkynes have generally 
been prepared in good to excellent yields (Scheme 2). The iodocyclization reactions have 
been performed using our previously published procedures for the corresponding 
heterocycles. 
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SCHEME 2. Generation of Polyheterocyclic Compounds by the General Strategya 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 X1 R1 yield (%) 
3a O Ph 72 
3b S Ph 100 
3c S TMS 97 
 X1 R1 yield (%) 
4a O Ph 81 
4b S Ph 99 
4c S TMS 99 
4d S H 95b 
 X1 R1 X2 R2 yield (%) 
6a O Ph CO2 H  98 
6b O Ph S H 84 
6c O Ph NMe H 81 
6d S Ph O H 65 
6e S H O OMe 95 
6f S TMS CO2 H 79 
 X1 R1 X2 R2 yield (%) 
7a O Ph CO2 H 91 
7b O Ph S H 98 
7c O Ph NMe H 96 
7d S Ph O H 67 
7e S H O OMe 66 
 X1 R1 X2 R2 X3 yield (%) 
8a O Ph CO2 H NMe 79 
8b O Ph CO2 H O 75 
8c O Ph CO2 H S 55 
8d O Ph S H CO2 89 
8e S H O OMe CO2 81 
 X1 R1 X2 R2 X3 yield (%) 
9a O Ph CO2 H NMe 91 
9b O Ph CO2 H O 70 
9c O Ph CO2 H S 96 
9d O Ph S H CO2 63 
9e S H O OMe CO2 71 
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Conditions: aAll Sonogashira reactions were carried out on a 0.25-5.0 mmol scale and the iodocyclization 
reactions were carried out on a 0.10-0.25 mmol scale using I2 or ICl (see the Experimental Section). bThis 
compound was prepared from 4c by desilylation. 
 
Various 5- and 6-membered ring heterocycles linked through different positions have 
been conveniently synthesized by this general strategy. We believe that this basic 
methodology can be extended to all other functional groups and substituents that have 
previously been shown to undergo facile iodocyclization.1-27 An interesting feature of this 
approach is the fact that after starting the reaction sequence using an o-haloarene, only one 
other type of building block, namely a readily available functionalized terminal alkyne 5, is 
required for polyheterocycle generation and different heterocyclic units can be successfully 
inserted at the desired positions in the PHC by simply changing the sequence of 
functionalized alkyne building blocks. The iterative nature of this approach to linked PHCs 
lends itself well to the automated synthesis of large heterocyclic sequences of varying 
complexity. The solubility issues in larger heterocyclic systems should be resolved by 
adjusting the polarity of the individual alkyne building blocks.  
After successful implementation of this general strategy for the efficient synthesis of 
PHCs, several variations in the approach have been explored that further highlight the 
versatility and scope of this methodology. First, iodocyclization can be carried out quite 
selectively affording a variety of intermediates, which should prove quite versatile for further 
elaboration (Scheme 3). For example, 2-silyl-3-alkynylbenzothiophene derivative 6f can be 
converted to the benzothiophene-isocoumarin di-heterocycle 11 in one step in excellent yield 
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or 6f can be very efficiently cyclized to the corresponding silicon-containing 
iodoisocoumarin 10, allowing for further selective functionalization and/or iodocyclization.  
 
SCHEME 3. Simultaneous and Stepwise Diiodination 
 
 
As noted earlier, a variety of heterocyclic units are readily accessible by this 
iodocyclization strategy. This approach can be combined with other efficient transformations 
to broaden the scope of the methodology and allow easy access to heterocycles that are not 
presently accessible by iodocyclization. For example, alkyne 12 has been subjected to well 
known click chemistry using benzyl azide and the desired triazole 13 was obtained in good 
yield (Scheme 4).32 Upon iodo-desilylation, the iodotriazole 14 was obtained, providing 
avenues for the further introduction of heterocycles using our Sonogashira 
coupling/iodocyclization methodology or other coupling reactions, such as Suzuki-Miyaura 
couplings.33  
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SCHEME 4. Click Chemistry Followed by Iodo-desilylation 
 
In an effort to synthesize fused polyheterocyclic compounds, the benzothiophene 
derivative 4c was subjected to silyl-iodine exchange (Scheme 5). The resulting 2,3-
diiodobenzothiophene (15) on double Sonogashira coupling with an appropriate o-
functionalized terminal alkyne, followed by double cyclization, quickly leads to a compound 
17, having three linked heterocyclic units and two iodine handles. 
 
SCHEME 5. Double Sonogashira Coupling, Followed by Double Iodocyclization 
 
The diiodo compound 17 was then subjected to a palladium-catalyzed Ullmann 
reaction leading to the formation of fused heterocycle 18 (Scheme 6).34 Similar fused 
heterocyclic systems have been shown to exhibit interesting electronic and luminescent 
properties.35 This approach can be conveniently extended to the synthesis of symmetrical 
fused heterocycles as well. PHCs such as these should prove useful as ligands in coordination 
and organometallic chemistry.  
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SCHEME 6. Palladium-catalyzed Ullmann Reaction 
 
The above variations in our basic strategy (Schemes 4 and 6) highlight the ability to 
couple our methodology with other efficient methodologies to synthesize molecules with 
diverse functionalities quickly and efficiently. In another variation, the cyclization of 1,3-
diynes has been explored. Efficient examples of homo 1,3-diyne cyclization have been 
reported (Scheme 7) previously by us and others.2b,3h,7a,13,36 
SCHEME 7. Previously Reported Examples of 1,3-Diyne Cyclization 
 
In an effort to cover other functional groups and heteroatom-containing diynes, 
several additional 1,3-diynes have been synthesized using our optimized Sonogashira 
conditions (Scheme 8). The hetero-1,3-diynes were obtained in only moderate yields as the 
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cross-coupling suffers from formation of homocoupling by-products. Nonetheless, the homo- 
and hetero-1,3-diynes were subjected to iodocyclization and the double cyclized products 30-
32 were obtained in good to excellent yields (Scheme 9). Furthermore, in the case of hetero-
1,3-diyne 27, the reaction conditions were tuned to achieve single or double cyclization 
(Scheme 10). Thus, symmetrical, as well as unsymmetrical, bisheterocyclic units with 
dihalide functionality are readily accessible using our methodology. Recently, similar dihalo 
compounds have been used as precursors for the synthesis of more complex fused 
heterocycles exhibiting potential applications as organic field effect transistors (OFETs).37 
 
SCHEME 8. Preparation of 1,3-Diynes 
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SCHEME 9. Iodocyclization of Homo- and Hetero-1,3-diynes 
 
 
SCHEME 10. Tuning of Reaction Conditions for Single or Double Cyclization 
 
 
As observed in all of the processes outlined above, the end products contain iodine, 
an important handle for further modifications. Thus, these heterocyclic iodides can either be 
subjected to reductive hydrodehalogenation,38 or they can be used to introduce further 
diversity and polarity into the molecules using conventional palladium-catalyzed 
transformations (Scheme 11), for example Suzuki-Miyaura couplings (eqs 1 and 2) and 
Sonogashira alkynylation (eq 3). 
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SCHEME 11. Elaboration of the Iodine-containing Products 
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Finally, palladium-catalyzed annulations have been examined in order to extend the 
scope of this methodology for the generation of complex fused PHCs. For example, in an 
attempt to perform the cyclocarbonylation reaction, bisheterocyclic compound 7b was 
subjected to our previously published conditions (Scheme 12).39 However, neither of the two 
expected regioisomeric annulated products was formed presumably due to the ring strain. 
Instead, the reaction led to the corresponding carboxylic acid 38, whose structure was 
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confirmed by single crystal X-ray analysis, in 61% yield. Carboxylic acid formation probably 
happens because of nucleophilic attack by the pivalate anion on the initially formed 
acylpalladium intermediate, which leads to the corresponding anhydride, followed by 
hydrolysis during aqueous work up of the reaction mixture (Scheme 12).  
 
SCHEME 12. Cyclocarbonylation Attempt 
 
 
On the other hand, the alkyne annulation of polyheterocyclic compound 7b affords 
the fused ring heterocycle 39 in 52% yield (Scheme 13).40 The regioisomeric assignment is 
based on X-ray crystallographic data. Such annulation processes provide considerable scope 
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in terms of the types of heterocycles that can be included in different positions, the ring size, 
etc., allowing one to introduce a wide variety of heterocycles in desired positions. 
 
SCHEME 13. Alkyne Annulation Reaction Leading to a Fused PHC 
 
 
Conclusions 
Several iodocyclization/palladium-catalyzed approaches have been reported for the 
generation of linked and fused polyheterocyclic compounds. The ability to quickly put 
together multiple heterocyclic rings and accommodate various other subsequent 
transformations adds to the synthetic utility and scope of the methodology, making this a 
very practical approach for PHC synthesis. In some cases, the potential exists for 
combinatorial automated synthesis. Considering the broad scope and considerable flexibility 
of this methodology and the widespread potential applications of the resulting products, rapid 
advances in this area of research are anticipated.  
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Experimental Section 
General 
The 1H NMR and 13C NMR spectra were recorded at 25 °C at 300 MHz or 400 MHz 
and 75 MHz or 100 MHz, respectively, with Me4Si as an internal standard. The chemical 
shifts (δ) and coupling constants (J) are given in ppm and in Hz, respectively. Thin layer 
chromatography was performed using commercially prepared 60-mesh silica gel plates and 
visualization was effected with short wavelength UV light (254 nm). Purification of the 
compounds has been performed by column chromatography and/or recrystallization. All 
melting points are uncorrected. HRMS data: the electron impact ionization experiments were 
performed on a Finnigan TSQ700 triple quadrupole mass spectrometer (Finnigan MAT, San 
Jose, CA) fitted with a Finnigan EI/CI ion source. The samples were introduced to the mass 
spectrometer using a solids probe. The probe was heated gradually from 100 to 400 oC. The 
instrument was used as a single quadrupole and scanned from 50 to 1000 daltons. Accurate 
mass measurements were conducted using a manual peak matching technique with the 
KRATOS MS50 double focusing mass spectrometer.  
Reagents. All reagents were used directly as obtained commercially unless otherwise noted.  
Solvents. All solvents were used directly as obtained commercially except for DCM that was 
distilled over CaH2. 
Terminal alkyne building blocks (5). Commercially available terminal alkynes were used 
as received. Non-commercial terminal alkynes were prepared using the two-step approach, 
which involves Sonogashira coupling of the commercially available haloarene with 
trimethylsilyl acetylene, followed by removal of the TMS group (Scheme S1).1a 
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Scheme S1. Preparation of the Requisite Terminal Alkynes 
 
 
[(2,4-Dimethoxyphenyl)ethynyl]trimethylsilane. To a solution of 1-iodo-2,4-
dimethoxybenzene (5.0 mmol), PdCl2(PPh3)2 (0.07 g, 2 mol %), and CuI (0.02 g, 2 mol %) in 
TEA (20 mL) (stirring for 5 min beforehand), 6.0 mmol of trimethylsilyl acetylene (1.2 
equiv) in 5 mL of TEA was added dropwise over 10 min. The reaction flask was flushed with 
Ar and the mixture was stirred at room temperature for 1.5 h. The resulting solution was 
filtered, washed with brine, and extracted with ethyl acetate (2 x 10 mL). The combined 
fractions were dried over MgSO4 and concentrated under vacuum to yield the crude product. 
Purification by flash chromatography afforded the product (yield = 93%) as a brown solid: 
mp 45-47 oC; 1H NMR (400 MHz, CDCl3) δ 0.25 (s, 9H), 3.72 (s, 3H), 3.78 (s, 3H), 6.34 (s, 
1H), 6.36 (d, J = 8.0 Hz, 1H), 7.32 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 0.16, 
55.2, 55.6, 96.3, 98.1, 101.6, 104.6, 104.7, 134.8, 161.2, 161.4; HRMS Calcd for 
C13H18O2Si: 234.10760. Found: 234.10815. 
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1-Ethynyl-2,4-dimethoxybenzene. A solution of NaOH (24.0 mmol, 6 equiv) in 5 mL of 
water was added dropwise to [(2,4-dimethoxyphenyl)ethynyl]trimethylsilane (4.0 mmol) in 
15 mL of CH3OH:diethyl ether (1:1). After stirring the reaction mixture for 2 h at 25 oC, 
CH3OH was removed under vacuum, the reaction mixture was diluted with ether and the 
excess NaOH was neutralized with 2M HCl. The ether layer was washed with water, dried 
(Na2SO4), filtered, and the solvent removed under vacuum. Purification by flash 
chromatography afforded the product (yield = 92%) as a clear oil:41 1H NMR (400 MHz, 
CDCl3) δ 3.25 (s, 1H), 3.78 (s, 3H), 3.84 (s, 3H), 6.41 (s, 1H), 6.42 (d, J = 8.4 Hz, 1H), 7.36 
(d, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.4, 55.8, 79.7, 80.2, 98.2, 103.6, 104.8, 
134.8, 161.5, 161.8; HRMS Calcd for C10H10O2: 162.06808. Found: 162.06848. 
 
Synthesis of Compounds 3-9 by the General Strategy. 
 
General Sonogashira Coupling Procedure Used for the Preparation of 3a-c.  To a 
solution of o-iodoarene 1 (5.0 mmol), PdCl2(PPh3)2 (0.07 g, 2 mol %), and CuI (0.01 g, 1 mol 
%) in TEA (20 mL) (stirring for 5 min beforehand), 6.0 mmol of terminal acetylene 2 (1.2 
equiv) in 5 mL of TEA was added dropwise over 10 min. The reaction flask was flushed with 
Ar and the mixture was stirred at room temperature for 3 h. The resulting solution was 
filtered, washed with brine, and extracted with EtOAc (2 x 10 mL). The combined fractions 
were dried over MgSO4 and concentrated under vacuum to yield the crude product. 
Purification of the products was performed using flash chromatography. 
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2-(Phenylethynyl)anisole (3a). This compound was isolated (reaction time: 2 h; yield: 72%) 
as a yellow oil. The spectral properties were identical to those previously reported.2b 
 
 
2-(Phenylethynyl)thioanisole (3b). This compound was isolated (yield: 100%) as a yellow 
oil. The spectral properties were identical to those previously reported.42 
 
 
2-(Trimethylsilylethynyl)thioanisole (3c). This compound was isolated (yield: 97%) as a 
yellow oil. The spectral properties were identical to those previously reported.4b 
 
General Iodocyclization Procedure for the Synthesis of 4a-c. The iodocyclization 
reactions have been performed using our previously published procedures for the 
corresponding heterocycles.2b,4b To a solution of the starting alkyne 3 (4.0 mmol) in DCM 
(30 mL) was gradually added the I2 (1.5-2.0 equiv) dissolved in 10 mL of DCM. The reaction 
mixture was allowed to stir at 25 °C and the reaction was monitored by TLC for completion. 
The excess I2 was removed by washing with satd aq Na2S2O3. The mixture was then 
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extracted by EtOAc or diethyl ether. The combined organic layers were dried over anhydrous 
MgSO4 and concentrated under vacuum to yield the crude product, which was purified by 
flash chromatography on silica gel using hexane-EtOAc as the eluent. 
 
 
3-Iodo-2-phenylbenzo[b]furan (4a). This reaction was performed using 2.0 equiv of iodine. 
This compound was obtained as a yellow oil (reaction time: 3 h; yield: 81%). The spectral 
properties were identical to those previously reported.2b 
 
 
3-Iodo-2-phenylbenzo[b]thiophene (4b). This reaction was performed using 1.5 equiv of 
iodine. This compound was obtained as a yellow oil (reaction time: 1 h; yield: 99%). The 
spectral properties were identical to those previously reported.39a 
 
 
3-Iodo-2-(trimethylsilyl)benzo[b]thiophene (4c). This reaction was performed using 1.5 
equiv of iodine. This compound was isolated as a yellow oil (reaction time: 0.5 h; yield: 
99%). The spectral properties were identical to those previously reported.4b 
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3-Iodobenzo[b]thiophene (4d). To a solution of 4c (4 mmol) in THF (13 mL) was slowly 
added TBAF (3.0 equiv, 1M solution in THF, 13 mL) and the reaction mixture was allowed 
to stir at 25 oC for 3 h. The reaction was worked up using satd aq NaHCO3, washed with 
brine and water, extracted with ether, and dried with Na2SO4. After purification by flash 
chromatography, the compound was isolated as a yellow liquid (yield: 95%). The spectral 
properties were identical to those previously reported.43 
 
Preparation of 6a-f by Sonogashira Coupling. 
 
 
Methyl 2-[(2-phenylbenzofuran-3-yl)ethynyl]benzoate (6a). A solution of 4a (0.47 g, 1.48 
mmol), PdCl2(PPh3)2 (0.042 g, 4 mol %), and CuI (0.012 g, 4 mol %) in TEA (15 mL) was 
stirred for 5 min. The reaction flask was flushed with Ar and a solution of methyl 2-
ethynylbenzoate (0.36 g, 2.22 mmol, 1.5 equiv) in 5 mL of TEA was added dropwise over 10 
min. The reaction mixture was stirred at 60 oC for 21 h. The resulting solution was filtered, 
washed with brine, and extracted with EtOAc (2 x 10 mL). The combined fractions were 
dried over MgSO4 and concentrated under vacuum to yield the crude product. After 
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purification by flash chromatography, the product (yield = 98%) was obtained as an orange 
solid: mp 73-76 oC;  1H NMR (400 MHz, CDCl3) δ 3.88 (s, 3H), 7.28-7.49 (m, 8H), 7.66 (d, 
J = 8.0 Hz, 1H), 7.84-7.86 (m, 1H), 7.94-7.96 (m, 1H), 8.40-8.42 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 52.2, 86.5, 96.1, 99.4, 111.2, 120.6, 123.5, 123.9, 125.4, 126.2, 127.9, 128.7, 
129.3, 130.0, 130.2, 130.6, 131.2, 131.8, 134.1, 153.5, 156.6, 166.3; HRMS Calcd for 
C24H16O3: 352.10994. Found: 352.11081. 
 
 
3-[(2-(Methylthio)phenyl)ethynyl]-2-phenylbenzofuran (6b). To a solution of 4a (1.0 
mmol) in DMF (8 mL) were added PdCl2(PPh3)2 (21.0 mg, 3 mol %) and CuI (8.0 mg, 4 mol 
%). The reaction vial was flushed with Ar and the reaction mixture was stirred for 5 min at 
room temperature. DIPA (405 mg, 4.0 equiv) was added by syringe. The reaction mixture 
was then heated to 80 °C. A solution of 2-ethynylthioanisole (1.2 equiv) in DMF (2 mL) was 
added dropwise over 10 min, and the mixture was allowed to stir at 80 oC for 3.5 h. After 
cooling, the reaction mixture was diluted with EtOAc, and washed with satd aq NH4Cl and 
water. The organic layer was dried over MgSO4 and concentrated under vacuum to give the 
crude product, which was purified by column chromatography on silica gel using hexane-
EtOAc as eluent. After purification, the product was obtained (yield: 84%) as a white solid: 
mp 110-112 oC; 1H NMR (400 MHz, CDCl3) δ 2.53 (s, 3H), 7.14 (td, J = 1.2, 7.6 Hz, 1H), 
7.19-7.21 (m, 1H), 7.29-7.41 (m, 4H), 7.47-7.52 (m, 3H), 7.56-7.58 (m, 1H), 7.84-7.86 (m, 
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1H), 8.41-8.44 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 15.5, 87.7, 94.7, 99.4, 111.3, 120.8, 
121.7, 123.6, 124.5, 124.6, 125.5, 126.3, 128.8, 129.0, 129.3, 130.17, 130.22, 132.6, 141.5, 
153.6, 156.4; HRMS Calcd for C23H16OS: 340.09218. Found: 340.09304. 
 
 
N,N-Dimethyl-2-[(2-phenylbenzofuran-3-yl)ethynyl]aniline (6c). Starting with the iodo 
compound 4a and the corresponding terminal alkyne, the reaction was run by using the 
procedure used for the preparation of 6b above, except that the reaction was run on a 0.5 
mmol scale and the reaction time was 2 h. After purification, the product was obtained (yield 
= 81%) as a yellow solid: mp 66-69 oC; 1H NMR (400 MHz, CDCl3) δ 3.00 (s, 3H), 6.91-
6.96 (m, 2H), 7.24-7.30 (m, 3H), 7.31-7.37 (m, 1H), 7.43-7.50 (m, 3H), 7.56-7.58 (m, 1H), 
7.74-7.76 (m, 1H), 8.41 (d, J = 7.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 44.1, 86.4, 96.5, 
99.9, 111.3, 115.9, 117.4, 120.5, 120.9, 123.5, 125.4, 126.1, 128.7, 129.2, 129.6, 130.2, 
130.4, 134.3, 153.6, 154.9, 155.9; HRMS Calcd for C24H19NO: 337.14666. Found: 
337.14717. 
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3-[(2-Methoxyphenyl)ethynyl]-2-phenylbenzo[b]thiophene (6d). Starting with the iodo 
compound 4b and the corresponding terminal alkyne, the reaction was run by using the 
procedure used for the preparation of 6b, except that the reaction was run on a 0.5 mmol 
scale. The product was obtained (yield = 65%) as a white solid: mp 90-92 oC; 1H NMR (400 
MHz, CDCl3) δ 3.96 (s, 3H), 6.92-6.98 (m, 2H), 7.31-7.41 (m, 3H), 7.45-7.50 (m, 3H), 7.54 
(dd, J = 7.6, 2.0 Hz, 1H), 7.81 (d, J = 8.0, 1H), 8.11 (d, J = 8.0, 1H), 8.19 (d, J = 7.6 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 56.0, 88.4, 91.9, 110.9, 112.9, 114.1, 120.7, 122.2, 123.7, 
125.1, 125.4, 128.6, 128.76, 128.82, 130.0, 133.4, 134.1, 137.6, 141.5, 145.7, 160.4; HRMS 
Calcd for C23H16OS: 340.09219. Found: 340.09269. 
 
S
H
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3-[(2,4-Dimethoxyphenyl)ethynyl]benzo[b]thiophene (6e). Starting with the iodo 
compound 4d and the corresponding terminal alkyne, the reaction was run by using the 
procedure used for the preparation of 6b. The product was obtained (yield = 95%) as a 
yellow gel: 1H NMR (400 MHz, CDCl3) δ 3.85 (s, 3H), 3.95 (s, 3H), 6.52 (s, 1H), 6.54 (d, J 
= 1.6 Hz, 1H), 7.42 (t, J = 7.2 Hz, 1H), 7.47-7.53 (m, 2H), 7.68 (s, 1H), 7.88 (d, J = 8.0 Hz, 
1H), 8.13 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.6, 56.0, 85.8, 88.5, 98.6, 
105.01, 105.04, 119.1, 122.7, 123.4, 124.7, 125.1, 128.8, 134.4, 138.9, 139.5, 161.40, 
161.44; HRMS Calcd for C18H14O2S: 294.07145. Found: 294.07216. 
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Methyl 2-[(2-(trimethylsilyl)benzo[b]thiophen-3-yl)ethynyl]benzoate (6f). Starting with 
the iodo compound 4c and the corresponding terminal alkyne, the reaction was run by using 
the procedure used for the preparation of 6b. The product was obtained (yield = 79%) as a 
yellow oil: 1H NMR (400 MHz, CDCl3) δ 0.59 (s, 9H), 4.02 (s, 3H), 7.42 (t, J = 7.6 Hz, 2H), 
7.51-7.57 (m, 2H), 7.75 (d, J = 7.6 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 8.05 (d, J = 8.0 Hz, 
1H), 8.36 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ -0.36, 52.4, 90.2, 92.4, 122.1, 
123.4, 124.1, 124.81, 124.83, 125.0, 127.9, 130.7, 131.6, 131.9, 133.8, 141.8, 142.1, 146.4, 
166.6;  HRMS Calcd for C21H20O2SSi: 364.09532. Found: 364.09634. 
 
General Iodocyclization Procedure for the Synthesis of 7a-e. The iodocyclization 
reactions have been performed using our previously published procedures for the 
corresponding heterocycles.2b,4b,10d,13 The appropriate alkyne starting material 6 (0.25-0.30 
mmol) in 4 mL of CH2Cl2 was placed in a 4-dram vial and flushed with Ar. I2 (2 equiv) [ICl 
(1.2 equiv) in the case of 7a] in 2 mL CH2Cl2 was added and the reaction was stirred at room 
temperature for the indicated time. After the reaction was over, the reaction mixture was 
diluted with 30 mL of EtOAc, washed with 25 mL of satd aq Na2S2O3, dried (MgSO4), and 
filtered. The solvent was evaporated under reduced pressure and the product was isolated by 
chromatography on a silica gel column. 
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4-Iodo-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin (7a). For this reaction, the ICl (1.2 
equiv) in 1 mL of CH2Cl2 was added dropwise to the reaction vial with a syringe (reaction 
time: 30 min). After purification, the product was obtained (yield = 91%) as a white solid: 
mp 204-207 oC; 1H NMR (400 MHz, CDCl3) δ 7.30 (t, J = 8.0 Hz, 1H), 7.36-7.41 (m, 4H), 
7.51 (d, J = 8.0 Hz, 1H), 7.60 (d, J = 8.0 Hz, 1H), 7.64-7.68 (m, 1H), 7.76-7.78 (m, 2H), 
7.85-7.86 (m, 2H), 8.37 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 81.6, 111.7, 
112.4, 120.6, 120.9, 123.7, 125.5, 126.75, 126.81, 128.1, 129.2, 129.8, 130.0, 130.2, 131.5, 
136.0, 138.0, 149.6, 153.8, 154.4, 161.9; HRMS Calcd for C23H13IO3: 463.99094. Found: 
463.99233. 
 
O
Ph
S
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3-(3-Iodobenzo[b]thiophen-2-yl)-2-phenylbenzofuran (7b). Reaction time: 30 min. After 
purification, the product was obtained (yield = 98%) as a white solid: mp 158-161 oC; 1H 
NMR (400 MHz, CDCl3) δ 7.24-7.52 (m, 8H), 7.60 (d, J = 8.4 Hz, 1H), 7.68-7.70 (m, 2H), 
7.85 (d, J = 8.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 84.5, 110.7, 111.5, 120.7, 122.7, 
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123.5, 125.3, 125.6, 125.9, 126.3, 126.9, 128.9, 129.2, 129.9, 130.2, 134.6, 140.3, 141.7, 
153.2, 153.9; HRMS Calcd for C22H13IOS: 451.97318. Found: 451.97428. 
 
 
3-Iodo-1-methyl-2-(2-phenylbenzofuran-3-yl)-1H-indole (7c). Reaction time: 1 h. After 
purification, the product was obtained (yield = 96%) as a white solid: mp 201-204 oC (turns 
black); 1H NMR (400 MHz, CDCl3) δ 3.52 (s, 3H), 7.23-7.39 (m, 9H), 7.57-7.64 (m, 4H); 
13C NMR (100 MHz, CDCl3) δ 31.6, 61.4, 107.6, 110.2, 111.6, 120.9, 121.0, 121.6, 123.2, 
123.6, 125.3, 126.2, 129.1, 129.3, 129.8, 130.2, 130.9, 134.0, 138.1, 153.9, 154.1; HRMS 
Calcd for C23H16INO: 449.02767. Found: 449.02867. 
 
S
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3-Iodo-2-(2-phenylbenzo[b]thiophen-3-yl)benzofuran (7d). Reaction time: 3 h. After 
purification, the product was obtained (yield = 67%) as a brown solid: mp 134-137 oC; 1H 
NMR (300 MHz, CDCl3) δ 7.23-7.45 (m, 10H), 7.49-7.51 (m, 1H), 7.63-7.66 (m, 1H), 7.87-
7.90 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 68.1, 111.7, 121.0, 121.8, 122.4, 123.7, 123.9, 
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125.1, 125.2, 125.8, 126.86, 128.97, 129.1, 131.6, 134.0, 138.6, 140.1, 146.7, 151.9, 154.9; 
HRMS Calcd for C22H13IOS: 451.97319. Found: 451.97380. 
 
 
2-(Benzo[b]thiophen-3-yl)-3-iodo-5-methoxybenzofuran (7e). Reaction time: 3 h. After 
purification, the product was obtained (yield = 66%) as a yellow solid: mp 63-66 oC; 1H 
NMR (400 MHz, CDCl3) δ 3.90 (s, 3H), 7.02 (dd, J = 2.0, 8.4 Hz, 1H), 7.12 (d, J = 2.0, 1H), 
7.36 (d, J = 8.4, 1H), 7.46-7.53 (m, 2H), 7.95 (d, J = 8.0, 1H), 8.25 (s, 1H), 8.42 (d, J = 8.4 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.9, 63.3, 95.7, 112.9, 121.9, 122.7, 124.6, 124.86, 
124.96, 125.1, 125.8, 128.2, 137.3, 139.8, 150.4, 154.7, 159.1; HRMS Calcd for C17H11IO2S: 
405.95245. Found: 405.95354. 
 
General Sonogashira Coupling Procedure for the Preparation of 8a-e. To a solution of 
the appropriate iodo starting material 7 (0.2 mmol) in DMF (3 mL) were added PdCl2(PPh3)2 
(3 mol %) and CuI (4 mol %). The reaction vial was flushed with Ar and the reaction mixture 
was stirred for 5 min at room temperature. DIPA (4.0 equiv) was added by a syringe. The 
reaction mixture was then heated to 80 °C. A solution of the corresponding terminal alkyne 
(1.2 equiv) in DMF (1 mL) was added dropwise over 5 min, and the mixture was allowed to 
stir at 80 oC for 2-4 h (the reaction progress was monitored by TLC). After cooling, the 
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reaction mixture was diluted with EtOAc, and washed with satd aq NH4Cl and water. The 
organic layer was dried over MgSO4 and concentrated under vacuum to give the crude 
product, which was purified by column chromatography on silica gel using hexane-EtOAc as 
the eluent. 
 
 
4-[(2-(Dimethylamino)phenyl)ethynyl]-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin 
(8a). After purification, the product was obtained (yield = 79%) as a yellow solid: 1H NMR 
(400 MHz, CDCl3) δ 2.61 (s, 3H), 6.72 (td, J = 0.8, 7.6 Hz, 1H), 6.79 (d, J = 8.4 Hz, 1H), 
6.84-6.86 (m, 1H), 7.16 (td, J = 2.0, 7.6 Hz, 1H), 7.27-7.29 (m, 1H), 7.34-7.38 (m, 4H), 7.58 
(d, J = 8.0 Hz, 1H), 7.64 (td, J = 1.2, 7.6 Hz, 1H), 7.75 (dd, J = 0.8, 7.6 Hz, 1H), 7.82-7.89 
(m, 3H), 8.15 (d, J = 7.6 Hz, 1H), 8.41 (dd, J = 0.8, 7.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 43.5, 86.4, 98.4, 104.7, 109.8, 111.4, 114.7, 117.1, 120.3, 120.5, 121.4, 123.7, 
125.3, 125.7, 127.3, 128.4, 128.8, 129.2, 129.69, 129.72, 129.9, 130.2, 134.2, 135.4, 137.0, 
151.3, 153.9, 154.8, 155.1, 161.6; HRMS Calcd for C33H23NO3: 481.16779. Found: 
481.16886. 
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4-[(2-Methoxyphenyl)ethynyl]-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin (8b). After 
purification, the product was obtained (yield = 75%) as a yellow solid: mp 159-161 oC; 1H 
NMR (400 MHz, CDCl3) δ 3.74 (s, 3H), 6.74-6.78 (m, 3H), 7.18-7.21 (m, 1H), 7.27-7.38 (m, 
5H), 7.57-7.63 (m, 2H), 7.78 (d, J = 7.6 Hz, 1H), 7.82-7.87 (m, 3H), 8.21 (d, J = 8.0 Hz, 1H), 
8.40 (d, J = 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.8, 85.6, 95.9, 104.3, 109.7, 
110.5, 111.3, 111.8, 120.2, 120.3, 121.6, 123.5, 125.2, 125.9, 127.4, 128.4, 128.8, 129.2, 
129.6, 129.8, 130.2, 130.3, 132.9, 135.4, 137.0, 151.5, 153.9, 155.2, 160.0, 161.6; HRMS 
Calcd for C32H20O4: 468.13616. Found: 468.13682. 
 
 
4-[(2-(Methylthio)phenyl)ethynyl]-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin (8c).  
After purification, the product was obtained (yield = 55%) as a yellow solid: 1H NMR (400 
MHz, CDCl3) δ 2.38 (s, 3H), 6.66 (d, J = 7.2 Hz, 1H), 6.91 (t, J = 7.2 Hz, 1H), 7.07 (d, J = 
8.0 Hz, 1H), 7.21 (t, J = 8.0 Hz, 1H), 7.30-7.39 (m, 5H), 7.59 (d, J = 8.0 Hz, 1H), 7.66 (t, J = 
7.6 Hz, 1H),  7.76 (d, J = 7.6 Hz, 1H), 7.83-7.85 (m, 2H), 7.91 (t, J = 7.6 Hz, 1H), 8.30 (d, J 
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= 8.0 Hz, 1H), 8.41 (d, J = 7.6 Hz, 1H); HRMS Calcd for C32H20O3S: 484.11332. Found: 
484.11396. 
 
 
Methyl 2-[(2-(2-phenylbenzofuran-3-yl)benzo[b]thiophen-3-yl)ethynyl]benzoate (8d). 
After purification, the product was obtained (yield = 89%) as a yellow semisolid: 1H NMR 
(400 MHz, CDCl3) δ 3.78 (s, 3H), 6.89-6.91 (m, 1H), 7.24-7.38 (m, 7H), 7.46 (t, J = 7.2 Hz, 
1H), 7.53-7.60 (m, 2H), 7.74 (d, J = 7.6 Hz, 1H), 7.80 (d, J = 6.4 Hz, 2H), 7.85-7.87 (m, 2H), 
8.28 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 52.2, 88.3, 94.8, 109.8, 111.3, 
118.2, 121.2, 122.5, 123.4, 123.6, 123.9, 125.2, 125.3, 125.6, 127.5, 127.9, 128.6, 129.2, 
129.9, 130..37, 130.43, 131.4, 131.6, 134.3, 137.9, 139.2, 140.5, 153.2, 154.2, 166.7; HRMS 
Calcd for C32H20O3S: 484.11331. Found: 484.11445. 
 
 
Methyl 2-[(2-(benzo[b]thiophen-3-yl)-5-methoxybenzofuran-3-yl)ethynyl]benzoate (8e). 
After purification, the product was obtained (yield = 81%) as a yellow solid: mp 173-175 oC; 
1H NMR (400 MHz, CDCl3) δ 3.91 (s, 3H), 3.94 (s, 3H), 7.01 (dd, J = 2.0, 8.4 Hz, 1H), 7.14 
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(d, J = 2.0, 1H), 7.39-7.43 (m, 2H), 7.51-7.53 (m, 2H), 7.69-7.74 (m, 2H), 7.92 (d, J = 8.0, 
1H), 8.00-8.03 (m, 1H), 8.69 (d, J = 8.0, 1H), 8.84 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
52.5, 56.0, 86.9, 95.8, 96.1, 99.9, 112.9, 120.7, 122.7, 122.8, 124.1, 124.95, 124.98, 125.0, 
126.2, 127.8, 128.1, 130.7, 131.4, 132.0, 134.4, 136.8, 140.2, 154.3, 154.5, 158.9, 166.6; 
HRMS Calcd for C27H18O4S: 438.09257. Found: 438.09418. 
 
General Iodocyclization Procedure for the Synthesis of 9a-e. The appropriate alkyne 
starting material 8 (0.10 mmol) in 1.5 mL of CH2Cl2 was placed in a 2-dram vial and flushed 
with Ar. I2 (2 equiv) [ICl (1.2 equiv) in the case of 9d and 9e] in 0.5 mL of CH2Cl2 was 
added and the reaction was stirred at room temperature for the indicated time. After the 
reaction was over, the reaction mixture was diluted with 15 mL of EtOAc, washed with 10 
mL of satd aq Na2S2O3, dried (MgSO4), and filtered. The solvent was evaporated under 
reduced pressure and the product was isolated by chromatography on a silica gel column 
and/or recrystallization. 
 
 
4-(3-Iodo-1-methyl-1H-indol-2-yl)-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin (9a). 
Reaction time: 1 h. The product was obtained (yield = 91%) as a brown solid: mp 241-243 oC 
(turns black); 1H NMR (400 MHz, CDCl3) δ 3.01 (s, 3H), 6.87 (d, J = 7.2 Hz, 1H), 7.02 (d, J 
= 8.0 Hz, 1H), 7.13 (t, J = 7.2 Hz, 1H), 7.18-7.33 (m, 7H), 7.38-7.43 (m, 3H), 7.59-7.66 (m, 
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2H), 7.72 (d, J = 7.6 Hz, 1H), 8.49 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 31.9, 
63.0, 109.9, 111.1, 111.4, 120.6, 120.8, 121.4, 121.7, 123.2, 123.4, 125.3, 125.4, 128.2, 
128.4, 128.8, 129.3, 129.7, 129.9, 130.2, 130.4, 133.4, 135.4, 137.4, 137.5, 150.6, 154.1, 
155.2, 162.0 (one signal missing due to overlap); HRMS Calcd for C32H20INO3: 593.04880. 
Found: 593.04960. 
 
 
4-(3-Iodobenzofuran-2-yl)-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin (9b). Reaction 
time: 24 h. This product could not be completely purified (yield: approx.70%): 1H NMR (400 
MHz, CDCl3) δ 7.11-7.28 (m, 6H), 7.30-7.39 (m, 2H), 7.45-7.47 (m, 2H), 7.52-7.65 (m, 5H), 
7.68-7.72 (m, 1H), 8.47 (d, J = 8.0 Hz, 1H); HRMS Calcd for C31H17IO4: 580.01716. Found: 
580.01799. 
 
 
4-(3-Iodobenzo[b]thiophen-2-yl)-3-(2-phenylbenzofuran-3-yl)-1H-isocoumarin (9c). 
Reaction time: 1 h. The product was obtained (yield = 96%) as a yellow solid: mp 210-213 
oC; 1H NMR (400 MHz, CDCl3) δ 7.14 (d, J = 8.0 Hz, 1H), 7.21 (t, J = 7.6 Hz, 1H), 7.24-
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7.29 (m, 1H), 7.32 (d, J = 7.6 Hz, 1H), 7.35-7.38 (m, 4H), 7.43 (d, J = 8.0 Hz, 1H), 7.57 (d, J 
= 8.0 Hz, 1H), 7.60-7.72 (m, 6H), 8.50 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
86.5, 109.3, 111.4, 114.9, 120.8, 121.0, 122.3, 123.4, 125.2, 125.4, 125.9, 126.0, 126.1, 
127.5, 128.9, 129.1, 129.3, 129.8, 129.9, 130.2, 134.2, 135.3, 136.7, 139.9, 140.8, 149.2, 
153.9, 154.9, 162.2; HRMS Calcd for C31H17IO3S: 595.99432. Found: 595.99538. 
 
 
4-Iodo-3-(2-(2-phenylbenzofuran-3-yl)benzo[b]thiophen-3-yl)-1H-isocoumarin (9d). For 
this reaction, the ICl (1.2 equiv) in 0.5 mL of CH2Cl2 was added dropwise to the vial by 
syringe (reaction time: 30 min). The product was obtained (yield = 63%) as a white solid: mp 
249 oC (became a brown gel that completely melted at 265 oC); 1H NMR (400 MHz, CDCl3) 
δ 7.19 (t, J = 7.6 Hz, 2H), 7.27-7.29 (m, 1H), 7.33 (t, J = 7.6 Hz, 1H), 7.43-7.61 (m, 8H), 
7.70 (t, J = 7.2 Hz, 2H), 7.80 (d, J = 7.6 Hz, 1H), 7.94 (d, J = 6.8 Hz, 1H), 8.10 (d, J = 8.0 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 80.9, 109.4, 111.4, 120.4, 120.9, 122.5, 123.6, 
123.7, 125.2, 125.3, 125.4, 127.7, 128.6, 129.46, 129.54, 129.7, 131.4, 135.5, 137.1, 137.7, 
138.7, 139.6, 150.4, 153.6, 154.3, 160.9 (three signals missing due to overlap); HRMS Calcd 
for C31H17IO3S: 595.99431. Found: 595.99628. 
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3-(2-(Benzo[b]thiophen-3-yl)-5-methoxybenzofuran-3-yl)-4-iodo-1H-isocoumarin (9e). 
For this reaction, the ICl (1.2 equiv) in 0.5 mL of CH2Cl2 was added dropwise to the vial by 
syringe (reaction time: 30 min). The product was obtained (yield = 71%) as a yellow solid: 
mp 148-151 oC; 1H NMR (400 MHz, CDCl3) δ 3.91 (s, 3H), 6.98 (d, J = 8.4 Hz, 1H), 7.18 (s, 
1H), 7.38-7.47 (m, 3H), 7.61 (t, J = 7.2 Hz, 1H), 7.70 (s, 1H), 7.76-7.83 (m, 2H), 7.87 (d, J = 
7.6 Hz, 1H), 8.31-8.33 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 56.0, 81.4, 96.2, 113.0, 
113.6, 120.6, 120.7, 121.0, 122.9, 124.1, 125.1, 125.2, 126.3, 127.7, 129.9, 130.1, 131.5, 
135.9, 136.9, 138.0, 140.2, 149.6, 150.8, 155.0, 158.9, 161.9; HRMS Calcd for C26H15IO4S: 
549.97359. Found: 549.97467. 
 
Simultaneous and Stepwise Diiodination: Synthesis of 10 and 11. 
 
4-Iodo-3-(2-(trimethylsilyl)benzo[b]thiophen-3-yl)-1H-isocoumarin (10). The alkyne 
starting material 6f (0.25 mmol) in 4 mL of CH2Cl2 was placed in a 4-dram vial and flushed 
with Ar. ICl (2.2 equiv) in 1 mL of CH2Cl2 was added slowly and the reaction was stirred at 
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room temperature for 3 h. After the reaction was over, the reaction mixture was diluted with 
25 mL of EtOAc, washed with 15 mL of satd aq Na2S2O3, dried (MgSO4), and filtered. The 
solvent was evaporated under reduced pressure and the product was isolated by 
chromatography on a silica gel column. The product was obtained (yield = 92%) as a white 
solid: mp 168-171 oC; 1H NMR (400 MHz, CDCl3) δ 0.33 (s, 9H), 7.36-3.38 (m, 2H), 7.56-
7.58 (m, 1H), 7.62-7.66 (m, 1H), 7.86 (d, J = 4.0 Hz, 2H), 7.90-7.92 (m, 1H), 8.36 (d, , J = 
7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ -0.07, 81.2, 120.6, 122.5, 122.9, 124.7, 124.9, 
129.8, 130.2, 131.2, 136.0, 137.8, 137.9, 139.1, 142.6, 144.9, 151.7, 161.7; HRMS Calcd for 
C20H17IO2SSi: 475.97633. Found: 475.97746. 
 
 
4-Iodo-3-(2-iodobenzo[b]thiophen-3-yl)-1H-isocoumarin (11). The trimethylsilyl-
containing starting material 10 (0.10 mmol, 48 mg) in 0.7 mL of CH2Cl2 was placed in a 2-
dram vial and flushed with Ar. The vial was cooled to -78 oC and ICl (0.11 mmol, 1.1 equiv, 
18 mg) in 0.3 mL of CH2Cl2 was added slowly and the reaction was stirred at -78 oC for 1 h. 
After the reaction was over, the reaction mixture was diluted with 15 mL of EtOAc, washed 
with 5 mL of satd aq Na2S2O3, dried (MgSO4), and filtered. The solvent was evaporated 
under reduced pressure and the product was isolated by chromatography on a silica gel 
column. The product was obtained (yield = 95%) as a white solid: mp 236-238 oC (turns 
black); 1H NMR (300 MHz, CDCl3) δ 7.32-7.39 (m, 2H), 7.53-7.56 (m, 1H), 7.65-7.70 (m, 
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1H), 7.80-7.85 (m, 1H), 7.88-7.89 (m, 2H), 8.37 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, 
CD2Cl2) δ 82.4, 87.2, 121.4, 122.3, 122.7, 125.8, 130.3, 130.6, 131.8, 136.4, 137.9, 138.0, 
138.6, 144.2, 150.8, 161.8 (one signal missing due to overlap); HRMS Calcd for C17H8I2O2S: 
529.83345. Found: 529.83470. 
Alternatively, diiodo compound 11 can be prepared from alkyne 6f using the 
following procedure. The alkyne starting material 6f (0.1 mmol, 36 mg) in 0.7 mL of CH2Cl2 
was placed in a 2-dram vial and flushed with Ar. ICl (2.2 equiv) in 0.3 mL of CH2Cl2 was 
added slowly and the reaction was stirred at room temperature for 3 h. Additional ICl (4 
equiv) in 0.5 mL CH2Cl2 was added slowly and the reaction was stirred at room temperature 
for 1 h. After the reaction was over, the reaction mixture was diluted with EtOAc, washed 
with satd aq Na2S2O3, dried (MgSO4), and filtered. The solvent was evaporated under 
reduced pressure and the product was isolated (yield = 91%) by chromatography on a silica 
gel column. The 1H and 13C NMR data matched that of 11 prepared from compound 10 
above. 
 
Click Chemistry, Followed by Iodo-desilylation: Synthesis of 12-14  
 
(Benzo[b]thiophen-3-ylethynyl)trimethylsilane (12). This reaction was run using 4d (1.0 g, 
3.85 mmol) as the starting material and following the Sonogashira coupling procedure used 
for the synthesis of 6b. The product was obtained (yield = 88%) as a yellow liquid: 1H NMR 
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(400 MHz, CDCl3) δ 0.50 (s, 9H), 7.47 (t, J = 7.6 Hz, 1H), 7.58 (t, J = 7.6 Hz, 1H), 7.77 (s, 
1H), 7.91 (d, J = 8.0Hz, 1H), 8.14 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 0.3, 
97.2, 98.7, 118.5, 122.6, 123.1, 124.8, 125.1, 130.8, 138.8, 139.3; HRMS Calcd for 
C13H14SSi: 230.05854. Found: 230.05905. 
 
 
5-(Benzo[b]thiophen-3-yl)-1-benzyl-4-trimethylsilyl-1H-1,2,3-triazole (13). A modified 
literature procedure was used.32b In a round bottom flask, compound 12 (270 mg, 1.17 mmol) 
was dissolved in 9 mL of reagent grade toluene. Benzyl azide (282 mg, 2.12 mmol, 1.81 
equiv) was added and the reaction mixture was refluxed for 24 h. The reaction mixture was 
concentrated in vacuo and the crude product was purified by column chromatography. The 
product was obtained (yield = 73%) as a yellow solid: mp 59-61 oC; 1H NMR (400 MHz, 
CD2Cl2) δ 0.05 (s, 9H), 5.20 (d, J = 14.8 Hz, 1H), 5.43 (d, J = 14.8 Hz, 1H), 6.90-6.92 (m, 
2H), 7.13-7.17 (m, 4H), 7.28-7.31 (m, 2H), 7.40 (t, J = 7.6, 1H), 7.94 (d, J = 8.0 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ -1.1, 51.9, 122.3, 122.7, 123.6, 124.8, 125.0, 127.7, 127.9, 128.4, 
128.5, 135.2, 136.9, 138.4, 139.3, 146.6; HRMS Calcd for C20H21N3SSi: 363.12254. Found: 
363.12326. 
An HMBC NMR experiment was carried out to confirm the regiochemistry of the 
product 13 (Figure S1). Observation: An HMBC correlation was observed from the TMS 
group (δ 0.05)  to C-4 [(δ 146.6); assignment based on literature data].  
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Figure S1. HMBC NMR Observation 
  
 
 
5-(Benzo[b]thiophen-3-yl)-1-benzyl-4-iodo-1H-1,2,3-triazole (14). The trimethylsilyl 
starting material 13 (60 mg, 0.17 mmol) in 1.0 mL of CH2Cl2 was placed in a 2-dram vial 
and the vial was cooled to -78 oC. ICl (110 mg, 0.68 mmol, 4 equiv) in 0.5 mL of CH2Cl2 
was added slowly and the reaction was stirred at -78 oC for 0.5 h and then at room 
temperature for 21 h. The reaction was periodically monitored by TLC. After 21 h, the 
reaction mixture was diluted with EtOAc, washed with satd aq Na2S2O3, dried (MgSO4), and 
filtered. The solvent was evaporated under reduced pressure and the product was isolated by 
chromatography on a long silica gel column. The product was obtained (yield: 39%) as a 
white solid: mp 114-116 oC; 1H NMR (400 MHz, CDCl3) δ 5.27 (d, J = 14.8 Hz, 1H), 5.59 
(d, J = 14.8 Hz, 1H), 6.90 (d, J = 8.0 Hz, 2H), 7.15-7.20 (m, 3H), 7.25-7.28 (m, 2H), 7.36 (t, 
J = 7.6 Hz, 1H), 7.44 (t, J = 7.6 Hz, 1H), 7.93 (d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 53.6, 92.2, 121.2, 122.7, 123.2, 125.2, 125.5, 127.8, 128.6, 128.9, 129.9, 134.7, 
135.7, 137.1, 139.8; HRMS Calcd for C17H12IN3S: 416.97967. Found: 416.98064. 
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Double Sonogashira Coupling, Followed by Double Iodocyclization: Synthesis of 15-17. 
 
2,3-Diiodobenzo[b]thiophene (15). This diidobenzothiophene was prepared from 4c using 
an iodination procedure from the literature.44 To a solution of 4c (0.315 g, 0.95 mmol) in 
CH2Cl2 (2 mL) was added ICl (0.170 g, 1.04 mmol) in CH2Cl2 (3 mL) at -78 oC. The reaction 
mixture was stirred at -78 oC for 1 h. Then the excess ICl was destroyed by adding satd aq 
Na2S2O3 (15 mL) and diluted with 50 ml of EtOAc. The organic layer was dried (MgSO4), 
filtered, and the solvent removed under reduced pressure. The crude compound was purified 
by column chromatography using 20:1 hexanes/ethyl acetate to afford 0.318 g (88%) of the 
desired compound 15 as a white solid: mp 58-61 oC; 1H NMR (400 MHz, CDCl3) δ 7.30-7.40 
(m, 2H), 7.67-7.73 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 89.5, 95.3, 121.6, 125.5, 125.9, 
126.8, 141.5, 143.9; HRMS Calcd for C8H4I2S: 385.81232. Found: 385.81336. 
 
 
2,3-Bis((2-methoxyphenyl)ethynyl)benzo[b]thiophene (16). To a solution of 15 (97 mg, 
0.25 mmol) in DMF (3 mL) were added PdCl2(PPh3)2 (11 mg, 6 mol %) and CuI (4 mg, 8 
mol %). The reaction vial was flushed with Ar and the reaction mixture was stirred for 5 min 
at room temperature. DIPA (202 mg, 8.0 equiv) was added by syringe. The reaction mixture 
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was then heated to 65 °C. A solution of 2-ethynylanisole (79 mg, 0.6 mmol, 2.4 equiv) in 
DMF (1 mL) was added dropwise over 10 min, and the mixture was allowed to stir at 65 oC 
for 1 h. After 1 h, another batch of 2-ethynylanisole (40 mg, 0.3 mmol, 1.2 equiv) in DMF (1 
mL) was added dropwise over 5 min, and the mixture was allowed to stir at 65 oC for 1 h. 
After cooling, the reaction mixture was diluted with EtOAc, and washed with satd aq NH4Cl, 
brine and water. The organic layer was dried over MgSO4 and concentrated under vacuum to 
give the crude product, which was purified by column chromatography on silica gel using 
hexane-EtOAc as the eluent. After purification, the product was obtained (yield = 65%) as a 
yellow solid: mp 103-105 oC;  1H NMR (400 MHz, CDCl3) δ 3.88 (s, 3H), 3.91 (s, 3H), 6.90-
6.98 (m, 4H), 7.33 (t, J = 7.6 Hz, 2H), 7.41-7.46 (m, 2H), 7.58-7.63 (m, 2H), 7.75 (d, J = 7.6 
Hz, 1H), 8.04 (d, J = 7.6 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 56.0, 56.1, 86.9, 87.2, 93.0, 
96.4, 111.01, 111.03, 112.2, 112.8, 120.67, 120.70, 122.2, 123.2, 123.8, 125.2, 126.2, 130.1, 
130.6, 133.9, 134.0, 138.7, 139.1, 160.29, 160.32 (one signal missing due to overlap); HRMS 
Calcd for C26H18O2S: 394.10274. Found: 394.10362. 
 
 
2,2'-(Benzo[b]thiophene-2,3-diyl)bis(3-iodobenzofuran) (17). The alkyne starting material 
16 (59 mg, 0.15 mmol) in 4 mL of CH2Cl2 was placed in a 4-dram vial. I2 (152 mg, 0.60 
mmol, 4 equiv) in 1 mL of CH2Cl2 was added and the reaction was stirred at room 
temperature for 2 h. After the reaction was over, the reaction mixture was diluted with 
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EtOAc, washed with satd aq Na2S2O3, dried (MgSO4), and filtered. The solvent was 
evaporated under reduced pressure and the product was isolated by chromatography on a 
silica gel column. The product was obtained (yield = 62%) as a yellow solid: mp 211-213 oC;  
1H NMR (400 MHz, CDCl3) δ 7.25-7.50 (m, 9H), 7.52-7.58 (m, 1H), 7.92 (t, J = 7.6 Hz, 
2H); 13C NMR (100 MHz, CDCl3) δ 68.0, 68.6, 111.5, 111.6, 122.0, 122.3, 122.4, 122.5, 
123.7, 123.9, 124.7, 125.5, 125.9, 126.3, 126.6, 131.9, 132.2, 138.8, 139.6, 149.6, 151.2, 
154.6, 154.9 (one signal missing due to overlap); HRMS Calcd for C24H12I2O2S: 617.86476. 
Found: 617.86583. 
 
Palladium-catalyzed Ullmann Reaction: Synthesis of 18.  
 
 
A modified literature procedure was used:34 A mixture of diiodo compound 17 (0.09 
mmol), Pd(OAc)2 (2 mg, 10 mol %), dppf (10 mg, 20 mol %), and KOAc (44 mg, 0.45 
mmol, 5 equiv) was stirred in DMF (0.7 mL) at 100 oC for 3 h. The reaction was monitored 
by TLC (the compound looks fluorescent blue under UV). The mixture was diluted with 
EtOAc, washed with aq NH4Cl, satd aq NaCl and water. The organic layer was dried over 
anhydrous MgSO4 and evaporated under vacuum. The residue was purified by flash column 
chromatography (hexane/ethyl acetate) to afford the product (yield = 64%) as a white solid: 
m.p. 258-261 oC (turns black); 1H NMR (400 MHz, CDCl3 + CD2Cl2) δ 7.57-7.63 (m, 5H), 
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7.67 (t, J = 7.6 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 8.02 (d, J = 8.0 
Hz, 1H), 8.54 (d, J = 7.2 Hz, 2H), 8.94 (d, J = 8.0 Hz, 1H); 13C NMR data could not be 
obtained because of the poor solubility of the product in common NMR solvents; HRMS 
Calcd for C24H12O2S: 364.05580. Found: 364.05669. 
 
Preparation of 1,3-Diynes: Preparation of 25-27. 
 
 
1-Iodoethynyl-2-methoxybenzene (25). A literature procedure was used.45 In a 6-dram vial, 
2-alkynylanisole (132 mg, 1.0 mmol) was dissolved in 2.5 mL of dry THF. The vial was then 
sealed, purged with Ar and cooled to -78 oC.  BuLi (0.5 mL of 2.5 M solution in hexanes, 1.2 
equiv) was added dropwise by syringe through the septum and the reaction mixture was 
stirred for 30 min at -78 oC. I2 (356 mg, 1.4 mmol, 1.4 equiv) dissolved in 1.5 mL of THF 
was added and the reaction mixture was stirred for 30 min at -78 oC and warmed to room 
temperature. The reaction was quenched with satd aq Na2S2O3 (20 mL), extracted with ether, 
washed with water, and dried (Na2SO4). The crude product was purified by column 
chromatography.  The product was obtained (yield = 100%) as a yellow oil: 1H NMR (300 
MHz, CDCl3) δ 3.79 (s, 3H), 6.79-6.87 (m, 2H), 7.23 (td, J = 1.5, 8.4 Hz, 1H), 7.36 (dd, J = 
1.5, 7.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 10.1, 55.7, 90.4, 110.5, 112.3, 120.3, 130.3, 
134.2, 160.8; HRMS Calcd for C9H7IO: 257.95417. Found: 257.95450. 
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2-[(2-Methoxyphenyl)buta-1,3-diynyl]thioanisole (26). In a 6-dram vial, iodo alkyne 25 
(65 mg, 0.25 mmol) was dissolved in DMF (2 mL) and 2-alkynylthioanisole (44 mg, 1.2 
equiv) in 1 mL of DMF was added. PdCl2(PPh3)2 (5 mg, 3 mol %) and CuI (2 mg, 4 mol %) 
were added, the reaction vial was flushed with Ar, and the reaction mixture was stirred for 5 
min at room temperature. DIPA (101 mg, 4.0 equiv) was added through a syringe and the 
reaction mixture was then heated at 70 °C for 1 h. After cooling, the reaction mixture was 
diluted with EtOAc, washed with satd aq NH4Cl, brine and water. The organic layer was 
dried over MgSO4 and concentrated under vacuum to give the crude product, which was 
purified by column chromatography on silica gel using hexane-EtOAc as the eluent. The 
product was obtained (yield = 60%) as a yellow solid: mp 79-81 oC; 1H NMR (300 MHz, 
CDCl3) δ 2.47 (s, 3H), 3.86 (s, 3H), 6.84-6.92 (m, 2H), 7.04-7.14 (m, 2H), 7.26-7.33 (m, 
2H), 7.44-7.48 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 15.2, 55.9, 77.5, 79.5, 80.2, 80.4, 
110.8, 110.9, 120.1, 120.6, 124.4, 129.6, 130.9, 133.5, 133.6, 134.4, 143.2, 161.4; HRMS 
Calcd for C18H14OS: 278.07654. Found: 278.07715. 
 
 
99 
 
 
 
Methyl 2-[(2-methoxyphenyl)buta-1,3-diynyl]benzoate (27). The reaction was run by 
using the procedure used for the preparation of 26 above. The product was obtained (yield = 
55%) as a white solid: mp 89-91 oC; 1H NMR (400 MHz, CDCl3) δ 3.86 (s, 3H), 3.94 (s, 
3H), 6.86-6.92 (m, 2H), 7.31 (t, J = 7.6 Hz, 1H), 7.38 (t, J = 7.6 Hz, 1H), 7.45-7.49 (m, 2H), 
7.63 (d, J = 7.6 Hz, 1H), 7.96 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 52.3, 55.8, 
77.9, 79.2, 80.0, 80.4, 110.7, 110.9, 120.5, 122.7, 128.6, 130.5, 130.9, 131.8, 132.4, 134.4, 
135.1, 161.4, 166.0; HRMS Calcd for C19H14O3: 290.09429. Found: 290.09488. 
 
 
1,4-Bis(2-methoxyphenyl)buta-1,3-diyne (28). This compound was isolated as a side 
product (32% with respect to the 2-ethynylanisole starting material) during the preparation of 
16. The product was obtained as a colorless solid: mp 135-137 oC; 1H NMR (400 MHz, 
CDCl3) δ 3.89 (s, 6H), 6.86-6.92 (m, 4H), 7.31 (t, J = 7.6 Hz, 2H), 7.47 (d, J = 7.6 Hz, 2H); 
13C NMR (100 MHz, CDCl3) δ 56.0, 78.2, 78.9, 110.9, 111.5, 120.7, 130.7, 134.6, 
161.5; HRMS Calcd for C18H14O2: 262.09937. Found: 262.10004. 
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1,4-Bis(2-(methylthio)phenyl)buta-1,3-diyne (29). This compound was isolated as a side 
product (34% with respect to the 2-ethynylthioanisole starting material) during the 
preparation of 26. The product was obtained as a yellow solid: mp 98-101 oC; 1H NMR (400 
MHz, CDCl3) δ 2.51 (s, 6H), 7.09 (t, J = 7.6 Hz, 2H), 7.17 (d, J = 8.0 Hz, 2H), 7.70 (s, 1H), 
7.32 (t, J = 7.6 Hz, 2H), 7.49 (d, J = 7.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 15.5, 80.1, 
80.9, 120.3, 124.6, 124.7, 129.8, 133.8, 143.4; HRMS Calcd for C18H14S2: 294.05369. 
Found: 294.05431. 
 
Iodocyclization of Homo- and Hetero-1,3-diynes: Synthesis of 30-34. 
 
3-Iodo-2-(3-iodobenzo[b]thiophen-2-yl)benzofuran (30). The alkyne starting material 26 
(70 mg, 0.25 mmol) in 3 mL of CH2Cl2 was placed in a 4-dram vial and stirred at room 
temperature to get a clear solution. I2 (254 mg, 4 equiv) in 1 mL of CH2Cl2 was added and 
the reaction was stirred at room temperature for 40 min. After the reaction was over, the 
reaction mixture was diluted with EtOAc, washed with satd aq Na2S2O3, dried (MgSO4), and 
filtered. The solvent was evaporated under reduced pressure and the product was isolated by 
recrystallization from hexanes/EtOAc. The product was obtained (yield = 94%) as a yellow 
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solid: mp 164-166 oC; 1H NMR (400 MHz, CDCl3) δ 7.37 (t, J = 7.6 Hz, 1H), 7.42-7.56 (m, 
5H), 7.84 (d, J = 7.6 Hz, 1H), 7.89 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 69.1, 
84.7, 111.8, 122.3, 122.4, 124.1, 125.9, 126.76, 126.80, 126.9, 130.6, 131.7, 139.7, 141.3, 
149.5, 154.7; HRMS Calcd for C16H8I2OS: 501.83854. Found: 501.83912. 
 
3,3'-Diiodo-2,2'-bibenzofuran (31). Using the starting diyne 28, the reaction was run using 
the same procedure used for the preparation of 30 above (reaction time: 2 h). This compound 
was obtained (yield = 76%) as a white solid: mp 208-211 oC (turned dark brown). The 
spectral properties were identical to those previously reported.3h 
 
 
3,3'-Diiodo-2,2'-bibenzo[b]thiophene (32). Using the starting diyne 29, the reaction was run 
using the same procedure used for the preparation of 30 above (reaction time: 1 h). The 
product was obtained (yield = 98%) as a brown solid: mp 215-217 oC; 1H NMR (400 MHz, 
CDCl3) δ 7.45-7.54 (m, 4H), 7.85 (t, J = 7.6 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 86.7, 
122.5, 125.9, 126.6, 126.7, 135.5, 140.3, 141.2; HRMS Calcd for C16H8I2S2: 517.81569. 
Found: 517.81698. 
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4-Iodo-3-[(2-methoxyphenyl)ethynyl]-1H-isocoumarin (33). The hetero diyne starting 
material 27 (73 mg, 0.25 mmol) in 3 mL of CH2Cl2 was placed in a 4-dram vial. I2 (191 mg, 
0.75 mmol, 3 equiv) in 1 mL of CH2Cl2 was added and the reaction was stirred at room 
temperature for 1 h. The reaction mixture was diluted with EtOAc, washed with satd aq 
Na2S2O3, dried (MgSO4), and filtered. The solvent was evaporated under reduced pressure 
and the product was isolated by column chromatography, followed by recrystallization using 
hexanes/EtOAc. The product was obtained (yield = 85%) as a yellow solid: mp 223-225 oC; 
1H NMR (400 MHz, CDCl3) δ 3.94 (s, 3H), 6.92-6.99 (m, 2H), 7.40 (t, J = 7.6 Hz, 1H), 7.56 
(t, J = 8.0 Hz, 2H), 7.74-7.82 (m, 2H), 8.27 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 56.1, 83.2, 88.7, 94.9, 110.5, 111.2, 120.8, 121.3, 129.8, 130.2, 131.6, 131.8, 134.1, 
135.9, 137.9, 141.1, 161.1, 161.2; HRMS Calcd for C18H11IO3: 401.97529. Found: 
401.97606. 
 
 
4-Iodo-3-(3-iodobenzofuran-2-yl)-1H-isocoumarin (34). The alkyne starting material 33 
(40 mg, 0.1 mmol) in 2 mL of CH2Cl2 was placed in a 4-dram vial. ICl (18 mg, 0.11 mmol, 
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1.1 equiv) in 0.5 mL of CH2Cl2 was slowly added and the reaction was stirred at room 
temperature for 2 h. The reaction mixture was diluted with EtOAc, washed with satd aq 
Na2S2O3, dried (MgSO4), and filtered. The solvent was evaporated under reduced pressure 
and the product was isolated (yield = 35%) by column chromatography using 
hexanes/EtOAc.  
Alternatively, diiodo compound 34 can be prepared directly from the diyne 27 using 
the following procedure. The alkyne starting material 27 (0.25 mmol, 73 mg) in 2 mL of 
CH2Cl2 was placed in a 4-dram vial and the reaction mixture was stirred at room temperature 
to obtain a clear solution. ICl (89 mg, 0.55 mmol, 2.2 equiv) in 1 mL of CH2Cl2 was added 
dropwise and the reaction was stirred at room temperature for 5 h. Our standard 
iodocyclization work-up was followed and the product was isolated by chromatography on a 
silica gel column using hexanes/EtOAc. The product was obtained (yield = 54%) as a white 
solid: mp 173-175 oC; 1H NMR (400 MHz, CDCl3) δ 7.40 (t, J = 7.6 Hz, 1H), 7.46-7.57 (m, 
3H), 7.67 (t, J = 7.6 Hz, 1H), 7.85-7.92 (m, 2H), 8.35 (d, J = 7.6 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 71.0, 82.2, 112.1, 121.5, 122.7, 124.3, 127.6, 130.2, 130.7, 132.2, 136.0, 
137.4, 145.8, 149.2, 154.4, 160.7 (one signal missing due to overlap); HRMS Calcd for 
C17H8I2O3: 513.85630. Found: 513.85756. 
 
General Procedure for Suzuki-Miyaura Cross-coupling. A literature procedure was 
used.16c To a 4-dram vial was added the appropriate iodoheterocycle (0.125 mmol), the 
boronic acid (1.4 equiv, 0.175 mmol), KHCO3 (1.4 equiv, 0.175 mmol) and PdCl2 (5 mol %) 
in 4:1 DMF:H2O (2.5 mL). The solution was stirred for 5 min at room temperature and 
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flushed with Ar and then heated to 80 oC for 2 h. After cooling, the reaction mixture was 
diluted with EtOAc, washed with satd aq NH4Cl, brine and water. The organic layer was 
dried over MgSO4 and concentrated under vacuum to give the crude product, which was 
purified by column chromatography on silica gel using hexane-EtOAc as the eluent. 
 
 
6-[2-(2-Phenylbenzofuran-3-yl)benzo[b]thiophen-3-yl]-1H-indole (35). The product was 
obtained (yield = 71%) as a brown solid: mp 226-228 oC; 1H NMR (400 MHz, CDCl3) δ 6.37 
(s, 1H), 7.04-7.06 (m, 2H), 7.12 (t, J = 8.0 Hz, 2H), 7.19-7.25 (m, 4H), 7.34-7.45 (m, 4H), 
7.50 (s,  1H), 7.67-7.68 (m, 2H), 7.81 (d, J = 8.0 Hz, 1H), 7.92 (d, J = 7.2 Hz, 1H), 7.96 (br s, 
1H); 13C NMR (100 MHz, CDCl3) δ 103.07, 103.12, 110.5, 110.9, 111.1, 120.6, 121.9, 
122.6, 123.2, 124.1, 124.4, 124.7, 124.8, 126.5, 127.0, 127.9, 128.6, 128.7, 129.1, 130.4, 
130.8, 135.2, 138.2, 140.6, 140.8, 153.1, 153.9 (one signal missing due to overlap); HRMS 
Calcd for C30H19NOS: 441.11873. Found: 441.12003. 
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5-[2-(Benzo[b]thiophen-3-yl)-5-methoxybenzofuran-3-yl]-2-methoxypyrimidine (36). 
The product was obtained (yield = 86%) as a yellow semisolid: 1H NMR (400 MHz, CDCl3) 
δ 3.91 (s, 3H), 4.04, (s, 3H), 6.98 (dd, J = 2.4, 8.4 Hz, 1H), 7.16 (d, J = 2.0 Hz, 1H), 7.38-
7.40 (m, 2H), 7.46 (d, J = 8.4 Hz, 1H), 7.50 (s, 1H), 7.88-7.90 (m, 1H), 7.97-8.00 (m, 1H), 
8.61 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 55.3, 56.0, 96.3, 111.9, 112.9, 115.5, 119.7, 
120.8, 121.7, 122.9, 124.0, 125.0, 125.2, 125.9, 127.5, 137.0, 140.3, 147.4, 155.7, 158.9, 
159.3, 164.9; HRMS Calcd for C22H16N2O3S: 388.08816. Found: 388.08932. 
 
 
3-[2-(Benzo[b]thiophen-3-yl)-5-methoxybenzofuran-3-yl]-4-(3-hydroxyprop-1-ynyl)-1H-
isocoumarin (37). To a solution of the iodo starting material 9e (55 mg, 0.1 mmol) in DMF 
(2 mL) were added PdCl2(PPh3)2 (4 mg, 5 mol %) and CuI (1 mg, 5 mol %). The reaction 
vial was flushed with Ar and the reaction mixture was stirred for 5 min at room temperature. 
DIPA (40 mg, 0.4 mmol, 4.0 equiv) was added by syringe. The reaction mixture was then 
heated to 85 °C. A solution of the terminal alkyne (4 equiv) in DMF (1 mL) was added 
dropwise over 5 min, and the mixture was allowed to stir at 85 oC for 2 h. The reaction was 
worked up and the product was purified by column chromatography on silica gel using 
hexane-EtOAc as the eluent. The product was obtained (yield = 62%) as a yellow solid: mp 
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234-236 oC;  1H NMR (400 MHz, CDCl3) δ 1.61 (br s, 1H), 3.68 (s, 2H), 3.91 (s, 3H), 7.00 
(d, J = 8.4 Hz, 1H), 7.15 (s, 1H), 7.43-7.45 (m, 2H), 7.56-7.59 (m, 1H), 7.74-7.76 (m, 4H), 
7.92-7.94 (m, 1H), 8.15-8.18 (m, 1H), 8.35 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 51.2, 56.0, 77.4, 96.0, 96.9, 101.9, 111.3, 113.1, 119.8, 120.7, 121.8, 123.1, 123.7, 
125.2, 125.39, 125.44, 127.1, 128.1, 129.1, 129.8, 135.4, 136.9, 140.3, 150.7, 152.9, 155.3, 
159.0, 161.3 (one signal missing due to overlap);  IR (CHCl3, cm-1) 3454, 3018, 2359, 1720; 
HRMS Calcd for C29H18O5S: 478.08749. Found: 478.08846. 
 
  
Palladium-catalyzed Cyclocarbonylation. 
 2-(2-Phenylbenzofuran-3-yl)benzo[b]thiophene-3-carboxylic acid (38). A literature 
procedure was used.39b DMF (4 mL), Pd(PCy3)2 (5 mg, 0.008 mmol, 5 mol %), anhydrous 
cesium pivalate (0.075 g, 0.32 mmol, 2 equiv), and the iodo starting material 7b (0.070 g, 
0.16 mmol) were stirred under an Ar atmosphere at room temperature for 5 min. The mixture 
was flushed with CO and fitted with a CO filled balloon. The reaction mixture was heated to 
110 °C with vigorous stirring for 8 h. The reaction mixture was then cooled to room 
temperature, diluted with EtOAc (25 mL), and washed with aq NH4Cl, brine and water. The 
aqueous layer was reextracted with EtOAc (15 mL). The organic layers were combined, 
dried (MgSO4) and filtered, and the solvent was removed under reduced pressure. The 
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residue was purified by column chromatography on a silica gel column. The product was 
obtained (yield = 61%) as a yellow solid: mp 258-261 oC (turned black); 1H NMR (400 MHz, 
DMF-d7) δ 7.34 (t, J = 7.2 Hz, 1H), 7.43-7.45 (m, 5H), 7.57 (t, J = 7.6 Hz, 1H), 7.63 (t, J = 
7.6 Hz, 1H), 7.73-7.77 (m, 3H), 8.16 (d, J = 7.6 Hz, 1H), 8.64 (d, J = 8.0 Hz, 1H); 13C NMR 
(100 MHz, d-DMF) δ 111.7, 112.4, 121.1, 123.7, 124.8, 126.3, 126.5, 126.6, 126.7, 127.7, 
128.4, 130.0, 130.4, 130.9, 131.4, 139.7, 140.5, 142.6, 152.8, 154.7, 165.2; IR (CHCl3, cm-1) 
3463, 1642, 1110; HRMS Calcd for C23H14O3S: 370.06636. Found: 370.06721. 
 
  
Palladium-catalyzed Alkyne Annulation. (39). A literature procedure was used.40 The iodo 
starting material 7b (50 mg, 0.11 mmol), Pd(OAc)2 (2.4 mg, 0.012 mmol), NaOAc (18 mg, 
0.22 mmol, 2 equiv), n-Bu4NCl (92 mg, 0.33 mmol, 3 equiv), diphenyl acetylene (39 mg, 
0.22 mmol, 2 equiv), and 2.2 mL of DMF were placed in a 2-dram vial, which was heated at 
100 °C for 24 h. The reaction mixture was allowed to cool, diluted with EtOAc, washed with 
satd aq NH4Cl, dried over anhydrous MgSO4, and filtered. The solvent was evaporated under 
reduced pressure and the product was isolated by chromatography. The product was obtained 
(yield = 52%) as a yellow solid: mp > 275 oC; 1H NMR (400 MHz, CD2Cl2) δ 6.65 (d, J = 
7.6 Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H), 6.82 (t, J = 7.6 Hz, 1H), 7.02-7.06 (m, 5H), 7.12-7.14 
(m, 4H), 7.20-7.33 (m, 4H), 7.48 (d, J = 7.6 Hz, 1H), 7.58-7.61 (m, 3H), 8.03 (d, J = 4.0 Hz, 
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2H); 13C NMR (100 MHz, CD2Cl2) δ 110.5, 114.9, 121.9, 124.0, 124.6, 125.25, 125.31, 
125.8, 126.6, 126.8, 127.5, 128.5, 129.1, 129.9, 130.5, 131.20, 131.24, 133.5, 133.7, 135.4, 
136.9, 137.2, 138.9, 140.3, 142.5, 142.8, 144.1, 151.1, 154.3 (three signals missing due to 
overlap); HRMS Calcd for C36H22OS: 502.13913. Found: 502.14038. 
   
X-ray Crystallographic Data for Compounds 38 and 39 
Data Collection for 38 
A very small crystal was selected under ambient conditions. The crystal was mounted 
and centered in the X-ray beam by using a video camera. The crystal evaluation and data 
collection were performed at 153K on a APEX2 CCD diffractometer with Mo Kα (λ = 
0.71073 Å) radiation and the detector to crystal distance of 5.03 cm. The initial cell constants 
were obtained from three series of ω scans at different starting angles. Each series consisted 
of 30 frames collected at intervals of 0.3º in a 10º range about ω with the exposure time of 40 
seconds per frame. The obtained reflections were successfully indexed by an automated 
indexing routine built in the SMART program. The final cell constants were calculated from 
a set of strong reflections from the actual data collection. The data were collected using the 
full sphere routine by collecting four sets of frames with 0.3º scans in ω with an exposure 
time 40 sec per frame. This dataset was corrected for Lorentz and polarization effects. The 
absorption correction was based on a fit of a spherical harmonic function to the empirical 
transmission surface as sampled by multiple equivalent measurements using SADABS 
software.46,47   
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Structure Solution and Refinement 
The systematic absences in the diffraction data were consistent for the space groups 
P1 and P1¯  .47 The E-statistics strongly suggested the centrosymmetric space group P1¯   
yielded chemically reasonable and computationally stable results of refinement. The position 
of almost all non-hydrogen atoms were found by direct methods. The remaining atoms were 
located in an alternating series of least-squares cycles and difference Fourier maps. All non-
hydrogen atoms were refined in full-matrix anisotropic approximation. All hydrogen atoms 
were placed in the structure factor calculation at idealized positions and were allowed to ride 
on the neighboring atoms with relative isotropic displacement coefficients. The H-atom of 
CO(OH)  was not located, but was included in calculations of the metric parameters. The 
ORTEP diagram was drawn at the 50% probability level. H-atoms were omitted for clarity. 
The resulting CIF file has been tested with PLATON software.48 The results and comments 
have been included in the output package (Platon_Lar35.doc.).  
 
Figure S2. Molecular structure of 38. 
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Table S1.  Crystal data and structure refinement for 38. 
 
Empirical formula  C23H14O3S 
Formula weight  370.40 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 7.407(2) Å α = 81.428(4)° 
 b = 8.400(2) Å β = 82.824(4)° 
 c = 13.789(4) Å γ = 86.874(4)° 
Volume 841.1(4) Å3 
Z 2 
Density (calculated) 1.463 Mg/m3 
Absorption coefficient 0.215 mm-1 
F(000) 384 
Crystal size 0.22 x 0.14 x 0.08 mm3 
Theta range for data collection 1.50 to 22.61°. 
Index ranges -8<=h<=7, -9<=k<=9, -14<=l<=14 
Reflections collected 5269 
Independent reflections 2200 [R(int) = 0.0384] 
Completeness to theta = 22.61° 99.3 %  
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Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9830 and 0.9543 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2200 / 0 / 244 
Goodness-of-fit on F2 1.069 
Final R indices [I>2sigma(I)] R1 = 0.0695, wR2 = 0.1664 
R indices (all data) R1 = 0.0926, wR2 = 0.1830 
Largest diff. peak and hole 1.306 and -0.646 e.Å-3 
----------------------------------------------------------------------------- 
R1  = Σ | |Fo| – |Fc| |  / Σ |Fo|  and  wR2  =  { Σ [ w(Fo2–Fc2)2 ]  / Σ [ w(Fo2)2 ]  }1/2 
 
Data Collection for 39 
A well-shaped crystal was selected under ambient conditions. The crystal was 
mounted and centered in the X-ray beam by using a video camera. The crystal evaluation and 
data collection were performed at 173K on a Bruker APEX2 diffractometer with Mo Kα (λ = 
0.71073 Å) radiation and the detector to crystal distance of 5.03 cm. The initial cell constants 
were obtained from three series of ω scans at different starting angles. Each series consisted 
of 30 frames collected at intervals of 0.3º in a 10º range about ω with the exposure time of 10 
seconds per frame. The obtained reflections were successfully indexed by an automated 
indexing routine built in the SMART program. The final cell constants were calculated from 
a set of strong reflections from the actual data collection. The data were collected using the 
full sphere routine by collecting four sets of frames with 0.3º scans in ω with an exposure 
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time 10 sec per frame. This dataset was corrected for Lorentz and polarization effects. The 
absorption correction was based on a fit of a spherical harmonic function to the empirical 
transmission surface as sampled by multiple equivalent measurements using SADABS 
software.46,47   
 
Structure Solution and Refinement 
The systematic absences in the diffraction data were consistent for the space group 
P21/c and yielded chemically reasonable and computationally stable results of refinement. 
The position of almost all non-hydrogen atoms were found by direct methods. The remaining 
atoms were located in an alternating series of least-squares cycles and difference Fourier 
maps. All non-hydrogen atoms were refined in a full-matrix anisotropic approximation. All 
hydrogen atoms were placed in the structure factor calculation at idealized positions and 
were allowed to ride on the neighboring atoms with relative isotropic displacement 
coefficients. The ORTEP diagram was drawn at the 50% probability level. H-atoms were 
omitted for clarity. The resulting CIF file has been tested with PLATON software. The 
results and comments have been included in the output package (Platon_Jef08.doc.).48  
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Figure S3. Molecular Structure of 39. 
  
Table S2.  Crystal data and structure refinement for 39. 
Empirical formula  C36H22OS 
Formula weight  502.60 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 13.3780(15) Å α = 90° 
 b = 11.9434(14) Å β = 91.457(2)° 
 c = 15.3988(18) Å γ = 90° 
Volume 2459.6(5) Å3 
Z 4 
Density (calculated) 1.357 Mg/m3 
Absorption coefficient 0.161 mm-1 
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F(000) 1048 
Crystal size 0.27 x 0.22 x 0.18 mm3 
Theta range for data collection 1.99 to 28.27°. 
Index ranges -17<=h<=17, -15<=k<=15, -20<=l<=20 
Reflections collected 24165 
Independent reflections 6079 [R(int) = 0.0408] 
Completeness to theta = 28.27° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9715 and 0.9577 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6079 / 0 / 343 
Goodness-of-fit on F2 0.980 
Final R indices [I>2sigma(I)] R1 = 0.0445, wR2 = 0.1138 
R indices (all data) R1 = 0.0619, wR2 = 0.1293 
Largest diff. peak and hole 0.435 and -0.336 e.Å-3 
----------------------------------------------------------------------------- 
R1  = Σ | |Fo| – |Fc| |  / Σ |Fo|  and  wR2  =  { Σ [ w(Fo2–Fc2)2 ]  / Σ [ w(Fo2)2 ]  }1/2 
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Abstract 
 
 
A variety of iodo-substituted isochromenes, dihydroisobenzofurans, and 
pyranopyridines are readily prepared in good to excellent yields under mild conditions by the 
iodocyclization of readily available 2-(1-alkynyl)benzylic alcohols or 2-(1-alkynyl)-3-
(hydroxymethyl)pyridines. The regiochemical outcome of the reaction strongly depends on 
the substitution pattern of the starting material. 
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Introduction 
The iodocyclization of alkynes has emerged as a powerful tool in organic synthesis.1 
Recently, we and others have utilized this methodology to accomplish efficient syntheses of a 
wide variety of interesting carbocyclic and heterocyclic compounds, including benzofurans,2 
furans,3 benzothiophenes,4 thiophenes,5 benzopyrans,6 benzoselenophenes,7 selenophenes,8 
naphthols,9 indoles,10 quinolines,11 isoquinolines,12 α-pyrones,13 isocoumarins,13 
naphthalenes14 and polycyclic aromatics,15 isoxazoles,16 chromones,17 bicyclic β-lactams,18 
cyclic carbonates,19 pyrroles,20 furopyridines,21 spiro[4.5]trienones,22 coumestrol and 
coumestans,23 furanones,24 benzothiazine-1,1-dioxides,25 and others.26 In general, these 
electrophilic cyclization reactions are very clean and efficient, and tolerate a wide variety of 
functional groups. Furthermore, the iodine-containing products can be further diversified 
using a number of subsequent palladium-catalyzed processes.  
Herein we report a simple and efficient method for the synthesis of 1H-isochromene 
and/or (Z)-1-(1-iodoalkylidene)-1,3-dihydroisobenzofuran derivatives, based on the 
iodocyclization of readily available 2-(1-alkynyl)benzylic alcohols (Eq 1). Isochromenes and 
1,3-dihydroisobenzofurans are important heterocyclic compounds, and there are several 
examples of naturally occurring and biologically active compounds containing these ring 
systems.27, 28  
 
 
125 
 
 
Over the years, several groups have reported a variety of synthetic approaches to 
isochromene and dihydroisobenzofuran derivatives by the heterocyclization of acyclic 
precursors.29 In particular, we30 and Barluenga and co-workers31 have independently reported 
the formation of 4-iodo-1H-isochromenes by the iodocyclization of 2-(1-
alkynyl)benzaldehydes in the presence of suitable nucleophiles (Eq 2). 
 
 
 
We have also previously disclosed the Pd(II)-catalyzed cycloisomerization of 2-(1-
alkynyl)benzylic alcohols to 1H-isochromenes and/or (Z)-1-alkylidene-1,3-
dihydroisobenzofurans, depending on the nature of the substrate and the reaction conditions 
(Eq 3).29k 
 
 
 
The new methodology reported in this work is complementary to those previously 
reported procedures, and allows the direct synthesis of 3-iodo-1H-isochromenes, (Z)-1-(1-
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iodoalkylidene)-1,3-dihydroisobenzofurans, and iodopyranopyridines by the iodocyclization 
of variously substituted 2-(1-alkynyl)benzylic alcohols or 2-(1-alkynyl)-3-
(hydroxymethyl)pyridines under mild conditions (see Eq 1). 
 
Results and Discussion 
2-(2-Phenylethynyl)benzyl alcohol (1a, Y = CH, R1 = R2 = R3 = H, R4 = Ph) was 
chosen as a model substrate for determining the optimum conditions for the iodocyclization 
reaction. A range of iodine sources, solvents, bases and reaction times were screened and the 
results of these optimization studies are shown in Table 1. 
 
Table 1. Iodocyclization of 2-(2-Phenylethynyl)benzyl Alcohol: Optimization Studiesa 
 
entry I+ base temp. (°C) time (h) solvent 
total 
yield (2a 
+ 3a)b 
(%) 
2a/3a 
ratioc 
1 1.5 I2 - 25 72 CH3CN - - 
2 3.0 I2 - 25 15 CH3CN - - 
3 1.5 I2 1.5 NaHCO3 25 72 CH3CN 49 29/20 
4 2.0 I2 2.0 NaHCO3 25 72 CH3CN 56 42/14 
5 2.0 I2 3.0 NaHCO3 25 72 CH3CN 56 40/16 
6 3.0 I2 3.0 NaHCO3 25 3 CH3CN 31 23/4 
7 3.0 I2 3.0 NaHCO3 25 8 CH3CN 61 56/5 
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8 3.0 I2 3.0 NaHCO3 25 15 CH3CN 71 65/6 
9 3.0 I2 3.0 NaHCO3 25 24 CH3CN 62 59/3 
10 3.0 I2 3.0 NaHCO3 25 15 CH2Cl2 45 45/0 
11 3.0 I2 3.0 NaHCO3 25 15 EtOH 45 45/0 
12d 3.0 I2 3.0 NaHCO3 25 15 CH3CN 33 21/12 
13e 3.0 I2 3.0 NaHCO3 40 3 CH3CN - - 
14 3.0 I2 3.0 K2CO3 25 24 CH3CN 56 27/29 
15 3.0 I2 3.0 KHCO3 25 24 CH3CN 46 22/24 
16 3.0 I2 3.0 NaH 25 24 CH3CN 10 10/0 
17 3.0 I2 
3.0 
Morpholine 25 24 CH3CN - - 
18 3.0 ICl 3 NaHCO3 25 1.5 CH3CN 38 38/0 
19 3.0 ICl 3 NaHCO3 25 1.5 CH2Cl2 25 25/0 
aUnless otherwise noted, all reactions were carried out on a 0.3 mmol scale in 6 mL of acetonitrile. bIsolated 
yield of 2a + 3a, based on starting 1a. In most cases, an inseparable mixture of the two regioisomers was 
obtained from column chromatography. cThe 2:3 ratio is based on 1H NMR spectroscopic data. dThe reaction 
was carried out in 2.5 mL of acetonitrile. eThe reaction led to a complex reaction mixture. 
 
As can be seen from Table 1, the isochromene derivative 2a derived from a 6-endo-
dig cyclization was consistently obtained in higher yield than the dihydroisobenzofuran 
derivative 3a derived from a 5-exo-dig cyclization.32 The optimal reaction conditions in 
terms of total yield for the iodocyclization of 1a are those reported in entry 8 (Substrate: I2 : 
NaHCO3 molar ratio = 1:3:3, T = 25 °C, substrate concentration = 0.05 M in CH3CN, time = 
15 h). Under these conditions, 1a was converted into approximately an 11:1 mixture of 2a 
and 3a in a total yield of 71%. On the other hand, no formation of 3a was observed using I2 
as the iodine source in CH2Cl2 or EtOH as the solvent (entries 10 and 11) or using ICl as the 
128 
 
 
iodine source either in MeCN or in CH2Cl2 (entries 18 and 19, respectively). However, the 
yields of 2a obtained under these conditions ranged from only 25 to 45%. 
A variety of 2-(1-alkynyl)benzylic alcohols 1b-t were then subjected to 
iodocyclization under the conditions of Table 1, entry 8. The results obtained are summarized 
in Table 2. 
 
Table 2. Synthesis of 3-Iodo-1H-isochromenes and 1-(1-Iodoalkylidene)-1,3-
dihydroisobenzofurans  by the Iodocyclization of 2-(1-Alkynyl)benzylic alcoholsa 
 
entry 1 Y R1 R2 R3 R4 
isolated yield (%) 
2 3 
1 1a CH H H H Ph 71b (11:1)c 
2 1b CH H H H 4-methylphenyl 92 - 
3 1c CH H H H 4-methoxyphenyl 85 - 
4 1d CH H H H 3,5-dimethoxyphenyl 41 35 
5 1e CH H H H 4-chlorophenyl 85b (3:1)c 
6 1f CH H H H 4-nitrophenyl 88b (1:3)c 
7 1g CH H H H 3,5-
bis(trifluoromethyl)phenyl 
74b (1:4)c 
8 1h CH H H H 3-thienyl 82 - 
9 1i CH H H H 1-cyclohexenyl 80 - 
10 1j CH H H H n-Bu 57 - 
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11d 1k CH H H H t-Bu - - 
12 d 1l CH H H H TMS - - 
13 d 1m CH H H H H - - 
14 1n CH OMe H H Ph 51  
15 1o CH OMe H H 4-methylphenyl 61  
16 1p CH NO2 H H 4-methylphenyl 92  
17 1q N H H H Ph 98  
18 1r N H H H 4-methylphenyl 92  
19 1s CH H Bu H Ph 76b (3:1)c 
20 1t CH H Bu H 4-methylphenyl 72  
21 1u CH H Et Et Ph - 70 
22 1v CH H Et Et 4-methylphenyl - 70 
23 1w CH H Bu Et Ph - 82 
aUnless otherwise noted, all reactions were carried out on a 0.3 mmol scale in 6 mL of acetonitrile. The 
reactions were allowed to stir at room temperature for 15 h. All yields are isolated yields after column 
chromatography. bAn inseparable mixture of the two regioisomers was obtained from column chromatography. 
cThe 2:3 ratio is based on 1H NMR spectroscopic data. dThis reaction resulted in a complex reaction mixture. 
 
As can be seen from the results reported in Table 2, the regiochemistry of the process 
strongly depends on the substitution pattern of the substrate. Interestingly, the presence of a 
electron-donating group in the para position of a phenyl ring conjugated with the triple bond 
(R4 = p-MeC6H4 or p-MeOC6H4, substrates 1b and 1c, respectively) led to preferential 
formation of the isochromene derivative (compare entries 2 and 3 with entry 1). In fact, the 
electron-donating effect of the para substituent should increase the electron density on C-1 of 
the arylethynyl group, thus favoring intramolecular nucleophilic attack of the hydroxyl group 
on C-2. As expected, this effect was not observed when the substituents are in the meta 
positions, as shown by the results obtained in the case of substrate 1d (R4 = 3,5-
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dimethoxyphenyl), whose iodocyclization led to a mixure of the isochromene and 
isobenzofuran derivatives (entry 4). A mixture of 2e and 3e was also obtained in the case of a 
p-chloro substituent (R4 = p-ClC6H4, substrate 1e, entry 5). On the other hand, the presence 
of a nitro group in the para position (R4 = p-O2NC6H4, substrate 1f, entry 6) significantly 
augments the electrophilicity of C-1 of the arylethynyl group, thus reversing the selectivity of 
the reaction in favor of the 5-membered ring product 3f. A similar effect is observed when R4 
is a 3,5-bis(trifluoromethyl)phenyl substituent (substrate 1g, entry 7). When the triple bond is 
substituted with a 3-thienyl, 1-cyclohexenyl, or butyl group, the reaction consistently follows 
a 6-endo-dig pathway, with selective formation of the corresponding isochromene derivatives 
2h-2j (entries 8-10). Substrates bearing a sterically demanding substituent [R4 = t-butyl (1k) 
or TMS (1l), entries 11 and 12)] led to complex reaction mixtures. The reaction did not 
proceed well with a terminal triple bond (R4 = H, 1m, entry 13), and partial decomposition of 
the substrate occurred. Interestingly, the presence of either an electron-donating or an 
electron-withdrawing group meta with respect to the hydroxymethyl group (R1 = OMe or 
NO2, substrates 1n-1p) also tended to favor selective formation of the 6-membered ring 
products 2n-2p (entries 14-16). Excellent yields of pyranopyridine derivatives 2q and 2r 
were obtained by 6-endo-dig iodocyclization of the corresponding 2-(1-alkynyl)-3-
(hydroxymethyl)pyridines 1q and 1r (entries 17 and 18). 
Substrates bearing a secondary alcoholic group (1s and 1t) behaved similarly to 
substrates with a primary alcoholic group, as can be seen by comparing entries 19 and 20 
(Table 2) with entries 1 and 2 (Table 2). On the other hand, as expected in view of the gem-
dialkyl effect,32 and in agreement with what has been previously observed in the Pd(II)-
catalyzed cycloisomerization of 2-(1-alkynyl)benzylic alcohols,29k substrates 1u-1w, bearing 
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a tertiary alcohol group, selectively proceed by a 5-exo-dig cyclization, with formation of the 
corresponding dihydroisobenzofurans 3u-3w in good yields (70-82%, entries 21-23). In fact, 
in the presence of α,α-dialkyl substitution, the hydroxyl group is forced closer to the triple 
bond, thus favoring the 5-exo-dig pathway with respect to the 6-endo-dig pathway. 
X-ray crystallographic experiments were performed in order to confirm the 
regiochemistry of the cyclized products.33 Interestingly, the 1-alkylidene-1,3-
dihydroisobenzofuran product 3u was found to be the Z-isomer, instead of the E-isomer that 
would be expected from an anti-5-exo-dig cyclization (Figure 1). This Z-stereochemistry was 
also found in other 5-membered ring products (by 1H NMR spectral data correlation with 
3u).  
Given the unexpected stereochemistry, an immediately reasonable hypothesis was 
that the predicted stereoisomer is originally formed, and then equilibrates to the observed 
isomer.  This would imply that the observed Z-isomer would need to be more stable than the 
expected E-isomer. In order to substantiate this idea, computations were carried out at MP2 
and B3LYP levels of theory using a 6-31G(d) basis set on carbon and hydrogen atoms, and 
an approximately equivalent electron core potential and valence basis set on I.  (Details are 
given in the Experimental Section)  At both levels of theory, the Z-isomer was favored, by 
3.6 and 3.9 kcal/mol using B3LYP and MP2, respectively. 
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Figure 1. X-ray Evidence for the Structural Assignment of 1-Alkylidene-1,3-
dihydroisobenzofurans 
OH
iodocyclization
O
I
O
I
Expected product from
anti-5-exo-dig cyclization
3u 70%
(Z-stereochemistry observed)
X-ray structure evidence for 3u
1u
 
On the basis of these observations, the following reaction mechanism can be 
proposed for the iodocyclization of 1 (Scheme 1).34 Coordination of an I+ equivalent to the 
alkyne leads to electrophilic activation of the alkyne carbon-carbon triple bond generating 
iodonium intermediate A. Nucleophilic attack by the hydroxyl group may then take place by 
either of two intramolecular cyclization modes (anti-6-endo-dig or anti-5-exo-dig, paths a 
and b, respectively) to give intermediates B or B’ respectively. Deprotonation of intermediate 
B leads to the isochromene product 2 that is isolated as the major product in most cases. 
However, dihydroisobenzofuran derivative 3’ with E stereochemistry derived from 
intermediate B’ was not isolated.  Presumably, isomerization of the initially formed E-
isobenzofuran (3’) leads to the more stable Z-isomer (3). A few examples of the 
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isomerization of substituted cis-alkenes to the more stable corresponding trans-isomers in the 
presence of iodine are known.35 In order to demonstrate the feasibility of the isomerization, 
cis-stilbene was subjected to our reaction conditions and partial isomerization was observed. 
The ratio of cis:trans stilbene was found to be 1:0.6 at 10 h and 1:0.9 at 19 h by 1H NMR 
spectral data.  
 
Scheme 1. Proposed Mechanistic Pathway for the Iodocyclization of 2-(1-
Alkynyl)benzylic alcohols (1) 
 
Conclusions 
A simple and mild synthesis of 6- and 5-membered iodoheterocyclic ether derivatives 
(2 and 3, respectively) via iodocyclization of readily available 2-(1-alkynyl)benzylic alcohols 
1 is reported. The nature of the substituents in the starting material governs the 
regiochemistry of the reaction products. The 5-membered ring products obtained (1-
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alkylidene-1,3-dihydroisobenzofurans 3) exhibit unexpected Z-stereochemistry, and are 
presumably derived from the initially formed less stable E-isomers through iodine-mediated 
isomerization. 
Experimental Section 
General. The 1H NMR and 13C NMR spectra were recorded at 25 °C in CDCl3 at 300 MHz 
or 400 MHz and 75 MHz or 100 MHz, respectively, with Me4Si as an internal standard. 
Chemical shifts (δ) and coupling constants (J) are given in ppm and in Hz, respectively. The 
IR spectra were taken with an FT-IR spectrometer. All reactions were analyzed by TLC on 
silica gel 60 [visualization was effected with short wavelength UV light (254 nm)], and by 
GLC using a gas chromatograph and capillary columns with polymethylsilicone + 5% 
phenylsilicone as the stationary phase. Column chromatography was performed on silica gel 
60 (70-230 mesh). All melting points are uncorrected. HRMS data: the electron impact 
ionization experiments were performed on a Finnigan TSQ700 triple quadrupole mass 
spectrometer (Finnigan MAT, San Jose, CA) fitted with a Finnigan EI/CI ion source. The 
samples were introduced to the mass spectrometer using a solids probe. The probe was 
heated gradually from 100 to 400 oC. The instrument was used as a single quadrupole and 
scanned from 50 to 1000 daltons. Accurate mass measurements were conducted using 
manual peak matching technique with the KRATOS MS50 double focusing mass 
spectrometer. 
 
Preparation of the Non-commercial o-Haloarenes. 2-Iodobenzyl alcohol (4) was 
commercially available and used as received; all of the other precursors 5-7 were prepared as 
described below. 
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General Procedure for Preparation of the 2-Bromobenzylic Alcohols 5 and 7 (Eq 1) 
 
To a stirred solution of commercially available 2-bromo-5-methoxybenzaldehyde or 
2-bromopyridine-3-carboxaldehyde (4.06 mmol) in EtOH (10.7 mL) was added NaBH4 (4.87 
mmol). After being stirred at 25 °C for 1 h (2-bromopyridine-3-carboxaldehyde) or 3 h (2-
bromo-5-methoxybenzaldehyde), the cooled mixture (0 °C) was acidified with 0.1 N HCl 
with stirring. After additional stirring at 0 °C for 15 min, Et2O and satd aq NaHCO3 were 
added. The phases were separated, and the aqueous layer was extracted with Et2O. The 
combined organic layers were washed with satd aq NaHCO3 and then with H2O to neutral 
pH. After drying over Na2SO4, the solvent was removed by rotary evaporation, and the crude 
products 537 and 738 thus obtained were used as such for the next step (5: white solid, 3.96 
mmol, 860 mg, 91%; 7: white solid, 2.72 mmol, 511 mg, 67%).  
 
Procedure for the Preparation of 2-Bromobenzylic Alcohol 6 
 
To a cooled (0 °C), stirred solution of commercially available 5-nitro-2-
bromobenzoic acid (2.32 mmol) in THF (5 mL) was added DIBAL (5.09 mmol). After being 
stirred at 0 °C for 4 h, the mixture was acidified with 0.1 N HCl at 0 °C with stirring. After 
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additional stirring at 0 °C for 15 min, Et2O and satd aq NaHCO3 were added. The phases 
were separated, and the aqueous layer was extracted with Et2O. The combined organic layers 
were washed with satd aq NaHCO3 and then with H2O to neutral pH. After drying over 
Na2SO4, the solvent was removed by rotary evaporation, and the crude product 639 thus 
obtained was purified by column chromatography on silica gel using 9:1 to 4:1 
hexane/EtOAc as the eluent (white solid, 188 mg, 35%). 
 
Preparation of the 2-(1-Alkynyl)benzylic Alcohols 
Preparation of Substrates Bearing a Primary Alcohol (1a-r) 
Substrates 1a-1o were prepared by Sonogashira coupling36 of the appropriate o-
halobenzylic alcohols 4-6 or (hydroxymethyl)pyridine 7 and terminal alkynes (Eq 3 and 
Table S1).  
 
 
General Procedure for the Sonogashira Coupling. To a mixture of the o-halobenzylic 
alcohol 4-6 or 2-bromo-3-(hydroxymethyl)pyridine (7, 2.0 mmol) in DMF (10 mL) were 
added PdCl2(PPh3)2 (14.0 mg, 0.02 mmol), and CuI (3.8 mg, 0.02 mmol) under argon. After 
the reaction mixture was stirred for 5 min at room temperature, DIPA (809 mg, 4.0 equiv) 
was added by a syringe. The reaction mixture was then heated at 70 °C. A solution of the 
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alkyne (1.2 equiv) in DMF (2 mL) was added dropwise over 10 min, and the mixture was 
allowed to stir at 70 oC for 2 h. After cooling, the reaction mixture was washed with satd aq 
NH4Cl and water, and then extracted with EtOAc (2 x 15 mL). The combined organic 
extracts were dried over MgSO4 and concentrated under vacuum to give the crude product 1, 
which was purified by column chromatography on silica gel using 9:1 to 4:1 hexane-EtOAc 
as eluent. 
TABLE S1 
 
entry 
o-halo- 
benzylic 
alcohol 
X Y R1 R2 R3 R4 1 
isolated 
yield (%) 
1 
1 4 I CH H H H Ph 1a 80 
2 4 I CH H H H 4-methylphenyl 1b 98 
3 4 I CH H H H 4-methoxyphenyl 1c 77 
4 4 I CH H H H 3,5-dimethoxyphenyl 1d 93 
5 4 I CH H H H 4-chlorophenyl 1e 99 
6 4 I CH H H H 4-nitrophenyl 1f 99 
7 4 I CH H H H 3,5-bis(trifluoromethyl)phenyl 
1g 86 
8 4 I CH H H H 3-thienyl 1h 94 
9 4 I CH H H H 1-cyclohexenyl 1i 90 
10 4 I CH H H H n-Bu 1j 71 
11 4 I CH H H H t-Bu 1k 81 
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12 4 I CH H H H TMS 1l 86 
13 5 Br CH OMe H H Ph 1n 35 
14 5 Br CH OMe H H 4-methylphenyl 10 91 
15 6 Br CH NO2 H H 4-methylphenyl 1p 80 
16 7 Br N H H H Ph 1q 80 
17 7 Br N H H H 4-methylphenyl 1r 92 
 
OH
 
[2-(Phenylethynyl)phenyl]methanol (1a). This reaction was run using TEA (10 mL) as the 
solvent. Also, TEA (2 mL) was used for alkyne addition to the reaction mixture. After 
purification, the product was obtained as a yellow solid (yield: 334 mg, 80%); mp 65-66 °C, 
lit. mp 65-66 °C40; IR (KBr) 3210 (br s), 2065 (w), 1598 (w), 1571 (w), 1491 (m), 1453 (m), 
1368 (w), 1191 (w), 1097 (w), 1039 (m), 987 (w), 919 (w), 757 (s), 692 (s) cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.55-7.40 (m, 4H, aromatic), 7.38-7.19 (m, 5H,  aromatic), 4.87 (s, 2H, 
CH2), 2.60 (br s, 1H, OH); 13C NMR (75 MHz, CDCl3) δ 142.5, 132.1, 131.5, 128.7, 128.5, 
128.4, 127.3, 127.1, 122.9, 121.1, 94.2, 86.7, 63.8; GC-MS m/z = 208 (M+, 11), 180 (24), 178 
(29), 165 (18), 152 (20), 149 (22), 130 (38), 79 (19), 78 (78), 77 (100); HRMS calcd for 
C15H12O  208.08881. Found 208.08909. 
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Me
 
[2-(p-Tolylethynyl)phenyl]methanol (1b). Colorless solid (205 mg, 92%): mp 102-103 °C, 
lit. mp 102-103 °C41; IR (KBr) 3346 (s), 3256 (s), 1949 (w), 1511 (s), 1479 (w), 1451 (m), 
1336 (w), 1250, (w), 1192 (w), 1097 (w), 1041 (s), 1034 (s), 1021 (m), 990 (w), 950 (w), 819 
(w), 760 (s), 754 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.55-7.50 (m, 1H, aromatic), 7.47-
7.40 (m, 3H,  aromatic), 7.32 (td, J = 7.5, 0.9 Hz, 1H, aromatic), 7.28-7.24 (m, 1H, aromatic), 
7.15 (d, J = 7.5 Hz, 2H, aromatic), 4.91 (d, J = 6.1 Hz, 2H, CH2), 2.37 (s, 3H, Me), 2.23 (t, J 
= 6.1 Hz, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 142.7, 139.0, 132.3, 131.7, 129.4, 128.8, 
127.7, 127.5, 121.7, 120.0, 94.7, 86.3, 64.3, 21.8; GC-MS m/z = 222 (M+, 9), 178 (19), 131 
(22), 130 (89), 115 (79), 111 (20), 110 (35), 103 (22), 102 (100), 92 (66), 91 (70), 89 (32); 
HRMS calcd for C16H14O  222.10446. Found 222.10486. 
 
OH
OMe
 
[2-(4-Methoxyphenylethynyl)phenyl]methanol (1c). Pale orange solid (377 mg, 77%); mp 
99-100 °C, lit. mp 102-103 oC42; IR (KBr) 3348 (br s), 3382 (br s), 2956 (m), 1909 (w), 1605 
(m), 1569 (w), 1512 (s),  1469 (m), 1366 (w), 1288 (m), 1248 (s), 1181 (m), 1108 (w), 1045 
(m), 1031 (m), 948 (w), 840 (s), 760 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 7.2 
Hz, 1H, aromatic), 7.47-7.41 (m, 3H, aromatic), 7.33 (t,  J = 7.2 Hz, 1H, aromatic), 7.26 (t, J 
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= 7.2 Hz, 1H, aromatic), 6.87 (d, J = 7.2 Hz, 1H, aromatic), 4.90 (s, 2H, CH2), 3.83 (s, 3H, 
OMe), 2.24 (br s, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 159.8, 142.3, 133.0, 131.9, 128.4, 
127.4, 127.2, 121.6, 114.9, 114.0, 94.2, 85.4, 64.1, 55.3; GC-MS m/z = 238 (M+, 18), 179 
(36), 167 (36), 166 (100), 152 (63), 149 (27), 135 (25), 129 (39) ; HRMS calcd for C16H14O2  
238.09937. Found 238.09980. 
 
OH
OMe
OMe
 
[2-(3,5-Dimethoxyphenylethynyl)phenyl]methanol (1d). Brown solid (499 mg, 93%); mp 
71-72 °C; IR (KBr) 3324 (br s), 2965 (m), 1969 (w), 1590 (s), 1451 (m), 1416 (m), 1449 (w), 
1357 (m), 1368 (w), 1235 (w), 1208 (s), 1158 (s), 1154 (m), 1066 (m), 928 (w), 846 (m), 825 
(m), 759 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 7.5, 2.4 Hz, 1H, aromatic), 
7.46 (dd , J = 7.5, 2.4 Hz, 1H, aromatic), 7.36 (td,  J = 7.5, 1.2 Hz, 1H, aromatic), 7.29 (td,  J 
= 7.5, 1.2 Hz, 1H, aromatic), 6.68 (d, J = 2.3 Hz, 2H, aromatic), 6.47 (t, J = 2.3 Hz, 1H, 
aromatic), 4.91 (d, J = 6.4 Hz, 2H, CH2), 3.82 (s, 6H, OMe), 2.20-2.09 (m, 1H, OH); 13C 
NMR (100 MHz, CDCl3) δ 160.5, 142.5, 132.2, 128.8, 127.4, 127.2, 124.1, 121.1, 109.3, 
101.9, 94.1, 86.2, 64.0, 55.5; GC-MS m/z = 268 (M+, 100), 267 (36), 240 (16), 239 (45), 238 
(18), 224 (17), 209 (16), 208 (21), 164 (27); HRMS calcd for C17H16O3  268.10994. Found 
268.11032. 
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OH
Cl
 
[2-(4-Chlorophenylethynyl)phenyl]methanol (1e). Yellow solid (480 mg, 99%); mp 90-92 
°C; IR (KBr) 3314 (br s), 2921 (m), 2216 (w), 1492 (s), 1449 (w), 1398 (w), 1368 (w), 1239 
(w), 1119 (w), 1093 (s), 1044 (s), 1015 (m), 942 (w), 830 (s), 757 (s) cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.55-7.43 (m, 4H, aromatic), 7.40-7.24 (m, 4H, aromatic), 4.90 (s, 2H, CH2), 
2.17 (br s, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 142.4, 134.5, 132.7, 132.1, 128.9, 128.7, 
127.5, 127.2, 121.3, 120.9, 92.3, 87.6, 63.9; GC-MS m/z 242 (M+, 100), 241 (28), 239 (18), 
208 (22), 207 (38), 179 (57), 178 (68), 177 (18), 176 (42); HRMS calcd for C15H11ClO  
242.04984. Found 242.05022. 
 
OH
NO2
 
[2-(4-Nitrophenylethynyl)phenyl]methanol (1f). Reaction time: 3h. After purification, the 
compound was obtained as an orange solid (501 mg, 99%): mp 114-115 °C; IR (KBr) 3325 
(br s), 2935 (m), 2217 (w), 1592 (m), 1514 (s), 1447 (w), 1342 (s), 1289 (w), 1192 (w), 1108 
(w), 1031 (m), 983 (w), 852 (s), 758 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 8.5 
Hz, 2H, aromatic), 7.67 (distorted d, J = 8.5 Hz, 2H, aromatic), 7.60-7.52 (m, 2H, aromatic), 
7.44 (t,  J = 7.5 Hz, 1H, aromatic), 7.29 (distorted t,  J = 7.5 Hz, 1H, aromatic), 4.94 (s, 2H, 
CH2), 2.05 (m, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 147.0, 142.3, 132.4, 132.2, 129.8, 
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129.7, 127.6, 127.3, 123.7, 120.1, 92.03, 92.00, 63.7; GC-MS m/z = 253 (M+, 43), 207 (12),  
206 (13), 179 (32), 178 (100), 177 (43), 176 (26), 165 (18), 152 (21), 151 (16); HRMS calcd 
for C15H11NO3  253.07389 Found 253.07419. 
 
OH
CF3
CF3
 
[2-(3,5-Bis-trifluoromethylphenylethynyl)phenyl]methanol (1g). Pale yellow solid (104 
mg, 74%): mp 105-106 °C; IR (KBr) 3341 (m), 3324 (m, br), 2957 (w), 2225 (w), 1467 (w), 
1435 (w), 1386 (s), 1284 (s), 1192 (m), 1169 (m), 1129 (s), 1043 (w), 1006 (w), 923 (m), 902 
(m), 847 (w), 763 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.97-7.92 (m, 2H, aromatic), 
7.86-7.81 (m, 1H, aromatic), 7.56 (t, J = 7.8 Hz, 2H, aromatic), 7.44 (t,  J = 7.8 Hz, 1H, 
aromatic), 7.32 (distorted t,  J = 7.8 Hz, 1H, aromatic), 4.95 (d, J = 5.4 Hz, 2H, CH2), 1.99 
(distorted t,  J = 5.4 Hz, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 142.8, 132.5, 132.2, 131.8, 
131.3, 129.7, 127.6, 127.3, 125.3, 121.8, 119.8, 90.8, 90.1, 63.7; GC-MS m/z 344 (M+, 100), 
343 (26), 325 (20), 323 (23), 296 (29), 295 (24), 275 (78), 247 (25), 246 (48), 227 (29), 225 
(22), 178 (31), 131 (33), 103 (21); HRMS calcd for C17H10F6O  344.06358. Found 
344.06398. 
 
OH
S
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(2-Thiophen-3-ylethynylphenyl)methanol (1h). Orange solid (402 mg, 94%): mp 78-80 °C; 
IR (KBr) 3350 (m), 3323 (m), 2918 (w), 1961 (w), 1517 (w), 1479 (s), 1450 (m), 1365 (m), 
1238 (w), 1205 (w), 1100 (w), 1045 (s), 990 (w), 941 (w), 868 (m), 785 (w), 760 (s) cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.54-7.49 (m, 2H, aromatic), 7.47-7.44 (m, 1H, aromatic), 7.37-
7.24 (m, 3H, aromatic), 7.21-7.17 (m, 1H, aromatic), 4.89 (s, 2H, CH2), 2.17 (br s, 1H, OH); 
13C NMR (100 MHz, CDCl3) δ 142.4, 132.1 129.7, 128.8, 128.6, 127.4, 127.2, 125.5, 121.9, 
121.2, 89.2, 86.2, 64.0; GC-MS m/z 214 (M+, 36), 213 (22), 186 (25), 185 (100), 184 (84), 
183 (29), 171 (20), 152 (40), 151 (23), 141 (37), 139 (32) ; HRMS calcd for C13H10OS  
214.04523. Found 214.04559. 
 
OH
 
(2-Cyclohex-1-enylethynylphenyl)methanol (1i). Yellow oil12b (394 mg, 90%): IR (KBr) 
3391 (br s), 2931 (s), 2859 (m), 2200 (w), 1481 (w), 1449 (m), 1436 (w), 1373 (w), 1241 
(m), 1091 (w), 1044 (s), 919 (w), 842 (w), 758 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.30 
(t, J = 7.2 Hz, 2H, aromatic), 7.32-7.26 (m, 1H, aromatic), 7.26-7.20 (m, 1H, aromatic), 6.25-
6.19 (m, 1H, C=CH), 4.80 (s, 2H, CH2OH), 2.30-2.21 (m, 3H, CCH2CH2CH2CH2CH + OH), 
2.19-2.10 (m, 2H, CCH2CH2CH2CH2CH), 1.73-1.60  (m, 4H, CCH2CH2CH2CH2CH); 13C 
NMR (100 MHz, CDCl3) δ 142.2, 135.6, 131.9, 128.1, 127.4, 127.2, 121.8, 120.5, 96.2, 84.1, 
64.1, 29.2, 25.8, 22.3, 21.4; GC-MS m/z 212 (M+, 100), 178 (33), 165 (43), 164 (91), 156 
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(66), 155 (53), 154 (51), 152 (56), 140 (65), 130 (62), 129 (42), 127 (71); HRMS calcd for 
C15H16O  212.12011. Found 212.12047. 
OH
Bu
 
(2-Hex-1-ynylphenyl)methanol (1j). Yellow oil29k (267.3 mg, 71%): IR (KBr) 3398 (br s), 
2957 (w), 2871 (w), 2227 (w), 1482 (m), 1453 (m), 1383 (m), 1041 (m), 757 (s) cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.42-7.34 (m, 2H, aromatic), 7.25 (td,  J = 7.7, 1.6 Hz, 1H, 
aromatic), 7.18 (td,  J = 7.7, 1.6 Hz, 1H, aromatic), 4.76  (s, 2H, CH2OH), 2.57 (br s, 1H, 
OH), 2.46 (t, J = 7.1 Hz, 2H, CH2CH2CH2CH3), 1.67-1.53 (m, 2H, CH2CH2CH3), 1.53-1.40 
(m, 2H, CH2CH2CH3), 0.95 (t, J = 7.3 Hz, 3H, Me); 13C NMR (75 MHz, CDCl3) δ 142.4, 
132.1, 127.9, 127.2, 127.0, 122.0, 95.4, 78.1, 63.9, 30.8, 22.0, 19.2, 13.6; GC-MS m/z 188 
(M+, 80), 155 (64), 145 (100), 144 (27), 132 (29), 131 (24), 128 (32), 117 (33), 116 (28), 115 
(58), 114 (23); HRMS calcd for C13H16O 188.12011. Found 188.12046. 
 
Alcohol 1k was isolated as a yellow oil29k (305 mg, 81%); 1l was isolated as a yellow 
oil29k (351 mg, 86%). The spectral data for these compounds matched those reported in the 
literature. 
 
Preparation of (2-Ethynylphenyl)methanol (1m)  
To a stirred solution of 1l (300 mg, 1.59 mmol) in MeOH (8.3 mL) was added KF 
(5.68 mmol). The mixture was allowed to stir at rt for 3 h, and then diluted with CH2Cl2 and 
quenched with water. The phases were separated, the aqueous layer extracted with CH2Cl2, 
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and the combined organic layers were dried over Na2SO4. After removal of the solvent by 
rotary evaporation, the crude product was purified by column chromatography on silica gel 
using 6:4 hexane-EtOAc as the eluent to give a yellow solid, which was then further purified 
by repeated crystallization (hexane) to give pure (2-ethynylphenyl)methanol (1m) as a 
colorless solid 29k (147 mg, 70%). 
 
OHMeO
 
 [5-Methoxy-2-(phenylethynyl)phenyl]methanol (1n). This reaction was run by following 
the general Sonogashira procedure above, except for a few differences: 4 mol % 
PdCl2(PPh3)2 (28.1 mg) and 3 mol % CuI (5.7 mg) were used and the reaction mixture was 
heated at 100 oC for 2 h. After purification, the product was obtained as a brown solid (152 
mg, 35%): mp 79-80 °C; IR (KBr) 3266 (br s), 2208 (w), 1605 (m), 1566 (w), 1454 (s), 1384 
(w), 1294 (m), 1266 (s), 1226 (m), 1160 (m), 1105 (m), 1050 (s), 895 (w), 817 (s), 807 (m), 
737 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.56-7.43 (m, 3H, aromatic), 7.39-7.30 (m, 3H, 
aromatic), 7.05 (br s, 1H, aromatic), 6.81 (d, J = 8.0 Hz, 1H, aromatic), 4.89 (s, 2H, CH2), 
3.84 (s, 3H, OMe), 2.21 (s, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 160.0, 144.4, 133.5, 
131.3, 128.4, 128.2, 123.2, 113.1, 112.5, 92.8, 86.7, 81.8, 64.0, 53.4; GC-MS m/z 238 (M+, 
100), 237 (38), 223 (35), 217 (27), 215 (24), 195 (22), 194 (27), 165 (22); HRMS calcd for 
C16H14O2 238.09937. Found 238.09979. 
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OH
Me
MeO
 
[5-Methoxy-2-(p-tolylethynyl)phenyl]methanol (1o). Reaction time: 14 h. After 
purification, the compound was obtained as an orange solid (459 mg, 91%): mp 99-100 °C; 
IR (KBr) 3341 (s), 2213 (w), 1607 (m), 1565 (w), 1497 (s), 1364 (m), 1294 (s), 1224 (s), 
1162 (m), 1107 (m), 1046 (s), 874 (m), 807 (m), 759 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.46-7.43 (m, 1H, aromatic), 7.43-7.36 (m, 2H, aromatic), 7.17-7.12 (m, 2H, aromatic), 7.05-
7.03 (m, 1H, aromatic), 6.84-6.77 (m, 1H, aromatic), 4.88 (s, 2H, CH2), 3.83 (s, 3H, OMe), 
2.37  (s, 3H, Me), 2.28 (br s, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 159.8, 144.3, 138.3, 
133.4, 131.2, 129.1, 120.1, 118.9, 113.3, 113.1, 112.5, 93.0, 86.0, 64.0, 55.3, 21.5; GC-MS 
m/z 252 (M+, 100), 249 (19), 237 (18), 236 (19), 209 (19), 179 (15), 178 (20), 166 (16), 165 
(19); HRMS calcd for C17H16O2 252.11502. Found 252.11541. 
 
OH
Me
O2N
 
[5-Nitro-2-(p-tolylethynyl)phenyl]methanol (1p). Yellow solid (428 mg, 80%): mp 136-
138 °C; IR (KBr) 3532 (br m), 2210 (m), 1603 (w), 1584 (w), 1520 (m), 1348 (s), 1183 (w), 
1089 (w), 1051 (w), 932 (w), 897 (w), 822 (m), 746 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 
8.42 (s, 1H, aromatic), 8.12 (d, J = 8.0 Hz, 1H, aromatic), 7.64 (d, J = 8.0 Hz, 1H, aromatic), 
7.50-7.40 (m, 2H, aromatic), 7.27-7.18 (m, 2H, aromatic), 5.00 (s, 2H, CH2), 2.40 (s, 3H, 
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Me), 2.22 (br s, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 147.2, 144.2, 139.9, 132.5, 131.7, 
129.4, 127.7, 122.2, 121.6, 118.7, 99.8, 84.5, 62.9, 21.6; GC-MS m/z 267 (M+, 100), 251 
(17), 221 (14), 208 (16), 181 (16), 179 (18); HRMS calcd for C16H13NO3 267.08954. Found 
267.09005. 
 
N
OH
 
[2-(Phenylethynyl)pyridin-3-yl]methanol (1q). Brown oil12b (335 mg, 80%): IR (KBr) 3254 
(br s), 2922 (m), 2218 (m), 1582 (m), 1577 (m), 1491 (m), 1428 (s), 1361 (m), 1251 (m), 
1189 (w), 1106 (w), 1047 (s), 917 (w), 792 (m), 757 (s), 690 (s) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 8.41 (d, J = 4.8 Hz, 1H, aromatic), 7.91 (d, J = 7.8 Hz, 1H, aromatic), 7.53-7.46 
(m, 2H, aromatic), 7.37-7.26 (m, 3H, aromatic), 7.20 (dd, J = 7.8, 4.8 Hz, 1H, aromatic), 4.97 
(s, 2H, CH2), 4.21 (br s, 1H, OH); 13C NMR (100 MHz, CDCl3) δ 148.1, 140.5, 139.3, 134.4, 
131.8, 129.1, 128.3, 123.0, 121.8, 94.2, 85.3, 61.5; GC-MS m/z 209 (M+, 92), 208 (82), 180 
(100), 77 (25), 52 (24), 51 (34), 50 (21); HRMS calcd for C14H11NO 209.08406. Found 
209.08432. 
 
N
OH
Me
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[2-(p-Tolylethynyl)pyridin-3-yl]methanol (1r). Brown solid (411 mg, 92%): mp 79-81 °C; 
IR (KBr) 3231 (br s), 2218 (m), 1581 (m), 1565 (m), 1509 (m), 1429 (s), 1364 (w), 1256 (w), 
1178 (w), 1106 (w), 1046 (s), 973 (w), 816 (s), 796 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 
8.48 (d, J = 4.6 Hz, 1H, aromatic), 7.87 (d, J = 7.9 Hz, 1H, aromatic), 7.45 (d, J = 7.9 Hz, 
2H, aromatic), 7.29-7.20 (m, 1H, aromatic), 7.15 (d, J = 7.9 Hz, 2H, aromatic), 4.96 (s, 2H, 
CH2), 3.11 (br s, 1H, OH), 2.37 (s, 3H, Me); 13C NMR (100 MHz, CDCl3) δ 148.4, 141.0, 
139.5, 138.8, 134.5, 131.8, 129.2, 122.9, 118.8, 94.5, 85.5, 62.0, 21.6; GC-MS m/z 223 (M+, 
33), 195 (25), 194 (33), 70 (37), 69 (21), 44 (100), 43 (66); HRMS calcd for C15H13NO 
223.09971. Found 223.10003. 
 
Preparation of Substrates Bearing a Secondary Alcohol (1s and 1t) 
According to a literature procedure, substrates 1s and 1t were prepared by 
Sonogashira coupling of 2-bromobenzaldehyde and the appropriate terminal alkyne, followed 
by addition of BuLi (Scheme S1).29k 
 
General Procedure for the Preparation of Alcohols 1s and 1t 
First step: Sonogashira coupling. To a stirred solution of 2-bromobenzaldehyde (10.0 
g, 54.0 mmol) in anhydrous Et3N (164 mL) were added Pd(OAc)2 (108.0 mg, 0.48 mmol), 
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PPh3 (218.0 mg, 0.83 mmol), CuI (16.0 mg, 0.084 mmol) and the alkyne (80.0 mmol). After 
being stirred at 80 °C for 5 h, the mixture was cooled, filtered and concentrated. Water was 
added to the residue, followed by Et2O. The phases were separated, and the aqueous layer 
was extracted with Et2O. The combined organic layers were washed several times with H2O 
and eventually dried over Na2SO4. After removal of the solvent by rotary evaporation, the 
crude product was purified by column chromatography on silica gel using as eluent 9:1 
hexane/EtOAc (8s: yellow oil,29k 9.4 g, 84% isolated yield; 8t: yellow solid, 10.0 g, 80% 
isolated yield).  
Second step: BuLi addition. To a cooled (0 °C), stirred solution of aldehyde 8s or 8t 
(45.0 mmol) in anhydrous THF (450 mL) was added dropwise a 2 M solution of BuLi in 
pentane (18 mL, 36.0 mmol). After being stirred at 0 °C for 2 h, the mixture was quenched 
with ice water, followed by HCl (10% by volume) to neutral pH. The phases were separated, 
and the aqueous layer was extracted with Et2O. The combined organic layers were washed 
with H2O and brine, and then dried over Na2SO4. After removal of the solvent by rotary 
evaporation, the crude product was purified by column chromatography on silica gel using 
8:2 hexane-EtOAc as eluent (1s was a yellow oil,29k 7.1 g, 60% with respect to starting 
aldehyde; 1t was a yellow solid, mp 55-56 °C, 6.6 g, 70% with respect to starting aldehyde). 
 
OH
Bu
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1-[2-(Phenylethynyl)phenyl]pentan-1-ol (1s). Yellow oil:29k IR (KBr) 3350 (br s), 2956 
(m), 2931 (m), 2859 (m), 2216 (w), 1600 (w), 1493 (m), 1444 (m), 1309 (w), 1251 (w), 1048 
(m), 890 (w), 756 (s), 690 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.59-7.44 (m, 4H, 
aromatic), 7.40-7.28 (m, 4H, aromatic), 7.22 (td, J = 7.5, 1.5 Hz, 1H, aromatic), 5.23 (dd,  J 
= 7.7, 5.3 Hz, 1H, CHOH), 2.34 (br s, 1H, OH), 1.94-1.70 (m, 2H, CHOHCH2), 1.53-1.24 
(m, 4H, CH2CH2CH3), 0.86 (t, J = 7.1 Hz, 3H, Me); 13C NMR (75 MHz, CDCl3) δ 147.0, 
132.3, 131.5, 128.8, 128.4, 127.0, 125.5, 123.4, 120.8, 94.3, 87.4, 72.5, 38.1, 28.2, 22.7, 
14.0; GC-MS m/z 264 (M+, 37), 221 (62), 208 (60), 207 (100), 179 (70), 178 (82), 176 (43), 
152 (33), 151 (20), 143 (22), 89 (25), 77 (21); anal. calcd for C19H20O (264.36) C, 86.32; H, 
7.63. Found C, 86.42; H, 7.68. 
 
OH
Me
Bu
 
1-[2-(p-Tolylethynyl)phenyl]pentan-1-ol (1t). Yellow solid: mp 55-56 °C; IR (KBr) 3350 
(br s), 3063 (m), 2956 (s), 2920 (s), 1911 (w), 1598 (w), 1511 (s), 1449 (m), 1272 (w), 1201 
(w), 1123 (m), 1055 (m), 1019 (w), 994 (w), 946 (w), 816 (s), 753 (s) cm-1; 1H NMR (300 
MHz, CDCl3) δ 7.54-7.45 (m, 2H, aromatic), 7.44-7.36 (m, 2H, aromatic), 7.31 (td, J = 7.5, 
1.2 Hz, 1H, aromatic), 7.10-7.25 (m, 3H, aromatic), 5.22 (dd,  J = 7.3, 5.3 Hz, 1H, CHOH), 
2.36 (s, 4H, Me + OH), 1.98-1.68 (m, 2H, CHOHCH2), 1.57-1.25 (m, 4H, CH2CH2CH3), 
0.86 (t, J = 6.9 Hz, 3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 147.0, 138.6, 132.1, 131.3, 
129.2, 128.6, 126.9, 125.4, 120.8, 120.1, 94.4, 86.6, 72.4, 38.1, 28.2, 22.6, 21.5, 14.1; GC-
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MS m/z 278 (M+, 25), 235 (28), 222 (23), 221 (100), 193 (15), 191 (14), 190 (13), 179 (13), 
178 (61), 165 (11), 143 (10), 115 (17); anal. calcd for C20H22O (278.39) C, 86.29; H, 7.97. 
Found C, 86.49; H, 8.01. 
 
Preparation of Substrates Bearing a Tertiary Alcohol (1u-w) 
According to the literature,29k substrates 1u and 1v were prepared by Sonogashira 
coupling of methyl 2-iodobenzoate and the appropriate terminal alkyne, followed by the 
addition of EtMgBr (Scheme S2). Substrate 1w was prepared by Swern oxidation of substrate 
1s, followed by the addition of EtMgBr (Scheme S3). 
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General Procedure for the Preparation of 1u and 1v 
First step: Sonogashira coupling. To a stirred solution of methyl 2-bromobenzoate 
(obtained by esterification of commercially available 2-bromobenzoic acid) (10.2 g, 38.9 
mmol) in anhydrous DMF (195 mL) were added PdCl2(PPh3)2 (2.7 g, 3.9 mmol), CuI (742 
mg, 3.9 mmol), (i-Pr)2NEt (21 mL) and phenylacetylene or 1-ethynyl-4-methylbenzene (78.0 
mmol). The mixture was allowed to stir at rt for 18 h, and then satd aq NH4Cl (200 mL) and 
hexane (200 mL) were added. The phases were separated, and the aqueous layer was 
extracted with hexane. The combined organic layers were washed with H2O and brine, and 
then dried over Na2SO4. After removal of the solvent by rotary evaporation, the crude 
product was purified by column chromatography on silica gel using 9:1 hexane–EtOAc as 
eluent (9u was a yellow oil,29k 8.8 g, 96%; 9v was a yellow oil, 8.7 g, 89%).  
Second step: EtMgBr addition. To a stirred solution of EtMgBr [78.0 mmol, prepared 
in anhydrous Et2O (33 mL) from 1.9 g of Mg (78.0 mmol) and 8.8 g of EtBr (81.0 mmol)] 
was added dropwise a solution of the alkynyl ester 9u or 9v (37.0 mmol) in anhydrous 
benzene (17 mL) with cooling. The mixture was then refluxed with stirring for 1 h (9u) or 3 
h (9v). After cooling, a mixture of ice (85.0 g) and conc. HCl (1.9 mL) was slowly added 
with external cooling, followed by the addition of NH4Cl (2.86 g) and Et2O. The phases were 
separated, and the organic layer was washed with water, 5% NaHCO3, and water again. After 
drying over Na2SO4, the solvent was removed by rotary evaporation and the crude product 
was purified by column chromatography on silica gel using as eluent 95:5 hexane–EtOAc 
(1u was a yellow oil,29k 7.1 g, 73%; 1v was a yellow oil, 6.3 g, 61%).  
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OH
EtEt
 
3-[2-(Phenylethynyl)phenyl]pentan-3-ol (1u). Yellow oil:29k IR (KBr) 3503 (br s), 2212 
(w), 1599 (w), 1492 (s), 1461 (m), 1442 (m), 1376 (w), 1160 (m), 1027 (w), 959 (m), 894 
(m), 846 (w), 756 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.68-7.45 (m, 4H, aromatic), 7.41-
7.28 (m, 4H, aromatic), 7.31 (td, J = 7.4, 1.3 Hz, 1H, aromatic), 2.56-2.40 [m, 2H, 
(CH3CHH)2COH)], 1.96 [sext, J = 7.3 Hz, 3H, (CH3CHH)2COH) + OH], 0.86 (t, J = 7.2 Hz, 
3H, Me); 13C NMR (75 MHz, CDCl3) δ 147.2, 134.5, 131.2, 128.5, 128.2, 127.2, 126.3, 
123.4, 119.6, 94.5, 89.8, 78.5, 33.3, 8.0; GC-MS m/z 264 (M+, 10), 236 (56), 235 (100), 220 
(35), 215 (16), 202 (26), 191 (28), 176 (19), 129 (23), 105 (31), 89 (15); anal. calcd for 
C19H20O (264.36) C, 86.32; H, 7.63. Found C, 86.12; H, 7.81. 
 
OH
EtEt
Me
 
3-[2-(p-Tolylethynyl)phenyl]pentan-3-ol (1v). Yellow oil: IR (KBr) 3509 (br m), 3028 (w), 
2969 (s), 2935 (m), 2878 (w), 2212 (w), 1511 (s), 1462 (m), 1376 (w), 1253 (w), 1160 (m), 
959 (m), 895 (w), 816 (s), 759 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.61-7.42 (m, 2H, 
aromatic), 7.43-7.36 (m, 2H, aromatic), 7.30 (td, J = 7.7, 1.6 Hz, 1H, aromatic), 7.24-7.12 
(m, 3H, aromatic), 2.60 (br s, 1H, OH), 2.47 [sext, J = 7.3 Hz, 2H, (CH3CHH)2COH)], 2.36 
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(s, 3H, Me), 1.95 [q, J = 7.3 Hz, 2H, (CH3CHH)2COH)], 0.78 [t, J = 7.3 Hz, 6H, 
(CH2CH3)2]; 13C NMR (75 MHz, CDCl3) δ 146.8, 138.6, 134.4, 131.0, 129.2, 128.0, 127.0, 
126.3, 120.1, 119.6,  94.7, 89.0, 78.5, 33.3, 21.5, 8.1; GC-MS m/z 288 (M+, 6), 250 (21),  
233 (10), 215 (5), 189 (7), 129 (6); anal. calcd for C20H22O (278.39) C, 86.29; H, 7.97. Found 
C, 86.49; H, 7.81. 
 
Procedure for the Preparation of 3-[2-(Phenylethynyl)phenyl]heptan-3-ol (1w). 
OH
BuEt
 
Swern oxidation. To a cooled (-78 °C), stirred solution of ClCOCOCl (4.4 g, 35.2 
mmol) in anhydrous CH2Cl2 (95 mL) under an inert atmosphere, was added dimethyl 
sulfoxide (3.7 g, 46.9 mmol). After being stirred at -78 °C for 15 min, a solution of the 
alcohol (6.2 g, 23.5 mmol) in anhydrous CH2Cl2 (31 mL) was added with stirring. After 
being stirred at -78 °C for an additional 15 min, anhydrous Et3N (9.4 mL, 93.9 mmol) was 
added with stirring. The reaction was allowed to warm up to rt and then allowed to stir at rt 
for 15 min. Et2O was added to the mixture, followed by water. The phases were separated 
and the aqueous layer was extracted with Et2O. The combined organic layers were washed 
several times with brine, 10% HCl, and eventually dried over Na2SO4. After removal of the 
solvent by rotary evaporation, the crude product was purified by column chromatography on 
silica gel using 9:1 hexane-EtOAc as eluent (yellow oil, 4.3 g, 70%). 
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EtMgBr addition: To a stirred solution of EtMgBr [19.8 mmol, prepared in anhydrous 
Et2O (8.3 mL) from 481 mg of Mg (19.8 mmol) and 2.2 g of EtBr (20.4 mmol)] was added 
dropwise a solution of the alkynyl ester (16.5 mmol) in anhydrous benzene (7.7 mL) with 
cooling. The mixture was then refluxed with stirring for 1 h. After cooling, a mixture of ice 
(85 g) and conc. HCl (0.25 mL) was slowly added with external cooling, followed by the 
addition of NH4Cl (0.75 g) and Et2O. The phases were separated, and the organic layer was 
washed with water, 5% NaHCO3, and water again. After drying over Na2SO4, the solvent 
was removed by rotary evaporation, and the crude product was purified by column 
chromatography on silica gel using 9:1 hexane–EtOAc as eluent to give pure 1w as a yellow 
oil (3.5 g, 73%):29k IR (KBr) 3492 (br s), 2212 (w), 1599 (m), 1492 (s), 1460 (s), 1441 (s), 
1378 (m), 1250 (w), 1158 (m), 1070 (m), 1026 (w), 960 (m), 846 (w), 756 (s) cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.62 (dd, J = 7.6, 1.2 Hz, 1H, aromatic), 7.56 (dd, J = 7.6, 1.2 Hz, 1H, 
aromatic), 7.53-7.47 (m, 2H,  aromatic), 7.40-7.28 (m, 4H,  aromatic), 7.20 (distorted td, J = 
7.6, 1.2 Hz, 1H, aromatic), 2.95-2.80 (m, 2H, CHHCH3), 2.60-2.40 (m, 3H, CH2CH2CH2CH3 
+ OH), 2.10-2.80 (m, 2H, CH2CH2CH2CH3), 1.39-1.20 (m, 3H, CHHCH3 + 
CH2CH2CH2CH3), 0.83 (t, J = 7.1 Hz, 3H, CH2CH3 or CH2CH2CH2CH3), 0.78 (t, J = 7.3 Hz, 
3H, CH2CH2CH2CH3 or CH2CH3); 13C NMR (75 MHz, CDCl3) δ 147.4, 134.4, 131.1, 128.5, 
128.2, 126.9, 126.3, 123.3, 119.3, 94.4, 89.7, 78.2, 45.2, 40.3, 33.6, 25.9, 23.4, 14.1, 8.0; GC-
MS m/z 292 (M+, 6), 264 (44),  263 (98), 236 (51), 235 (100), 221 (17), 220 (49), 215 (13), 
202 (24), 191 (34), 189 (14), 178 (21), 176 (21), 165 (12), 129 (15), 115 (21), 105 (33), 91 
(26), 77 (21); anal. calcd for C21H24O (292.41) C, 86.26; H, 8.27. Found C, 86.45; H, 8.32. 
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General Procedure for the Iodocylization of 1a-w. To a solution of 1 (0.30 mmol) in 
CH3CN (6.0 mL) was added NaHCO3 (75.6 mg, 0.90 mmol), followed by I2 (228.4 mg, 0.90 
mmol) at room temperature with stirring. The resulting mixture was allowed to stir at room 
temperature for 15 h. The excess I2 was removed by adding a satd aq soln of Na2S2O3, 
followed by stirring for 5-10 min. The phases were separated, and the aqueous phase was 
extracted with Et2O (2 × 10 mL). The combined organic phases were dried (Na2SO4) and 
concentrated under vacuum. The crude products were purified by column chromatography on 
silica gel using hexane-EtOAc (from 95:5 to 9:1) as the eluent. 
 
Characterization Data for the Products 
The products 4-iodo-3-aryl-1H-isochromene 2 and 3-(iodoarylmethylene)-1,3-
dihydro-isobenzofuran 3 were fully characterized by IR, MS, 1H NMR, and 13C NMR 
spectroscopic analyses. The structures of 4-iodo-3-p-methoxyphenyl-1H-isochromene (2c) 
and (Z)-1,1-diethyl-3-(iodophenylmethylene)-1,3-dihydroisobenzofuran (3u) were confirmed 
by X-ray diffraction analysis (Figures S1 and S2). In the case of 2e and 3e, 2f and 3f, 2g and 
3g, 2s and 3s, it was not possible to separate the two regioisomers, so we characterized them 
as a mixture. The ratio between the two regioisomers was determined by 1H NMR 
spectroscopy. 
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X-ray Crystallographic Data for Compounds 2c and 3u43 
Data Collection for 2c 
A colorless crystal of 2c was selected under ambient conditions. The crystal was 
mounted and centered in the X-ray beam by using a video camera. The crystal evaluation and 
data collection were performed at 173K on a Bruker CCD-1000 diffractometer with Mo Kα 
(λ = 0.71073 Å) radiation and the detector to crystal distance of 5.03 cm (Table S2). The 
initial cell constants were obtained from three series of ω scans at different starting angles. 
Each series consisted of 30 frames collected at intervals of 0.3º in a 10º range about ω with 
the exposure time of 10 seconds per frame. The obtained reflections were successfully 
indexed by an automated indexing routine built in the SMART program. The final cell 
constants were calculated from a set of strong reflections from the actual data collection. The 
data were collected using the full sphere routine by collecting four sets of frames with 0.3º 
scans in ω with an exposure time 10 sec per frame. This data set was corrected for Lorentz 
and polarization effects. The absorption correction was based on a fit of a spherical harmonic 
function to the empirical transmission surface as sampled by multiple equivalent 
measurements using SADABS software.44,45 
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Figure S1. Molecular Structure of 4-Iodo-3-(4-methoxyphenyl)-1H-isochromene (2c) 
 
TABLE S2. Crystallographic Data for 2c 
Empirical formula  C16H13IO2 
Formula weight  364.16 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pca2(1) 
Unit cell dimensions a = 11.537(7) Å α = 90° 
 b = 14.916(7) Å β = 90° 
 c = 7.794(4) Å γ  = 90° 
Volume 1341.2(13) Å3 
Z 4 
Density (calculated) 1.803 Mg/m3 
Absorption coefficient 2.382 mm-1 
F(000) 712 
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Crystal size 0.35 x 0.35 x 0.24 mm3 
Theta range for data collection 1.37 to 28.87° 
Index ranges -15<=h<=15, -19<=k<=19, -10<=l<=10 
Reflections collected 11635 
Independent reflections 3282 [R(int) = 0.0631] 
Completeness to theta = 25.00° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5987 and 0.4894 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3282 / 1 / 173 
Goodness-of-fit on F2 0.910 
Final R indices [I>2sigma(I)] R1 = 0.0408, wR2 = 0.0974 
R indices (all data) R1 = 0.0583, wR2 = 0.1137 
Absolute structure parameter 0.01(4) 
Largest diff. peak and hole 0.741 and -1.366 e.Å-3 
----------------------------------------------------------------------------- 
R1  = Σ | |Fo| – |Fc| |  / Σ |Fo|  and  wR2  =  { Σ [ w(Fo2–Fc2)2 ]  / Σ [ w(Fo2)2 ]  }1/2 
 
X-ray Crystallographic Data for Compound 3u43 
X-ray data for 3u were collected at room temperature on a Bruker-Nonius X8 Apex 
CCD area detector equipped with a graphite monochromator and Mo Kα radiation (λ = 
0.71073), and data reduction were performed using the SAINT programs; absorption 
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corrections based on multi-scan were obtained by SADABS.46 The structures were solved by 
direct methods (SHELXS/L program in the SHELXTL-NT software package)47 and refined 
by full-matrix least-squares based on F2. All non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were included as idealized atoms riding on the respective 
carbon atoms with C-H bond lengths appropriate to the carbon atoms hybridization. Details 
of the crystal data, data collection and structure refinement are listed in Table S3. 
 
Figure S2. Molecular Structure of (Z)-1,1-Diethyl-3-(iodophenylmethylene)-1,3-
dihydroisobenzofuran 3u 
 
TABLE S3. Crystallographic data for (Z)-1,1-Diethyl-3-(iodophenylmethylene)-1,3-
dihydroisobenzofuran (3u)  
 3u  
Empirical formula C9H19IO  
Formula weight 390.24  
Space group  P21/n  
a (Å) 11.264(2)  
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b (Å) 10.372(2)  
c (Å) 15.229(3)  
α (°) 90  
β (°) 108.350(3)  
γ (°) 90  
V (Å3) 1688.7(5)  
Z 4  
Density (g/cm3) 1.535  
Absorption coefficient (mm–1) 1.893  
F(000) 776  
Reflection collected 26961  
Unique reflections 3481 [R(int) = 0.0322]  
Refined parameters 192  
goodness-of-fit 1.048  
R indices a, b R1 = 0.0246, wR2 = 0.0610  
R indices (all data) R1 = 0.0271, wR2 = 0.0626  
a
 R1 = Σ(|Fo| - |Fc|)/Σ|Fo|.  b wR2 = [Σw(Fo2 - Fc2)2 /Σw(Fo2)2]1/2. 
 
O
I
 
4-Iodo-3-phenyl-1H-isochromene (2a). Yellow oil: IR (KBr) 3059 (m), 2978 (m), 2918 
(m), 2843 (m), 1602 (m), 1587 (m), 1564 (m), 1478 (m), 1443 (m), 1374 (w), 1247 (m), 1085 
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(s), 979 (m), 919 (m), 845 (w), 754 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.67-7.61 (m, 
2H, aromatic), 7.47 (d, J = 7.5 Hz, 1H, aromatic), 7.44-7.38 (m, 3H, aromatic), 7.44-7.38 (m, 
3H, aromatic), 7.35 (distorted td, J = 7.5, 1.1 Hz, 1H, aromatic), 7.23 (distorted td, J = 7.5, 
1.1 Hz, 1H,  aromatic), 7.01 (d, J = 7.5 Hz, 1H, aromatic), 5.23  (s, 2H, CH2); 13C NMR (100 
MHz, CDCl3) δ 156.3, 136.5, 133.5, 130.4, 129.5, 128.7, 128.6, 128.5, 127.8, 127.6, 123.3, 
73.3, 69.6; GC-MS m/z 334 (M+, 100), 179 (37), 178 (38), 176 (13); HRMS calcd for 
C15H11IO 333.98546. Found 333.98588. 
 
 
4-Iodo-3-phenyl-1H-isochromene and (Z)-1-(Iodophenylmethylene]-1,3-
dihydroisobenzofuran (mixture 2a + 3a). Yellow oil (yield = 71%; 11:1 mixture 2a:3a 
determined by 1H NMR spectroscopy): IR (KBr) 3059 (m), 2978 (m), 2918 (m), 2843 (m), 
1602 (m), 1587 (m), 1564 (m), 1478 (m), 1443 (m), 1374 (w), 1247 (m), 1085 (s), 979 (m), 
919 (m), 845 (w), 754 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.68-7.59 (m, 2H, aromatic, 
2a), 7.50-7.28 (m, 5H, aromatic, 2a + 7H, aromatic, 3a), 7.22-7.15 (m, 1H, aromatic, 2a + 
1H, aromatic, 3a), 6.96 (d, J = 7.1 Hz, 1H, aromatic, 2a), 6.43 (d, J = 8.1 Hz, 1H, aromatic, 
3a), 5.39 (s, 2H, CH2 , 3a), 5.18 (s, 2H, CH2 , 2a); GC-MS (2a) m/z 334 (M+, 99), 207 (21), 
180 (27), 179 (100), 176 (32), 152 (30), 151 (15), 105 (17), 102 (46), 89 (31), 88 (12); GC-
MS (3a) GC-MS m/z 334 (M+, 69), 207 (934), 179 (164), 178 (100), 177 (18), 176 (23), 152 
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(22), 151 (13), 90 (13), 89 (64); anal. calcd for C15H11IO (334.15): C, 53.92; H, 3.32; I, 
37,98. Found C, 53.99; H, 3.28; I, 37.86. 
 
O
I Me
 
4-Iodo-3-p-tolyl-1H-isochromene (2b). Yellow solid (yield = 92%): mp 42-44 °C; IR (KBr) 
3051 (m), 2924 (m), 2851 (m), 1590 (m), 1509 (m), 1477 (m), 1452 (m), 1265 (s), 1183 (w), 
1084 (s), 919 (m), 819 (m), 737 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.57-7.52 (m, 2H,  
aromatic), 7.45 (d, J = 7.6 Hz, 1H, aromatic), 7.33 (t, J = 7.6 Hz, 1H, aromatic), 7.25-7.16 
(m, 3H, aromatic), 6.97 (d, J = 7.6, 1H, aromatic), 5.20 (s, 2H, CH2), 2.39 (s, 3H, Me); 13C 
NMR (100 MHz, CDCl3) δ 156.4, 140.0, 133.7, 133.5, 130.3, 128.6, 128.5, 128.4, 127.4, 
123.3, 121.2, 72.8, 69.5, 21.5; GC-MS m/z 348 (M+, 100), 347 (7), 222 (4), 221 (4), 220 (3), 
194 (5), 193 (8), 192 (6); HRMS calcd for C16H13IO 348.00111. Found 348.00173. 
 
O
I OMe
 
4-Iodo-3-(4-methoxyphenyl)-1H-isochromene (2c). Colorless solid (yield = 85%): mp 99-
101 °C; IR (KBr) 3053 (m), 2965 (m), 2928 (m), 2850 (m), 1607(m), 1507 (m), 1448 (m), 
1263 (s), 1175, 1079 (m), 1024 (m),  919 (w), 834 (m), 738 (s) cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.70-7.58 (m, 2H, aromatic), 7.44 (distorted dd, J = 7.7, 1.2 Hz, 1H aromatic), 7.33 
(td,  J = 7.7, 1.2 Hz, 1H, aromatic), 7.20 (td, J = 7.7, 1.2 Hz, 1H, aromatic), 6.98 (d, J = 7.7 
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Hz, 1H, aromatic), 6.95-6.88 (m, 2H, aromatic), 5.18 (s, 2H, CH2), 3.82 (s, 3H, OMe); 13C 
NMR (75 MHz, CDCl3) δ 160.5, 156.1, 133.9, 132.2, 128.6, 128.5, 127.4, 123.3, 113.1, 72.1, 
69.5, 55.3, 30.0; GC-MS m/z 364 (M+, 28), 195 (44), 194 (41), 176 (20), 167 (48), 165 (100), 
162 (56), 151 (34); HRMS calcd for C16H13IO2 363.99603, Found 363.99664. 
 
O
I
OMe
OMe
 
3-(3,5-Dimethoxyphenyl)-4-iodo-1H-isochromene (2d). White solid (yield = 41%): mp 
101-102 °C; IR (KBr) 3053 (m), 2986 (w), 2840 (w), 1594 (s), 1456 (m), 1424 (m), 1330 
(w), 1265 (s), 1205 (m), 1157 (m), 1063 (m), 1007 (w), 920 (w), 896 (w), 738 (s) cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.47 (dd, J = 7.5, 1.0 Hz, 1H, aromatic), 7.34 (td, J = 7.5, 1.0 Hz, 
1H, aromatic), 7.23 (td, J = 7.5, 1.0 Hz, 1H, aromatic), 6.99 (dd, J = 7.5, 1.0 Hz, 1H, 
aromatic), 6.78 (d,  J = 2.4 Hz, 2H, aromatic), 6.50 (t, J = 2.4 Hz, 1H, aromatic), 5.21 (s, 2H, 
CH2), 3.81 [(s, 6H, (OMe)2]; 13C NMR (75 MHz, CDCl3) δ 160.1, 156.2, 138.1, 133.4, 128.7, 
128.6, 128.5, 127.7, 123.4, 108.4, 102.1, 73.4, 70.0, 55.5; GC-MS m/z 394 (M+, 100), 267 
(39), 240 (15), 239 (80),  235 (18), 224 (25), 209 (30), 208 (72), 181 (26), 178 (15),165 (64), 
153 (24), 152 (38), 102 (22). HRMS calcd for C17H15IO3 394.00659. Found 394.00741. 
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(Z)-1-[(3,5-Dimethoxyphenyl)iodomethylene]-1,3-dihydroisobenzofuran (3d). Yellow 
solid (yield = 35%): mp 82-83 °C; IR (KBr) 3053 (w), 2965 (s), 2832 (s), 1633 (m), 1461 (s), 
1439 (w), 1350 (w), 1283 (w), 1215 (m), 1009 (m), 1059 (m), 940 (m), 855 (m), 776 (m), 
746 (m), 709 (s) cm-1;  1H NMR (300 MHz, CDCl3) δ 7.31-7.21 (m, 2H, aromatic), 7.10-7.00 
(m, 1 H, aromatic), 6.67-6.60 (m, 1H, aromatic), 6.57 (d, J = 2.4 Hz, 2H, aromatic), 6.46 (t, J 
= 2.4 Hz, 1H, aromatic), 5.40 (s, 2H, CH2), 3.78 [(s, 6H, (OMe)2]; 13C NMR (75 MHz, 
CDCl3) δ 160.9, 156.9, 142.5, 142.1, 130.8, 129.0, 127.8, 123.5, 121.3, 108.1, 101.0, 73.3, 
62.8, 55.4; GC-MS m/z 394 (M+, 100), 268 (17), 237 (10), 236 (10),  224 (13), 209 (20), 181 
(22), 165 (32), 153 (18), 152 (30), 89 (13); anal. calcd for C17H15IO3 (394.20) C, 51.80; H, 
3.84; I, 12.18. Found C, 51.75; H, 3.81; I, 12.18. 
 
 
3-(4-Chlorophenyl)-4-iodo-1H-isochromene and (Z)-1-[(4-
Chlorophenyl)iodomethylene]-1,3-dihydroisobenzofuran (2e + 3e). Yellow solid (yield = 
85%; 3:1 mixture 2e:3e, determined by 1H NMR spectroscopy): IR (KBr) 3064 (m), 2971 
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(m), 2920 (m), 2855 (m), 1645 (w), 1594 (m), 1488 (s), 1453 (m), 1399 (m), 1242 (m), 1206 
(w), 1091 (s), 1017 (m), 978 (w), 919 (m), 826 (m), 750 (s) cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.65-7.55 (m, 2H, aromatic, 2e), 7.50-7.41 (m, 1H, aromatic, 2e), 7.40-7.17 (m, 
4H, aromatic, 2a + 6H, aromatic, 3e), 7.06-6.95 (m, 1H, aromatic, 2e + 1H, aromatic, 3e), 
6.56-6.48 (m, 1H, aromatic, 3e), 5.43 (s, 2H, CH2 , 3e), 5.20 (s, 2H, CH2 , 2e); GC-MS (2e) 
m/z 368 (M+, 31), 213 (12), 179 (18), 178 (100), 176 (22), 111 (13), 102 (17), 89 (12), 88 
(12); GC-MS (3e) m/z 368 (M+, 52), 242 (14), 241 (24), 213 (24), 206 (21), 179 (22), 178 
(100), 176 (39), 152 (15), 103 (11), 89 (37), 88 (26); HRMS calcd for C15H10ClIO 
367.94649. Found 367.94726. 
 
 
4-Iodo-3-(4-nitrophenyl)-1H-isochromene and (Z)-1-[Iodo-(4-nitrophenyl)methylene]-
1,3-dihydroisobenzofuran (2f + 3f). Yellow solid (yield = 88%; 1:3 mixture 2f:3f 
determined by 1H NMR spectroscopy): IR (KBr) 3100 (w), 3065 (w), 2927 (w) 2875 (w), 
1637 (w), 15891 (m), 1516 (s), 1346 (s), 1290 (w), 1195 (w), 1106 (m), 1071 (s), 999 (m), 
845 (m), 769 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 8.32-8.22 (m, 2H, aromatic, 3f), 8.20-
8.15 (m, 2H, aromatic, 2f), 7.82-7.75 (m, 2H, aromatic, 2f), 7.68-7.59 (m, 2H, aromatic, 3f), 
7.53-7.25 (m, 2H, aromatic, 3f + 4H, aromatic, 2f),  7.10-7.01 (m, 2H, aromatic, 3f ), 6.56 (d, 
J = 7.7 Hz, 1H, aromatic, 3f ), 5.48 (s, 2H, CH2, 3f), 5.34 (s, 2H, CH2, 2f); GC-MS (3f) m/z 
379 (M+, 96), 252 (16), 224 (15), 206 (38), 205 (24), 178 (100), 177 (39), 176 (65). 165 (45), 
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152 (33), 151 (23), 89 (36), 88 (23); HRMS calcd for C15H10INO3 378.97054. Found 
378.97098. 
 
 
3-(3,5-Bis-trifluoromethylphenyl)-4-iodo-1H-isochromene and (Z)-1-[(3,5-Bis-
trifluoromethylphenyl)iodomethylene]-1,3-dihydroisobenzofuran (2g + 3g). Yellow oil 
(yield = 74%; 4:1 mixture 2g:3g determined by 1H NMR spectroscopy): IR (KBr) 1656 (w), 
1614 (m), 1467 (m), 1373 (m), 1279 (s), 1265 (s), 1178 (s), 1136 (s), 1072 (w), 1014 (w), 
1079 (w), 898 (w), 737 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 8.05-8.0 (m, 1H, aromatic, 
3g), 7.87-7.82 (m, 2H, aromatic, 3g + 2H, aromatic, 2g), 7.57-7.23 (m, 2H, aromatic, 3g + 
4H, aromatic, 2g), 7.07-7.01 (m, 2H, aromatic, 3g + 2H, aromatic, 2g), 6.45 (d, J = 8.1 Hz, 
1H, aromatic, 3g), 5.48 (s, 2H, CH2, 3g), 5.34 (s, 2H, CH2, 2g); GC-MS (2g) m/z 470 (M+, 
100), 468 (28), 177 (14), 176 (14), 129 (10), 127 (32), 89 (14); GC-MS (3g) m/z 470 (M+, 
100), 469 (58), 468 (15), 467 (11), 344 (16), 343 (21), 316 (14), 315 (16), 295 (14), 275 (13), 
246 (21); HRMS calcd for C17H9F6IO 469.96023. Found 469.96130. 
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4-Iodo-3-(thiophen-3-yl)-1H-isochromene (2h). Yellow solid (yield = 82%): mp 26-27 °C. 
IR (KBr) 3052 (m), 2952 (m), 2851 (m), 1590 (m), 1477 (m), 1453 (w), 1362 (w), 1230 (w), 
1183 (w), 1089 (m), 1079 (m), 1004 (m), 922 (m), 838 (m), 735 (s) cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.87 (dd, J = 2.8, 1.2 Hz, 1H, aromatic), 7.57 (dd, J = 5.3, 1.2 Hz, 1H, 
aromatic), 7.45 (dd, J = 8.1, 0.8 Hz, 1H, aromatic), 7.36 -7.25 (m, 2H, aromatic), 7.57 (td, J 
= 7.3, 1.2 Hz, 1H, aromatic), 6.97 (d, J = 6.9 Hz, 1H, aromatic), 5.13 (s, 2H, CH2), 2.17 (br s, 
1H, OH); 13C NMR (75 MHz, CDCl3) δ 151.5, 136.7, 133.7, 129.0, 128.92, 128.88, 128.51, 
128.53, 127.5, 124.4, 123.3, 72.8, 69.2, 17.9; GC-MS m/z 340 (M+, 82), 185 (65), 184 (100), 
183 (90), 153 (34), 151 (37), 141 (18), 138 (22); HRMS calcd for C13H9IOS 339.94189. 
Found 339.94249. 
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3-(Cyclohex-1-enyl)-4-iodo-1H-isochromene (2i). Yellow solid (yield = 80%): mp 46-48 
°C; IR (KBr) 3055 (m), 2950 (m), 2847 (m), 1607 (m), 1507 (m), 1448 (m), 1263 (s), 1175 
(3), 1079 (m), 1024 (m), 919 (w), 834 (m), 738 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.37 
(d, J = 7.4 Hz, 1H, aromatic), 7.30 (t, J = 7.4 Hz, 1H, aromatic), 7.17 (t, J = 7.4 Hz, 1H, 
aromatic), 6.94 (d, J = 7.4 Hz, 1H, aromatic), 6.07 (s, 1H, C=CH), 5.05 (s, 2H, CH2O), 2.30-
2.11 ( m, 4H, CCH2CH2CH2CH2CH), 1.77-1.60  (m, 4H, CCH2CH2CH2CH2CH); 13C NMR 
(100 MHz, CDCl3) δ 158.9, 134.8, 133.3, 128.4, 128.3, 127.1, 123.2, 72.0, 69.1, 30.3, 29.7, 
26.9, 25.1, 22.4, 21.7; GC-MS m/z 338 (M+, 100), 336 (87), 213 (35), 212 (32), 209 (25); 
HRMS calcd for C15H15IO 338.01676. Found 338.01743. 
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3-Butyl-4-iodo-1H-isochromene (2j). Yellow oil (yield = 57%): IR (KBr) 2959 (m), 2870 
(m), 1603 (m), 1574 (m), 1516 (m), 1454 (s), 1379 (w), 1256 (w), 1103 (w), 752 (s) cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.35-7.22 (m, 2H, aromatic), 7.20-7.10 (m, 2H, aromatic), 6.93 
(d, J = 7.1 Hz, 1H, aromatic), 5.02 (s, 2H, CH2O), 2.60 (t, J = 7.6 Hz, 2H, CH2CH2CH2CH3), 
1.62-1.45 (m, 2H, CH2CH2CH3), 1.41 (sext, J = 7.3 Hz, 2H, CH2CH2CH3), 0.95 (t, J = 7.3, 
3H, Me); 13C NMR (75 MHz, CDCl3) δ 159.85, 132.8, 128.4, 128.0, 127.4, 126.9, 123.2, 
73.7, 68.7, 36.6, 29.5, 22.4, 14.0; GC-MS m/z 314 (M+, 60 ), 271 (11), 146 (15), 145 (97), 
144 (11), 131 (10), 129 (16), 128 (16), 117 (78), 116 (54), 115 (100), 103 (34), 102 (48), 91 
(20), 89 (16); anal. calcd for C13H15IO (314.16) C, 49.70; H, 4.81; I, 40.39. Found C, 49.81; 
H, 4.81; I, 40.48. 
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4-Iodo-7-methoxy-3-phenyl-1H-isochromene (2n). Yellow solid (yield = 51%): mp 106-
108 °C; IR (KBr) 3051 (w), 2960 (m), 2930 (m), 2856 (w), 1612 (w), 1490 (m), 1448 (m), 
1265 (s), 1075 (m), 1042 (m), 982 (w), 809 (m), 739 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.67-7.60 (m, 2H, aromatic), 7.45-7.35 (m, 4H, aromatic), 6.87 (dd, J = 8.5, 2.0 Hz, 1H, 
aromatic), 6.65-6.57 (m, 1H, aromatic), 5.19 (s, 2H, CH2), 3.83 (s, 3H, OMe); 13C NMR (100 
MHz, CDCl3) δ 159.4, 154.4, 136.6, 130.3, 130.2, 130.0, 129.3, 127.7, 126.4, 113.1, 109.4, 
170 
 
 
73.1, 69.5, 55.5; GC-MS m/z 364 (M+, 100), 237 (41), 209 (68), 208 (23), 194 (41), 165 (41); 
HRMS calcd for C16H13IO2 363.99603. Found 363.99664. 
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4-Iodo-7-methoxy-3-p-tolyl-1H-isochromene (2o). Yellow solid (yield = 61%): mp 76-78 
°C; IR (KBr) 3053 (w), 2925 (w), 2840 (w), 1611 (m), 1491 (m), 1312 (w), 1264 (s), 1084 
(m), 1043 (m), 1024 (w), 943 (w), 819 (m), 720 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 7.54 
(d, J = 7.8 Hz, 2H, aromatic), 7.38 (d, J = 8.5 Hz, 1H, aromatic), 7.20 (d, J = 7.8 Hz, 2H, 
aromatic), 6.85 (dd, J = 8.5, 1.6 Hz, 1H, aromatic), 6.59 (s, 1H, aromatic), 5.17 (s, 2H, CH2), 
3.82 (s, 3H, OMe), 2.39 (s, 3H, Me); 13C NMR (100 MHz, CDCl3) δ 159.3, 154.4, 139.4, 
133.6, 130.3, 130.1, 128.4, 126.7, 113.1, 109.4, 109.3, 72.6, 69.4, 55.5, 21.5; GC-MS m/z 
378 (M+, 31), 251 (25), 224 (41), 223 (64), 222 (36), 220 (34), 208 (52) 206 (38), 205 (100), 
178 (21); HRMS calcd for C17H15IO2 378.01168. Found 378.01227. 
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4-Iodo-7-nitro-3-p-tolyl-1H-isochromene (2p). Yellow solid (yield = 92%): mp 164-165 
°C; IR (KBr) 3054 (m), 2986 (w), 2927 (w), 1602 (w), 1505 (br m), 1344 (m), 1265 (s), 1079 
(w), 893 (w), 739 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J = 7.8 Hz, 1H, aromatic), 
7.94 (s, 1H, aromatic), 7.65-7.51 (m, 3H, aromatic), 7.32-7.15 (m, 2H, aromatic), 5.30 (s, 2H, 
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CH2), 2.42 (s, 3H, Me); 13C NMR (100 MHz, CDCl3) δ 160.2, 146.5, 140.8, 140.2, 132.6, 
130.4, 129.2, 128.7, 128.6, 124.1, 118.7, 70.0, 69.0, 21.5; GC-MS m/z 393 (M+, 100), 267 
(25), 265 (45), 237 (36),  193 (40), 192 (82), 191 (93), 189 (33), 176 (21), 165 (37), 91 (23); 
HRMS calcd for C16H12INO3 392.98619. Found 392.98689. 
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8-Iodo-7-phenyl-5H-pyrano[4,3-b]pyridine (2q). Yellow solid (yield = 98%): mp 95-97 
°C; IR (KBr) 3049 (m), 2982 (w), 2923 (w), 2854 (w),1613 (w), 1588 (m), 1420 (m), 1261 
(s), 1071 (m), 913 (w), 712 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.59 (s, 1H, aromatic), 
7.72 (s, 2H, aromatic), 7.54-7.26 (m, 4H, aromatic), 7.15 (m, 1H, aromatic), 5.31 (s, 2H, 
CH2); 13C NMR (100 MHz, CDCl3) δ 160.6, 150.2, 149.3, 135.8, 131.1, 130.3, 130.1, 127.8, 
123.2, 122.3, 118.9, 69.1; GC-MS m/z 335 (M+, 100), 334 (30), 180 (37), 179 (32), 77 (40); 
HRMS calcd for C14H10INO 334.98071. Found 334.98125. 
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8-Iodo-7-p-tolyl-5H-pyrano[4,3-b]pyridine (2r). Yellow solid (yield = 92%): mp 90-91 °C; 
IR (KBr) 3052 (m), 2985 (w), 2924 (w), 2853 (w), 1611 (w), 1582 (m), 1425 (m), 1265 (s), 
1088 (m), 922 (w), 729 (s) cm-1; 1H NMR (400 MHz, CDCl3) δ 8.58 (d, J = 5.0 Hz, 1H, 
aromatic), 7.62 (d, J = 8.0 Hz, 2H, aromatic), 7.30 (d, J = 7.3 Hz, 2H, aromatic), 7.23 (d, J = 
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8.0 Hz, 2H, aromatic), 7.13 (dd, J = 7.3, 5.0 Hz, 1H, aromatic), 5.27 (s, 2H, CH2), 2.40 (s, 
3H, Me); 13C NMR (100 MHz, CDCl3) δ 160.6, 150.4, 149.2, 140.3, 132.8, 131.1, 130.3, 
128.5, 123.2, 122.1, 75.2, 69.0, 21.5; GC-MS m/z 349 (M+, 50), 255 (38), 194 (100), 193 
(39), 86 (43), 84 (60); HRMS calcd for C15H12INO 348.99636. Found 348.99689. 
 
 
1-Butyl-4-iodo-3-phenyl-1H-isochromene and (Z)-1-Butyl-3-(iodophenylmethylene)-1,3-
dihydroisobenzofuran (2s + 3s). Yellow oil (yield = 76%; 3:1 mixture 2s:3s determined by 
1H NMR spectroscopy): IR (KBr) 3027 (m), 2953 (s), 2856 (m), 1671 (m), 1593 (s), 1503 
(m), 1458 (m), 1253 (m), 1080 (s), 1025 (w), 932 (m), 816 (m), 750 (s) cm-1; 1H NMR (300 
MHz, CDCl3) δ 7.65-7.55 (m, 2H, aromatic, 2s), 7.50-7.45 (m, 1H, aromatic, 2s), 7.44-7.10 
(m, 5H, aromatic, 2s + 7H, aromatic, 3s), 7.00-6.99 (m, 1H, aromatic, 2s + 1H, aromatic, 3s), 
6.43 (d, J = 7.7 Hz, 1H, aromatic, 3s), 5.55 (distorted dd, J = 7.3, 4.0 Hz, 1H, OCH, 3s), 5.55 
(distorted dd, J = 8.2, 5.5 Hz, 1H, OCH, 2s); 2.18-1.85 (m, 2H, CH2CH2CH2CH3, 2s + 2H, 
CH2CH2CH2CH3, 3s), 1.65-1.20 (m, 1H, 4H, CH2CH2CH2CH3, 2s + 4H, CH2CH2CH2CH3, 
3s), 1.01-0.79 (m, 3H, CH2CH2CH3, 2s + 3H, CH2CH2CH3, 3s); GC-MS (2s) m/z 390 (M+, 
22), 334 (16), 333 (100), 207 (16), 206 (56), 178 (16), 105 (29); GC-MS (3s) m/z 390 (M+, 
92), 333 (72), 207 (50), 206 (65), 191 (18), 178 (56), 176 (32), 152 (25), 149 (25), 131 (20), 
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115 (31), 105 (28), 91 (100), 89 (33); anal. calcd for C19H19IO (390.26) C, 58.47; H, 4.91; I, 
32.52 . Found C, 58.31; H, 4.99; I, 32.55. 
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1-Butyl-4-iodo-3-p-tolyl-1H-isochromene (2t). Yellow oil (yield = 72%): IR (KBr) 3028 
(m), 2955 (s), 2859 (m), 1675 (m), 1595 (s), 1567 (w), 1507 (m), 1451 (m), 1378 (w), 1253 
(m), 1182 (w), 1082 (s), 1021 (w), 934 (m), 818 (m), 757 (s) cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.55-7.50 (m, 2H, aromatic), 7.47 (distorted dd, J = 7.5, 1.2 Hz, 1H, aromatic), 
7.30 (td, J = 7.5, 1.2 Hz, 1H, aromatic), 7.24-7.17 (m, 3H, aromatic), 6.95 (d distorted, J = 
7.5 Hz, 1H, aromatic), 5.15 (dd, J = 8.1, 5.3 Hz, 1H, OCH), 2.38 (s, 3H, Me), 2.18-2.03 (m, 
1H, CHHCH2CH2CH3), 1.97-1.85 (m, 1H, CHHCH2CH2CH3 ), 1.68-1.23 (m, 4H, 
CH2CH2CH3), 0.93 (t, J = 7.1 Hz, 3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 154.5, 139.5, 
134.1, 132.7, 132.0, 130.2, 129.0, 128.5, 128.1, 127.4, 123.3, 78.5, 72.03, 32.9, 27.5, 22.5, 
21.5, 14.0; GC-MS m/z 404 (M+, 51), 348 (25), 347 (100), 221 (24), 220 (92), 205(11), 191 
(23), 189 (18), 178 (10), 165 (12), 119 (39), 91 (35); anal. calcd for C20H21IO (404.28) C, 
59.42; H, 5.24; I, 31.39. Found C, 59.54; H, 5.28; I, 31.42. 
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(Z)-1,1-Diethyl-3-(iodophenylmethylene)-1,3-dihydroisobenzofuran (3u). Yellow solid 
(yield = 70%): mp 93-95 °C; IR (KBr) 3071 (w), 2966 (s), 2934 (m), 2876 (w), 1635 (s), 
1461 (s), 1353 (w), 1290 (w), 1100 (m), 1076 (m), 1023 (w), 953 (s), 875 (m), 810 (w), 765 
(m), 750 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.47-7.27 (m, 5H, aromatic), 7.22 (t, J = 7.4 
Hz, 1H, aromatic), 7.04 (d, J = 7.4 Hz, 1H, aromatic), 6.95-6.90 (m, 1H, aromatic), 6.42 (d, J 
= 7.4 Hz, 1H, aromatic), 2.05 [sext, J = 7.3 Hz, 2H, (CHHCH3)2], 1.85 [(sext, J = 7.3 Hz, 2H, 
(CHHCH3)2], 0.76 [(t, J = 7.3 Hz, 6H, CH2CH3)2]; 13C NMR (75 MHz, CDCl3) δ 156.1, 
147.4, 141.2, 130.8, 128.83, 128.76, 128.1, 127.5, 122.8, 121.0, 92.7, 62.1, 32.6, 7.7; GC-MS 
m/z 390 (M+, 39), 362 (19), 361 (100), 235 (15), 234 (11), 205 (47), 177 (10), 176 (24), 151 
(12), 105 (16), 91 (20), 89 (10); anal. calcd for C19H19IO (390.26) C, 58.47; H, 4.91; I, 32.52. 
Found C, 58.59; H, 4.88; I, 32.51. 
 
 
(Z)-1,1-Diethyl-3-(iodo-p-tolylmethylene)-1,3-dihydroisobenzofuran (3v). Yellow solid 
(yield = 70%): mp 60-63 °C; IR (KBr) 3019 (w), 2965 (m), 2936 (w), 2878 (w), 1634 (m), 
1507 (w), 1462 (s), 1355 (w), 1291 (w), 1209 (w), 1099 (m), 1073 (m), 952 (s), 877 (m), 766 
(m) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.35-7.27 (m, 2H, aromatic), 7.26-7.15 (m, 3H, 
aromatic), 7.06-7.02 (m, 1H, aromatic), 7.00-6.92 (m, 1H, aromatic), 6.49 (d , J = 7.7 Hz, 
1H, aromatic), 2.40 (s, 3H, Me), 2.06 (sext, J = 7.3 Hz, 2H, (CHHCH3)2), 1.84 [(sext, J = 7.3 
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Hz, 2H, (CHHCH3)2], 0.77 [(t, J = 7.3 Hz, 6H, CH2CH3)2]; 13C NMR (75 MHz, CDCl3) δ 
156.0, 147.4, 138.3, 137.9, 132.0, 130.6, 129.6, 128.7, 127.4, 122.9, 121.0, 92.5, 62.5, 32.6, 
21.4, 7.7; GC-MS m/z 404 (M+,75), 376 (23), 375 (100), 248 (17), 220 (10), 219 (39), 189 
(20), 119 (11), 105 (13); anal. calcd for C20H21IO (404.28) C, 59.42; H, 5.24; I, 31.39. Found 
C, 59.35; H, 5.10; I, 31.31. 
 
 
(Z)-1-Butyl-1-ethyl-3-(iodophenylmethylene)-1,3-dihydroisobenzofuran (3w). Yellow 
solid (yield = 82%): mp 84-86 °C; IR (KBr) 3058 (w), 2968 (s), 2936 (s), 2873 (m), 1641 
(m), 1465 (s), 1441 (w), 1378 (w), 1291 (w), 1209 (m), 1005 (m), 1068 (m), 961 (m), 864 
(m), 771 (m), 753 (m), 700 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.46-7.27 (m, 5H, 
aromatic), 7.26-7.18 (m, 1H, aromatic), 7.05 (d, J = 7.9 Hz, 1H, aromatic), 6.99 (td, J = 7.9, 
0.8 Hz, 1H, aromatic), 6.42 (d , J = 7.9 Hz, 1H, aromatic), 2.14-1.93 (m, 2H, CH2CH3), 1.91-
1.70 (m, 2H, CH2CH2CH2CH3), 1.44-1.15 (m, 4H, CH2CH2CH2CH3), 0.85 (t, J = 7.3 Hz, 3H, 
CH2CH3 or CH2CH2CH2CH3), 0.76 (t, J = 7.3 Hz, 3H, CH2CH2CH2CH3 or CH2CH3); 13C 
NMR (75 MHz, CDCl3) δ 156.1, 147.8, 141.2, 131.7, 130.8, 128.8, 128.7, 128.1, 127.4, 
122.8, 121.0, 92.4, 62.1, 39.4, 32.9, 25.4, 22.8, 14.0, 7.7; GC-MS m/z 418 (M+, 80), 390 
(22), 389 (100), 362 (20), 361 (95), 235 (13), 220 (14), 206 (14), 205 (68), 191 (11), 189 
(11), 177 (18), 176 (30), 151 (12), 91 (21); anal. calcd for C21H23IO (418.31) C, 60.30; H, 
5.54; I, 30.34. Found C, 60.23; H, 5.61; I, 30.31. 
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Computational Details.  All computations were carried out using the GAMESS suite of 
programs.48 The 6-31G(d) basis set was used for all C and H atoms, and the SBKJC effective 
core potential and corresponding basis set (with polarization) was used for I.49,50  
Optimizations were carried out at RHF, MP2, and B3LYP levels of theory, all using Cs 
symmetry.  Hessians were calculated at the RHF level of theory and showed zero imaginary 
frequencies.  Zero point energies and corrections to 298 K were taken from this calculation.  
Table S4 gives the absolute energies obtained at each level of theory.  The coordinates for 
each molecule are given below. 
 
Table S4.  Absolute and relative energies of E and Z- 1,1-diethyl-3-(iodophenylmethylene)-
1,3-dihydroisobenzofuran (3u) 
 
Z-isomer energy 
(Hartree) 
E-isomer energy 
(Hartree) 
E-Z 
(kcal/mol) 
∆H, E-Z 
(kcal/mol) 
RHF -816.6343792 -816.6282395 3.85 3.79 
B3LYP -821.5739791 -821.5681677 3.65 3.59 
MP2 -819.3257530 -819.3194268 3.97 3.91 
ZPE + H, kcal/mol 233.401 233.341 -0.06  
 
E-isomer 
B3LYP: 
COORDINATES OF SYMMETRY UNIQUE ATOMS (ANGS) 
   ATOM   CHARGE       X              Y              Z 
 ------------------------------------------------------------ 
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 C           6.0  -0.8055600665   0.0161259902   0.0000000000 
 C           6.0  -1.7671509728   1.1470834420   0.0000000000 
 C           6.0  -3.5825656905   3.2930583197   0.0000000000 
 C           6.0   4.2716544721  -1.8127070308   0.0000000000 
 C           6.0   4.1322900796  -0.4219757675   0.0000000000 
 C           6.0   2.8517944980   0.1229940982   0.0000000000 
 C           6.0   1.7106268746  -0.6946801037   0.0000000000 
 C           6.0   1.8541272392  -2.0882063610   0.0000000000 
 C           6.0   3.1390788020  -2.6341712549   0.0000000000 
 C           6.0   0.5344342842   0.1933022997   0.0000000000 
 C           6.0   2.4392828984   1.5751478133   0.0000000000 
 C           6.0   2.8765014465   2.3421515730   1.2679493169 
 C           6.0  -3.1295241762   2.7578019775   1.2082045126 
 C           6.0   2.4143254607   1.7272486097   2.5923502475 
 C           6.0  -2.2304040954   1.6911295238   1.2083160527 
 O           8.0   0.9850441970   1.4980858629   0.0000000000 
 I          53.0  -1.7205456159  -1.9121181713   0.0000000000 
 H           1.0   2.4899192073   3.3657466871   1.1834105793 
 H           1.0   3.9725433761   2.4181053556   1.2504414796 
 H           1.0   1.3218681410   1.6711379578   2.6352542946 
 H           1.0   2.7531962467   2.3412260742   3.4343236128 
 H           1.0   2.8136449078   0.7166929741   2.7304500089 
 H           1.0  -1.8811758803   1.2709227532   2.1478707327 
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 H           1.0  -3.4778573902   3.1703043989   2.1518602958 
 H           1.0   3.2570105093  -3.7144316220   0.0000000000 
 H           1.0   5.2633759613  -2.2574908659   0.0000000000 
 H           1.0   0.9912244740  -2.7409174739   0.0000000000 
 H           1.0   5.0110226615   0.2184889007   0.0000000000 
 H           1.0  -4.2862583035   4.1217586345   0.0000000000 
MP2:  
COORDINATES OF SYMMETRY UNIQUE ATOMS (ANGS) 
   ATOM   CHARGE       X              Y              Z 
 ------------------------------------------------------------ 
 C           6.0  -0.8097088859  -0.0046101440   0.0000000000 
 C           6.0  -1.7425779271   1.1386897353   0.0000000000 
 C           6.0  -3.4892279278   3.3310361071   0.0000000000 
 C           6.0   4.2894331681  -1.7585811196   0.0000000000 
 C           6.0   4.1300798648  -0.3695357688   0.0000000000 
 C           6.0   2.8389482355   0.1520929369   0.0000000000 
 C           6.0   1.7114556599  -0.6832380371   0.0000000000 
 C           6.0   1.8700345611  -2.0765349247   0.0000000000 
 C           6.0   3.1662800907  -2.5970928143   0.0000000000 
 C           6.0   0.5327610024   0.1869562726   0.0000000000 
 C           6.0   2.4124052029   1.5888924513   0.0000000000 
 C           6.0   2.8295935166   2.3381469558   1.2670886282 
 C           6.0  -3.0529336692   2.7832664866   1.2103150895 
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 C           6.0   2.3569814297   1.6711905171   2.5547613254 
 C           6.0  -2.1857789692   1.6893043573   1.2121138261 
 O           8.0   0.9555901642   1.5074225455   0.0000000000 
 I          53.0  -1.7163534598  -1.9179727253   0.0000000000 
 H           1.0   2.4232967575   3.3549358802   1.1979590253 
 H           1.0   3.9242134886   2.4291675319   1.2596656636 
 H           1.0   1.2682722626   1.5750140174   2.5539521895 
 H           1.0   2.6465076565   2.2702101843   3.4235037784 
 H           1.0   2.7934491795   0.6751529102   2.6696153399 
 H           1.0  -1.8445032493   1.2555567555   2.1502307502 
 H           1.0  -3.3908944690   3.2074699502   2.1532608851 
 H           1.0   3.3035640864  -3.6759951676   0.0000000000 
 H           1.0   5.2874523307  -2.1910613050   0.0000000000 
 H           1.0   1.0163540995  -2.7433357134   0.0000000000 
 H           1.0   4.9991516366   0.2867728359   0.0000000000 
 H           1.0  -4.1670889805   4.1815462223   0.0000000000 
RHF: 
COORDINATES OF SYMMETRY UNIQUE ATOMS (ANGS) 
   ATOM   CHARGE       X              Y              Z 
 ------------------------------------------------------------ 
 C           6.0  -0.7865181320   0.0140741022   0.0000000000 
 C           6.0  -1.7446864770   1.1559376585   0.0000000000 
 C           6.0  -3.5365488286   3.2908285895   0.0000000000 
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 C           6.0   4.2594899136  -1.7928685738   0.0000000000 
 C           6.0   4.1141086496  -0.4160273522   0.0000000000 
 C           6.0   2.8367564861   0.1141006459   0.0000000000 
 C           6.0   1.7165209637  -0.7011900388   0.0000000000 
 C           6.0   1.8641343015  -2.0841382941   0.0000000000 
 C           6.0   3.1411116791  -2.6176056288   0.0000000000 
 C           6.0   0.5322635297   0.1887049340   0.0000000000 
 C           6.0   2.4152912199   1.5615068123   0.0000000000 
 C           6.0   2.8489120615   2.3292607913   1.2583933957 
 C           6.0  -3.0900410422   2.7568666311   1.1981098225 
 C           6.0   2.3926328207   1.7238497436   2.5843016044 
 C           6.0  -2.2013389094   1.6947290038   1.1974724644 
 O           8.0   0.9910222251   1.4654662430   0.0000000000 
 I          53.0  -1.7228368573  -1.8847080640   0.0000000000 
 H           1.0   2.4575079636   3.3383076688   1.1735544027 
 H           1.0   3.9327221915   2.4122188257   1.2447449373 
 H           1.0   1.3122755925   1.6533720225   2.6281032009 
 H           1.0   2.7175220808   2.3515001889   3.4080641407 
 H           1.0   2.8054620856   0.7334420146   2.7413471615 
 H           1.0  -1.8597836640   1.2786391365   2.1280943379 
 H           1.0  -3.4332656052   3.1652242326   2.1318997414 
 H           1.0   3.2663844820  -3.6850484492   0.0000000000 
 H           1.0   5.2428396642  -2.2275756449   0.0000000000 
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 H           1.0   1.0191240964  -2.7386249414   0.0000000000 
 H           1.0   4.9794838317   0.2223582016   0.0000000000 
 H           1.0  -4.2281911085   4.1142717614   0.0000000000 
 
Z-Isomer 
B3LYP: 
COORDINATES OF SYMMETRY UNIQUE ATOMS (ANGS) 
   ATOM   CHARGE       X              Y              Z 
 ------------------------------------------------------------ 
 C           6.0   2.6225569016   1.2298550856   2.5913569680 
 C           6.0  -1.9812901040  -1.9202877883   1.2090192274 
 C           6.0  -2.7031189729  -3.1145741603   1.2088271316 
 C           6.0   3.1888814923   1.7518077990   1.2678437752 
 C           6.0   2.6327650025   1.0678332442   0.0000000000 
 C           6.0   0.5327698737   0.0236995488   0.0000000000 
 C           6.0  -0.8134656237  -0.0598051656   0.0000000000 
 C           6.0  -1.6018135197  -1.3130000046   0.0000000000 
 C           6.0   3.8690192427  -2.5845263051   0.0000000000 
 C           6.0   2.6120884913  -3.2024122862   0.0000000000 
 C           6.0   1.4391206468  -2.4455629172   0.0000000000 
 C           6.0   1.5446521580  -1.0493554327   0.0000000000 
 C           6.0   2.8037461989  -0.4340374003   0.0000000000 
 C           6.0  -3.0636658201  -3.7155486695   0.0000000000 
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 C           6.0   3.9722777063  -1.1903074720   0.0000000000 
 O           8.0   1.1805740697   1.2291157439   0.0000000000 
 I          53.0  -1.9482952687   1.7487220983   0.0000000000 
 H           1.0  -1.7009254338  -1.4500058118   2.1476683532 
 H           1.0  -2.9840065928  -3.5754531729   2.1524784112 
 H           1.0   2.9860390014   2.8266280055   1.1793155180 
 H           1.0   4.2817449882   1.6371446925   1.2541616313 
 H           1.0   1.5359978112   1.3575369913   2.6267905943 
 H           1.0   3.0542297427   1.7840727903   3.4324089332 
 H           1.0   2.8476276476   0.1678407187   2.7393019057 
 H           1.0   4.9484914669  -0.7112756215   0.0000000000 
 H           1.0   4.7695979231  -3.1930031357   0.0000000000 
 H           1.0   2.5466907486  -4.2872004590   0.0000000000 
 H           1.0   0.4724074028  -2.9342141980   0.0000000000 
 H           1.0  -3.6259687923  -4.6458427776   0.0000000000 
MP2: 
COORDINATES OF SYMMETRY UNIQUE ATOMS (ANGS) 
   ATOM   CHARGE       X              Y              Z 
 ------------------------------------------------------------ 
 C           6.0   2.6013914851   1.1583551357   2.5554773998 
 C           6.0  -1.9302290925  -1.8692420718   1.2125097555 
 C           6.0  -2.5863703122  -3.1014909532   1.2107834929 
 C           6.0   3.1799805643   1.7348446202   1.2673673328 
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 C           6.0   2.6269922324   1.0812525798   0.0000000000 
 C           6.0   0.5143562411   0.0858139318   0.0000000000 
 C           6.0  -0.8368341650   0.0173613240   0.0000000000 
 C           6.0  -1.5814226195  -1.2522327671   0.0000000000 
 C           6.0   3.7915592366  -2.5803370296   0.0000000000 
 C           6.0   2.5201186216  -3.1734894366   0.0000000000 
 C           6.0   1.3563670147  -2.4010871060   0.0000000000 
 C           6.0   1.4946031410  -1.0055505223   0.0000000000 
 C           6.0   2.7643930369  -0.4132423060   0.0000000000 
 C           6.0  -2.9144024320  -3.7203219845   0.0000000000 
 C           6.0   3.9223526103  -1.1881419262   0.0000000000 
 O           8.0   1.1781256586   1.2879851521   0.0000000000 
 I          53.0  -1.9587919778   1.8090453534   0.0000000000 
 H           1.0  -1.6675518259  -1.3825219803   2.1497736270 
 H           1.0  -2.8463382864  -3.5777463522   2.1536127719 
 H           1.0   2.9659332854   2.8089858536   1.2043218294 
 H           1.0   4.2725992038   1.6240837052   1.2530141724 
 H           1.0   1.5126142170   1.2530822474   2.5595789956 
 H           1.0   2.9930577229   1.6969282333   3.4236747663 
 H           1.0   2.8592319837   0.1015737528   2.6674213804 
 H           1.0   4.9083298954  -0.7254655520   0.0000000000 
 H           1.0   4.6798301562  -3.2081115713   0.0000000000 
 H           1.0   2.4373615078  -4.2581058874   0.0000000000 
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 H           1.0   0.3809643539  -2.8766974462   0.0000000000 
 H           1.0  -3.4260755327  -4.6799700979   0.0000000000 
RHF: 
COORDINATES OF SYMMETRY UNIQUE ATOMS (ANGS) 
   ATOM   CHARGE       X              Y              Z 
 ------------------------------------------------------------ 
 C           6.0   2.6172718645   1.2142650623   2.5842454040 
 C           6.0  -1.9668986097  -1.9142344324   1.1983029815 
 C           6.0  -2.7026175666  -3.0878139462   1.1988230371 
 C           6.0   3.1640723976   1.7406848282   1.2587593470 
 C           6.0   2.6151355151   1.0523405708   0.0000000000 
 C           6.0   0.5398805195   0.0091865315   0.0000000000 
 C           6.0  -0.7857400463  -0.0655215845   0.0000000000 
 C           6.0  -1.5831581124  -1.3193728584   0.0000000000 
 C           6.0   3.8732298197  -2.5683308222   0.0000000000 
 C           6.0   2.6302913716  -3.1928210630   0.0000000000 
 C           6.0   1.4625534989  -2.4506742643   0.0000000000 
 C           6.0   1.5606908878  -1.0638702797   0.0000000000 
 C           6.0   2.7982894826  -0.4461206283   0.0000000000 
 C           6.0  -3.0705523102  -3.6783092399   0.0000000000 
 C           6.0   3.9671166039  -1.1868149629   0.0000000000 
 O           8.0   1.1903042847   1.1885992669   0.0000000000 
 I          53.0  -1.9131924489   1.7289801813   0.0000000000 
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 H           1.0  -1.6847956574  -1.4545366553   2.1281065380 
 H           1.0  -2.9886515192  -3.5384836406   2.1322652342 
 H           1.0   2.9382259034   2.7990887031   1.1745364480 
 H           1.0   4.2472932391   1.6497998273   1.2447975950 
 H           1.0   1.5392501798   1.3147975502   2.6281362587 
 H           1.0   3.0365225669   1.7832200191   3.4079889896 
 H           1.0   2.8701335590   0.1713920797   2.7412609396 
 H           1.0   4.9297009862  -0.7072508713   0.0000000000 
 H           1.0   4.7680103531  -3.1644446886   0.0000000000 
 H           1.0   2.5749833401  -4.2662658852   0.0000000000 
 H           1.0   0.5125247211  -2.9448931354   0.0000000000 
 H           1.0  -3.6432163113  -4.5883659681   0.0000000000 
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The solution-phase parallel synthesis of a 71 member diverse library of multi-
substituted cyclic imidates is described. The key intermediates, 3-iodomethylene-containing 
cyclic imidates, are readily prepared in good to excellent yields by the palladium/copper-
catalyzed cross-coupling of various o-iodobenzamides and terminal alkynes, followed by 
electrophilic cyclization with I2. These cyclic imidates were further functionalized by 
palladium-catalyzed Suzuki-Miyaura, Sonogashira, carbonylative amidation and Heck 
chemistry using sublibraries of commercially available building blocks. 
 
Introduction 
Heterocyclic compounds are of great importance in a variety of areas, including 
medicinal chemistry, materials chemistry etc. There has been an increasing demand for new 
and efficient strategies for the synthesis of important heterocyclic ring systems for the 
purpose of exploring their potential applications in pharmaceuticals and other relevant areas. 
We have previously reported the generation of various important heterocycles and 
carbocycles through very efficient electrophilic cyclization chemistry using halogen, sulfur 
and selenium electrophiles.1 In particular, we have recently found that the iodocyclization of 
2-alkynyl benzamides leads to formation of the corresponding cyclic imidates, also known in 
the literature as iminolactones (Scheme 1),2 where electrophilic attack occurs on oxygen 
rather than nitrogen.3,4  
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Scheme 1. Synthesis of Cyclic Imidates by Electrophilic Cyclization 
 
 
 
Over the years, several groups have reported various synthetic routes to cyclic 
imidates/iminolactones.5 In a few cases, the biological potential of this heterocyclic scaffold 
has also been investigated. For example, gossylic iminolactone (GIL, I) derived from the 
natural product Gossypol (II) has been found to exhibit anti-HIV activity.6 As a part of our 
ongoing library generation program,7 we continued to further incorporate diversity into the 
cyclic imidate/iminolactone heterocyclic ring system to study the biological profile of the 
resulting imidates. Here we report our studies on the solution phase synthesis of a 71 member 
diverse library of these cyclic imidates. 
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Results and Discussion 
Our strategy for library production is shown in Scheme 2. We anticipated that our 
previously described iodocyclization process should readily afford trisubstituted 3-
iodomethylene-containing cyclic imidates (4) as key intermediates. Further functionalization 
can be achieved by taking advantage of the iodine handle present on the exocyclic double 
bond at the 3-position, through various coupling reactions to generate a library with four 
points of diversity. 
 
Scheme 2. Library Design for Tetrasubstituted Cyclic Imidates 
 
The starting o-iodobenzamides (1) were conveniently prepared from the 
corresponding commercially available carboxylic acids by first refluxing the acid with 
thionyl chloride, followed by reaction with the corresponding amine in the same pot.2,8 The 
alkynes 3 required for cyclization are readily prepared by the palladium/copper-catalyzed 
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Sonogashira cross-coupling9 of the o-iodobenzamides 1 with terminal alkynes 2 and the 
results are summarized in Table 1. As shown in the Table, the requisite alkynes 3{1-6} are 
readily obtained in good to excellent yields by this straightforward approach. 
 
Table 1. Library Data for the 2-(1-Alkynyl)benzamides 3{1-6} 
 
compda R1 R2 R3 yieldb (%) 
3{1} H Ph n-Pr 91 
3{2} H Ph TMS 76 
3{3} 4,5-(MeO)2 PMB TMS 96 
3{4} 4,5-(MeO)2 Me Ph 87 
3{5} 4,5-(MeO)2 Me 2-pyr 76 
3{6} 4,5-(MeO)2 Me 2-thienyl 83 
aAll reactions were carried out on a 5.0 mmol scale using 1.2 equiv of the alkyne, 2 mol 
% PdCl2(PPh3)2, 1 mol % CuI and DIPA (4 equiv) in DMF (25 mL) at 65 oC (see the 
Supporting Information for the detailed procedures). bIsolated yields after column 
chromatography. 
 
As the key step in our library synthesis, variously substituted iodo cyclic imidates 4 
have been efficiently prepared within 1-2 h by electrophilic cyclization of the corresponding 
o-(1-alkynyl)benzamides 3{1-6} using I2/NaHCO3 in MeCN at ambient temperature (Table 
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2). All of the cyclized products 4 have been purified by column chromatography. The 
reaction works well for all substrates containing alkyl, aryl, TMS or heteroaryl groups at the 
distal end of the carbon-carbon triple bond. It is noteworthy that in the presence of electron-
donating methoxy groups on the amide phenyl ring 3{3-6}, only one regioisomer was 
isolated exclusively. In fact, the electron-donating effect of the para methoxy group (with 
respect to the alkyne) should increase the electron density on C-2 of the arylethynyl group, 
thus favoring intramolecular nucleophilic attack of the amide oxygen on C-1. The structure 
of the cyclized iodo imidates 4{2} and 4{4} has been confirmed by single crystal X-ray 
crystallography (see the Supporting Information).  
 
Table 2. Library Data for Compounds 4{1-6} 
 
compda R1 R2 R3 
yieldb (%) 
4 + 5 
4{1} H Ph n-Pr 92 + 6 
4{2} H Ph TMS 77 + 7 
4{3} 5,6-(MeO)2 PMB TMS 80 + 0 
4{4} 5,6-(MeO)2 Me Ph 79 + 0 
4{5} 5,6-(MeO)2 Me 2-py 91 + 0 
4{6} 5,6-(MeO)2 Me 2-thienyl 93 + 0 
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aAll reactions were carried out on a 4.0 mmol scale using I2 (3 equiv) and NaHCO3 (3 equiv) 
in MeCN (20 mL) at 25 oC for 1-2 h. bIsolated yields after column chromatography. 
 
Furthermore, the trimethylsilyl-containing cyclic imidates 4{2} and 4{3} were treated 
with fluoride to afford the corresponding deprotected cyclic imidates 4{7} and 4{8} 
respectively, in good yields (eq 1). 
 
 
 
 
 
Figure 2. Sublibrary of 3-Iodomethylene-containing Cyclic Imidates 4{1-8}. 
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The 3-iodomethylene-containing cyclic imidates 4 can be further elaborated by using 
a variety of palladium-catalyzed processes, such as Sonogashira coupling,9 Suzuki-Miyaura 
coupling,10 carbonylative amidation,11 Heck coupling,12 and amination13 (Scheme 4). The 
reagents used (e.g. boronic acids 6, terminal alkynes 2, styrenes 7, and amines 8) for 
substitution of the iodine-containing products 4 were chosen on the basis of their commercial 
availability, functional group diversity and potential drug-like properties (Figure 3). This 
could result in a library of ~1300 theoretically possible products. This number was arrived at 
by determining all possible combinations of the R group and available starting materials. 
However, only a small subset of 71 compounds out of these 1300 virtual structures was 
actually prepared in the laboratory. The crude products 9 were analyzed by LC/MS, followed 
by purification by either column chromatography or preparative HPLC. The results of this 
parallel library synthesis are summarized in Table 3, which indicates that the products 9 can 
be obtained in modest to good yields with high purities.  
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Scheme 4. Synthesis of Cyclic Imidates 9 Using Various Palladium-catalyzed Reactionsa 
 
 
aMethod A (Sonogashira coupling): 3 mol % PdCl2(PPh3)2, 2 mol % CuI, DIPA (4 equiv), 
 (2, 1.2 equiv), DMF, 70 °C, 2 h. Method B (Suzuki-Miyaura coupling): 5 mol % 
PdCl2, KHCO3 (1.4 equiv), R4B(OH)2 (6, 1.2 equiv), 4:1 DMF/H2O, 80 °C, 2 h. Method C 
(carbonylative amidation): CO (1 atm), 5 mol % PdCl2(PPh3)2, R4NH2 (7, 0.25 mL), DMF, 
65 °C, 3-6 h. Method D (Heck coupling): 5 mol % Pd(OAc)2, n-Bu4NCl (1.0 equiv), Na2CO3 
(2.5 equiv), R4CH=CH2 (8, 4 equiv), DMF, 85 °C, 5-24 h. Method E (amination): 5 mol % 
Pd2(dba)3·CHCl3, 5 mol % BINAP, t-BuONa (1.4 equiv), R4NH2 (7, 1.2 equiv), DMF, 80 °C, 
2.5 h.  
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Alkyne Sublibrary 
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Boronic Acid and Boronate Ester Sublibrary 
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Amine Sublibrary 
 
Styrene Sublibrary 
 
Figure 3. Diverse terminal alkynes 2{1-12}, boronic acids 6{1-2}, boronate ester 6{21}, 
amines 7{1-4}, and styrenes 8{1-6} used for library synthesis. 
 
Table 3. Library Data for Compounds 9{1-75} 
compd 4 R4 methoda yieldb (%) purityc (%) 
9{1} 4{1} 2{1} A 34 89 
9{2} 4{1} 2{5} A 26 98 
9{3} 4{1} 2{7} A 30 98 
9{4} 4{1} 2{8} A 34 100 
9{5} 4{1} 2{9} A 27 97 
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9{6} 4{1} 2{10} A 21 99 
9{7} 4{1} 2{11} A 14 100 
9{8} 4{1} 2{12} A 8 91 
9{9} 4{6} 2{4} A 51 87 
9{10} 4{6} 2{6} A 19 89 
9{11} 4{7} 2{1} A 55 97 
9{12} 4{7} 2{2} A 59 100 
9{13} 4{7} 2{3} A 38 91 
9{14} 4{7} 2{4} A 63 80 
9{15} 4{7} 2 {5} A 16 97 
9{16} 4{7} 2 {6} A 69 100 
9{17} 4{7} 2 {7} A 8 98 
9{18} 4{1} 6{1} B 43 100 
9{19} 4{1} 6{2} B 28 100 
9{20} 4{1} 6{3} B 62 99 
9{21} 4{1} 6{4} B 7 94 
9{22} 4{1} 6{5} B 52 100 
9{23} 4{1} 6{6} B 73 100 
9{24} 4{1} 6{7} B 67 100 
9{25} 4{1} 6{9} B 25 98 
9{26} 4{1} 6{10} B 59 99 
9{27} 4{1} 6{11} B 62 100 
207 
 
 
9{28} 4{1} 6{12} B 78 100 
9{29} 4{1} 6{13} B 16 100 
9{30} 4{1} 6{14} B 64 61 
9{31} 4{1} 6{15} B 13 98 
9{32} 4{1} 6{17} B 52 95 
9{33} 4{1} 6{18} B 7 100 
9{34} 4{1} 6{20} B 49 99 
9{35} 4{4} 6{1} B 30 100 
9{36} 4{4} 6{10} B 28 97 
9{37} 4{4} 6{16} B 92 58 
9{38} 4{5} 6{6} B 15 84 
9{39} 4{5} 6{10} B 32 64 
9{40} 4{5} 6{14} B 26 54 
9{41} 4{5} 6{16} B 36 60 
9{42} 4{6} 6{1} B 22 94 
9{43} 4{6} 6{6} B 30 84 
9{44} 4{6} 6{10} B 39 93 
9{45} 4{6} 6{19} B 32 81 
9{46} 4{7} 6{1} B 27 100 
9{47} 4{7} 6{2} B 33 96 
9{48} 4{7} 6{3} B 57 88 
9{49} 4{7} 6{4} B 18 95 
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9{50} 4{7} 6 {5} B 43 98 
9{51} 4{7} 6{6} B 29 93 
9{52} 4{7} 6{7} B 14 71 
9{53} 4{7} 6{8} B 25 98 
9{54} 4{7} 6{9} B 52 98 
9{55} 4{7} 6{10} B 32 87 
9{56} 4{7} 6{11} B 48 100 
9{57} 4{7} 6{12} B 38 82 
9{58} 4{7} 6{13} B 7 75 
9{59} 4{7} 6{14} B 34 85 
9{60} 4{7} 6{15} B 43 91 
9{61} 4{7} 6{20} B 36 99 
9{62} 4{7} 6{21} B 4 81 
9{63} 4{1} 7{2} C 0  
9{64} 4{1} 7{3} C 14 90 
9{65} 4{1} 7{4} C 0  
9{66} 4{1} 8{1} D 41 85 
9{67} 4{1} 8{2} D 50 95 
9{68} 4{1} 8{3} D 46 86 
9{69} 4{1} 8{4} D 20 92 
9{70} 4{1} 8{5} D 10 96 
9{71} 4{7} 8{2} D 50 80 
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9{72} 4{7} 8{5} D 14 100 
9{73} 4{7} 8{6} D 31 78 
9{74} 4{7} 7{1} E 0  
9{75} 4{7} 7{2} E 0  
aMethod A, Sonogashira coupling; B, Suzuki-Miyaura coupling; C, carbonylative amidation; 
D Heck coupling; E, amination. bIsolated yield after preparative HPLC. cUV purity 
determined at 214 nm after preparative HPLC. 
 
Sonogashira coupling of the 3-iodomethylene-containing cyclic imidates 4 with 
various terminal acetylenes 2 affords the corresponding alkynyl products 9{1-17} (method 
A). Suzuki-Miyaura coupling of the 3-iodomethylene-containing cyclic imidates 4 with 
various arylboronic acids 6 proceeded smoothly to give the desired products 9{18-62} in 
modest yields. Most reactions were complete within 2 h at 80 oC in DMF (method B). The 
reaction was also examined using a boronate ester 6{21}. However, the yield of the isolated 
compound 9{62} was very low in this case. The structure of one of the products from the 
Suzuki-Miyaura coupling 9{24} was confirmed using single crystal X-ray crystallography 
(see the Supporting Information for details). The stereochemistry around the C-C and C-N 
double bonds was found to be preserved during the Suzuki-Miyaura cross-coupling. Next, in 
an effort to synthesize amide-containing cyclic imidates, carbonylative amidation of the 3-
iodomethylene-containing cyclic imidates 4 using one atmosphere of carbon monoxide and 
various amines 7 in the presence of catalytic amounts of PdCl2(PPh3)2 was investigated 
(method C). However, the reaction product was isolated in only one case 9{64} and only in 
low yield. Furthermore, by allowing the compounds 4 to react under Heck reaction 
conditions in the presence of the styrenes 8, we obtained the substituted olefin-containing 
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cyclic imidate products 9{66-73} (method D). Palladium-catalyzed amination reactions have 
also been attempted to introduce amino substituents into the library (method E). However, 
the reaction did not proceed well and the process resulted in complex reaction mixtures. 
Because of our interest in the synthesis of potentially biologically active heterocycles 
for their use in high-throughput screening, an in silico evaluation of the library members was 
carried out to check their conformity with Lipinski’s “rule of five” and Veber’s rules.14,15 The 
molecular weight, clog P, number of hydrogen bond donors and acceptors, and the number of 
rotatable bonds were calculated for each of the library members using the SYBYL program.16 
Most of the 71 cyclic imidate library members were found to be either Lipinski compliant or 
had only one violation. In addition, the cell monolayer absorption model Caco-2, a parameter 
indicating the ability of a compound to passively permeate epithelial cells, i.e skin and 
muscle sheaths, was also calculated.17 The mean values, as well as the range of these 
parameters for this cyclic imidate library, is provided in Table 4. 
 
Table 4. In silico Data for Lipinski and Cell Permeability Parameters  
parameter mean range 
optimum 
value 
mol. weight 391.3 315.3-510.6 ≤ 500 
H-bond acceptors 3.9 2 -7 ≤ 10 
H-bond donors 1.5 1-3 ≤ 5 
C log P 5.7 2.9-9.2 ≤ 5.0 
rotatable bonds 4.8 2-7 ≤ 10 
Caco-2 1.2 0.2-2.1 ≥ 0.4 
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Conclusions 
A highly substituted 71 member library of cyclic imidates 9 with four points of 
diversity has been synthesized. 3-Iodomethylene-containing cyclic imidates 4 are readily 
prepared by iodocyclization chemistry. We have demonstrated the diversification of these 3-
iodomethylene-containing cyclic imidates 4 with various building blocks, for example, 
terminal alkynes 2, boronic acids 6, carbon monoxide plus amines 7, and styrenes 8, to 
construct a diverse library through a variety of C-C bond forming reactions. The cyclic 
imidate library members 9 will be evaluated against various biological screens by the 
National Institutes of Health Molecular Library Screening Center Network. 
 
Experimental Section 
General Information 
The 1H NMR and 13C NMR spectra were recorded at 25 °C in CDCl3 with Me4Si as 
an internal standard. Chemical shifts (δ) and coupling constants (J) are given in ppm and in 
Hz, respectively. Thin layer chromatography was performed using commercially prepared 
60-mesh silica gel plates and visualization was effected with short wavelength UV light (254 
nm).  
HRMS Data for Compounds 3{1-6} and 4{1-8}: The electron impact ionization 
experiments were performed on a Finnigan TSQ700 triple quadrupole mass spectrometer 
(Finnigan MAT, San Jose, CA) fitted with a Finnigan EI/CI ion source. The samples were 
introduced to the mass spectrometer using a solids probe. The probe was heated gradually 
from 100 to 400 oC. The instrument was used as a single quadrupole and scanned from 50 to 
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1000 daltons. Accurate mass measurements were conducted using a manual peak matching 
technique on a KRATOS MS50 double focusing mass spectrometer. 
 
General Methods Used for Analysis and Purification of the Library Members 9{1-75}. 
HPLC analysis was carried out using an XBridge MS C-18 column (5 µM, 4.6 × 150 mm) 
with gradient elution (5% CH3CN to 100% CH3CN) on a Waters Alliance 2795 Separation 
Module with a Waters 2996 Photodiode Array UV detector and a Waters/Micromass LCT 
Premier (TOF) detector. Purification was performed using an XBridge MS C-18 column (5 
µM, 19 × 150 mm) with gradient elution (a narrow CH3CN gradient was chosen based on the 
targets retention time from LCMS analysis of the crude sample) on a Mass Directed 
Fractionation instrument with a Waters 2767 sample manager, a Waters 2525 HPLC pump, a 
Waters 2487 dual λ absorbance detector, and a Waters/Micromass ZQ (quadrupole) detector. 
Fractions were triggered using an MS and/or UV threshold determined by an LCMS analysis 
of the crude sample. One of three aqueous mobile phases were chosen for both analysis and 
purification to promote the targets neutral state (water, 0.05% formic acid or pH 9.8 1mM 
HCO2NH4). High resolution mass spectra (HRMS) were obtained using a Waters/Micromass 
LCT Premier (TOF instrument). 
Reagents. All reagents were used directly as obtained commercially unless otherwise noted.  
Solvents. All solvents were used directly as obtained commercially, except for DCM which 
was distilled over CaH2. 
 
General Sonogashira Coupling Procedure Used for Preparation of the 2-(1-
Alkynyl)benzamides 3{1-6}. 
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To a solution of the appropriate o-iodobenzamide 1 (5.0 mmol) in DMF (20 mL) were 
added PdCl2(PPh3)2 (2 mol %) and CuI (1 mol %). The reaction vial was flushed with Ar and 
the reaction mixture was stirred for 5 min at room temperature. DIPA (4.0 equiv) was added 
by syringe. The reaction mixture was then heated to 65 °C. A solution of alkyne 2 (1.2 equiv) 
in DMF (5 mL) was added dropwise over 10 min, and the mixture was allowed to stir at 65 
oC for 2 h. After cooling, the reaction mixture was diluted with EtOAc, and washed with satd 
aq NH4Cl and water. The organic layer was dried over MgSO4 and concentrated under 
vacuum to give the crude product, which was purified by column chromatography on silica 
gel using hexane-EtOAc as eluent. 
 
Characterization Data for the 2-(1-Alkynyl)benzamides 3{1-6}. 
 
Benzamide 3{1}. 1H NMR (400 MHz, CDCl3) δ 0.96 (t, J = 7.6 Hz, 3H), 1.53-1.59 (m, 2H), 
2.40 (t, J = 7.2 Hz, 2H), 7.09 (t, J = 7.6 Hz, 1H), 7.27-7.33 (m, 4H), 7.41-7.43 (m, 1H), 7.67 
(d, J = 8.0 Hz, 2H), 7.95-7.97 (m, 1H), 9.43 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ 13.5, 
21.5, 21.9, 79.2, 97.9, 119.8, 120.2, 124.1, 128.0, 128.8, 129.7, 130.5, 133.5, 135.5, 138.0, 
164.4; HRMS Calcd for C18H17NO: 263.13101. Found: 263.13162. 
 
 
214 
 
 
Benzamide 3{2}. The spectral properties were identical to those previously reported.2 
 
  
Benzamide 3{3}. The spectral properties were identical to those previously reported.2 
 
 
Benzamide 3{4}. 1H NMR (400 MHz, CDCl3) δ 3.07 (d, J = 4.8 Hz, 3H), 3.94 (s, 3H), 3.96 
(s, 3H), 7.01 (s, 1H), 7.39-7.41 (m, 3H), 7.51-7.53 (m, 2H), 7.65 (br s, 1H), 7.67 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 27.0, 56.2, 56.3, 88.1, 94.5, 112.1, 112.7, 115.1, 122.4, 128.8, 
129.05, 129.13, 131.5, 149.6, 150.5, 166.6; HRMS Calcd for C18H17NO3: 295.12084. Found: 
295.12139. 
 
 
Benzamide 3{5}. 1H NMR (400 MHz, CDCl3) δ 3.09 (d, J = 4.8 Hz, 3H), 3.94 (s, 3H), 3.97 
(s, 3H), 7.09 (s, 1H), 7.28-7.32 (m, 1H), 7.50 (d, J = 7.6 Hz, 1H), 7.63 (br s, 1H), 7.67 (s, 
1H), 7.73 (t, J = 7.6 Hz, 1H), 8.66 (d, J = 4.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 27.2, 
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56.3, 56.4, 87.8, 93.6, 111.1, 112.9, 115.4, 123.4, 126.9, 130.1, 136.5, 142.9, 150.2, 150.5, 
150.6, 166.4; HRMS Calcd for C17H16N2O3: 296.11609. Found: 296.11664. 
 
 
Benzamide 3{6}. 1H NMR (400 MHz, CDCl3) δ 3.06 (d, J = 4.8 Hz, 3H), 3.94 (s, 3H), 3.96 
(s, 3H), 6.99 (s, 1H), 7.19 (dd, J = 1.2, 4.8 Hz, 1H), 7.36-7.38 (m, 1H), 7.56 (dd, J = 1.2, 3.2 
Hz, 1H), 7.60 (br s, 1H), 7.67 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 27.0, 56.26, 56.30, 
87.7, 89.7, 112.1, 112.7, 115.0, 121.4, 126.2, 128.9, 129.4, 129.6, 149.6, 150.5, 166.6; 
HRMS Calcd for C16H15NO3S: 301.07726. Found: 301.07786. 
 
General Iodocyclization Procedure Used for Preparation of the Cyclic Imidates 4{1-6}.2  
To a solution of the starting alkyne 3 (4.0 mmol) in MeCN (20 mL) were added I2 
(3.0 equiv) and NaHCO3 (3.0 equiv). The reaction mixture was allowed to stir at 25 °C and 
the reaction was monitored by TLC for completion. The excess I2 was removed by washing 
with satd aq Na2S2O3. The mixture was then extracted by EtOAc, and the combined organic 
layers were dried over anhydrous MgSO4 and concentrated under vacuum to yield the crude 
product, which was purified by flash chromatography on silica gel using hexane-EtOAc as 
the eluent. 
 
 
216 
 
 
Characterization Data for the 3-Iodomethylene-containing Cyclic Imidates 4{1-8} 
 
Imidate 4{1}. 1H NMR (400 MHz, CDCl3) δ 0.91 (t, J = 7.6 Hz, 3H), 1.56-1.62 (m, 2H), 
2.81 (t, J = 7.6 Hz, 2H), 7.13 (t, J = 7.2 Hz, 1H), 7.35 (t, J = 7.6 Hz, 2H), 7.42-7.51 (m, 4H), 
7.94 (d, J = 7.2 Hz, 1H), 8.56 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 13.2, 22.5, 
41.6, 82.2, 123.7, 123.9, 124.2, 124.8, 128.7, 129.9, 131.6, 132.2, 135.3, 145.5, 147.3, 152.1; 
HRMS Calcd for C18H16INO: 389.02766. Found: 389.02853. 
 
 
Imidate 4{2}. The spectral properties were identical to those previously reported.2 
 
 
Imidate 4{3}. The spectral properties were identical to those previously reported.2 
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Imidate 4{4}. 1H NMR (400 MHz, CDCl3) δ 3.15 (s, 3H), 3.97 (s, 3H), 4.03 (s, 3H), 7.25-
7.29 (m, 2H), 7.38 (t, J = 7.6 Hz, 2H), 7.63 (d, J = 7.6 Hz, 2H), 8.29 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 35.1, 56.46, 56.53, 71.6, 103.9, 106.9, 125.3, 128.0, 128.2, 129.5, 130.4,  
140.7, 147.3, 151.8, 154.8 (one signal missing due to overlap); HRMS Calcd for 
C18H16INO3: 421.01749. Found: 421.01870. 
 
 
Imidate 4{5}. 1H NMR (400 MHz, CDCl3) δ 3.21 (s, 3H), 3.98 (s, 3H), 4.05 (s, 3H), 7.18 (t, 
J = 6.4 Hz, 1H), 7.27 (s, 1H), 7.69 (t, J = 7.6 Hz, 1H), 7.89 (d, J = 8.0 Hz, 1H), 8.42 (s, 1H), 
8.74 (d, J = 4.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 35.2, 56.5, 56.6, 74.9, 104.0, 107.5, 
122.6, 124.5, 125.2, 129.7, 135.9, 149.3, 149.5, 152.0, 152.3, 154.7, 156.1; HRMS Calcd for 
C17H15IN2O3: 422.01274. Found: 422.01393. 
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Imidate 4{6}. 1H NMR (400 MHz, CDCl3) δ 3.30 (s, 3H), 3.96 (s, 3H), 4.01 (s, 3H), 7.25 (s, 
1H), 7.37-7.39 (m, 1H), 7.64 (d, J = 4.8 Hz, 1H), 7.73 (s, 1H), 8.28 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 35.4, 56.4, 56.5, 67.0, 103.9, 106.9, 124.6, 125.0, 127.4, 129.8, 129.9, 140.3, 
146.9, 151.6, 151.7, 154.8; HRMS Calcd for C16H14INO3S: 426.97391. Found: 426.97489. 
 
 
Imidate 4{7}. A modified literature procedure was used for TMS-deprotection.18 To a 
solution of compound 4{2} (4.0 g, 9.5 mmol) in 1:1 THF:MeOH (20 mL), KF·2H2O (5.37 g, 
57 mmol, 6 equiv) was added and the reaction mixture was stirred for 0.5 h at 25 oC. After 
the reaction was over, the methanol was removed under vacuum and the residue was 
extracted with EtOAc (3 x 20 mL), washed with 0.1M HCl and brine, dried (MgSO4), 
filtered, and the solvent removed under vacuum. Purification by flash chromatography 
afforded the deprotected product in a 76% yield. 1H NMR (400 MHz, CDCl3) δ 6.17 (s, 1H), 
7.18-7.20 (m, 1H), 7.37-7.43 (m, 4H), 7.53-7.56 (m, 2H), 7.98 (d, J = 7.2 Hz, 1H), 8.54 (d, J 
= 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 52.8, 123.8, 123.93, 123.97, 124.9, 128.7, 
130.8, 131.9, 132.4, 134.9, 145.3, 151.6, 152.2; HRMS Calcd for C15H10INO: 346.98071. 
Found: 346.98168.  
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Imidate 4{8}. A modified literature procedure was used.2 Compound 4{3} (440 mg, 0.84 
mmol) and KF·2H2O (132 mg, 1.4 mmol, 1.67 equiv) were dissolved in DMF (6 mL) and 
H2O (0.5 ml) and the resulting reaction mixture was stirred at 25 oC for 1 h.  The mixture was 
then diluted with EtOAc, washed with brine and H2O (3 × 25 ml), dried (MgSO4) and 
filtered. The filtrate was characterized as the deprotected product 4{8}. 1H NMR (400 MHz, 
CDCl3) δ 3.80 (s, 3H), 3.95 (s, 3H), 4.01 (s, 3H), 4.72 (s, 2H), 6.03 (s, 1H), 6.88 (d, J = 8.0 
Hz, 2H), 7.29 (s, 1H), 7.34 (d, J = 8.4 Hz, 2H), 8.05 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 
48.9, 51.4, 55.5, 56.5, 56.6, 104.4, 105.7, 114.1, 125.8, 129.1, 129.3, 132.3, 151.8, 152.0, 
152.3, 154.3, 158.7; HRMS Calcd for C19H18INO4: 451.02805. Found: 451.02921.  
 
Diversification of the 3-Iodomethylene-containing Cyclic Imidates 4 Using Various 
Palladium-catalyzed Reactions7a 
General Sonogashira Coupling Procedure Used for the Preparation of Alkynes 9{1-17}. 
To a solution of the appropriate 3-iodomethylene-containing cyclic imidate 4 (0.25 
mmol) in DMF (4 mL) were added PdCl2(PPh3)2 (3 mol %) and CuI (2 mol %). The reaction 
vial was flushed with Ar and the reaction mixture was stirred for 5 min at room temperature. 
DIPA (4.0 equiv) was added by syringe. The reaction mixture was heated to 70 °C. A 
solution of alkyne 2 (1.2 equiv) in DMF (1 mL) was added dropwise over 10 min, and the 
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mixture was allowed to stir at 70 oC for 2 h. After cooling, the reaction mixture was diluted 
with EtOAc, and washed with satd aq NH4Cl and water. The organic layer was dried over 
MgSO4 and concentrated under vacuum to give the crude product, which was either purified 
by column chromatography on silica gel using hexane-EtOAc as the eluent, or was flushed 
through a short silica gel plug and purified by preparative HPLC. 
 
General Suzuki-Miyaura Coupling Procedure Used for the Preparation of Imidates 
9{18-62}. 
To a 4-dram vial were added the appropriate 3-iodomethylene-containing cyclic 
imidate 4 (0.25 mmol), the boronic acid 6 (0.30 mmol), KHCO3 (0.35 mmol) and PdCl2 
(0.0125 mmol) in 4:1 DMF:H2O (2.5 mL). The reaction mixture was stirred for 5 min at 
room temperature and flushed with Ar and then heated to 80 oC for 2 h. After cooling, the 
reaction mixture was diluted with EtOAc, and washed with satd aq NH4Cl and water. The 
organic layer was dried over MgSO4 and concentrated under vacuum to give the crude 
product, which was either purified by column chromatography on silica gel using hexane-
EtOAc as the eluent, or was flushed through a short silica gel plug and purified by 
preparative HPLC. 
 
Carbonylative Amidation Procedure Used for the Preparation of Amide 9{64}. 
To a 4-dram vial were added the appropriate 3-iodomethylene-containing cyclic 
imidate 4 (0.25 mmol), PdCl2(PPh3)2 (5 mol %), DMF (1 mL) and the amine 7 (0.25 mL if 
liquid or 0.5 mmol if solid). The reaction mixture was stirred for 2 min at room temperature 
and flushed with carbon monoxide. A balloon of carbon monoxide was placed on the vial, 
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which was heated to 65 oC for 3-6 h. After cooling, the reaction mixture was diluted with 
EtOAc, and washed with satd aq NH4Cl and water. The organic layer was dried over MgSO4 
and concentrated under vacuum to give the crude product, which was flushed through a short 
silica gel plug and purified by preparative HPLC. 
 
General Heck Coupling Procedure Used for the Preparation of Alkenes 9{66-73}. 
To a 4-dram vial were added the appropriate 3-iodomethylene-containing cyclic 
imidate 4 (0.25 mmol), the styrene 8 (1.0 mmol), Pd(OAc)2 (5 mol %), n-Bu4NCl (0.25 
mmol), Na2CO3 (0.625 mmol) and DMF (2 mL). The reaction mixture was then heated to 85 
oC for 5-24 h. After cooling, the reaction mixture was diluted with EtOAc (20 mL), and 
washed with satd aq NH4Cl and water. The organic layer was dried over MgSO4 and 
concentrated under vacuum to give the crude product, which was flushed through a short 
silica gel plug and purified by preparative HPLC. 
 
Characterization Data for Representative Library Members: 
 
Imidate 9{4}. 1H NMR (500 MHz, CDCl3) δ 1.02 (t, J = 7.5 Hz, 3H), 1.73-1.80 (m, 2H), 
2.55 (t, J = 7.5 Hz, 2H), 3.03 (s, 6H), 6.71 (d, J = 8.5 Hz, 2H), 7.19 (t, J = 7.0 Hz, 1H), 7.40-
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7.54 (m, 7H), 7.63 (t, J = 7.5 Hz, 1H), 8.03 (d, J = 7.5 Hz, 1H), 8.49 (d, J = 8.0 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 14.0, 21.8, 33.4, 40.4, 85.9, 98.7, 104.0, 110.2, 112.1, 123.2, 
123.6, 124.5, 124.9, 128.9, 129.5, 130.9, 132.4, 132.7, 135.8, 145.8, 150.4, 151.6, 153.4; 
HRMS Calcd for C28H27N2O: 407.2118 [M+H]+, Found: 407.2129. 
 
 
Imidate 9{5}. 1H NMR (500 MHz, CDCl3) δ 1.02 (t, J = 7.5 Hz, 3H), 1.70-1.78 (m, 2H), 
2.55 (t, J = 7.5 Hz, 2H), 7.20 (tt, J = 1.0, 7.5 Hz, 1H), 7.40-7.43 (m, 2H), 7.45-7.48 (m, 2H), 
7.58 (td, J = 1.0, 7.5 Hz, 1H), 7.62-7.65 (m, 2H), 7.66-7.70 (m, 3H), 8.05 (d, J = 8.0 Hz, 1H), 
8.36 (d, J = 8.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 13.9, 21.8, 33.1, 92.6, 95.3, 101.7, 
111.7, 118.7, 123.1, 123.9, 124.5, 125.3, 128.4, 128.9, 130.4, 131.5, 131.9, 132.4, 132.5, 
135.2, 145.3, 152.5, 153.8; HRMS Calcd for C27H21N2O: 389.1648 [M+H]+, Found: 
389.1668. 
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Imidate 9{6}. 1H NMR (500 MHz, CDCl3) δ 0.97 (t, J = 7.5 Hz, 3H), 1.10 (t, J = 7.5 Hz, 
3H), 1.63-1.75 (m, 4H), 2.44 (t, J = 7.5 Hz, 2H), 2.53 (t, J = 7.0 Hz, 2H), 7.17 (tt, J = 1.5, 7.5 
Hz, 1H), 7.37-7.41 (m, 2H), 7.44-7.46 (m, 2H), 7.52 (td, J = 1.0, 7.5 Hz, 1H), 7.61 (td, J = 
1.0, 7.5 Hz, 1H), 8.01 (d, J = 8.0 Hz, 1H), 8.37 (d, J = 8.0 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 13.90, 13.93, 21.6, 22.2, 22.5, 33.6, 78.8, 98.7, 103.8, 122.9, 123.6, 124.4, 124.9, 
128.9, 129.6, 131.0, 132.3, 135.7, 145.8, 151.9, 153.4; HRMS Calcd for C23H24NO: 
330.1852 [M+H]+, Found: 330.1864. 
 
O
N
OMe
H
 
Imidate 9{11}. 1H NMR (400 MHz, CDCl3) δ 3.99 (s, 3H), 5.92 (s, 1H), 6.93-6.99 (m, 2H), 
7.17-7.22 (m, 1H), 7.32-7.42 (m, 5H), 7.49 (d, J = 7.2 Hz, 1H), 7.60 (t, J = 7.6 Hz, 1H), 7.68 
(t, J = 7.6 Hz, 1H), 8.02 (d, J = 7.6 Hz, 1H), 8.81 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 55.9, 87.6, 89.3, 94.3, 110.8, 112.9, 120.9, 123.6, 124.0, 124.1, 125.1, 128.9, 130.1, 
130.8, 131.3, 132.5, 133.3, 135.3, 145.6, 153.0, 157.4, 160.1; HRMS Calcd for C24H18NO2: 
352.1332 [M+H]+, Found: 352.1325. 
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Imidate 9{12}. 1H NMR (400 MHz, CDCl3) δ 3.84 (s, 3H), 5.87 (s, 1H), 6.92 (d, J = 8.8 Hz, 
2H), 7.16-7.19 (m, 1H), 7.38-7.42 (m, 4H), 7.48 (d, J = 8.4 Hz, 2H), 7.59 (t, J = 7.2 Hz, 1H), 
7.66 (t, J = 7.2 Hz, 1H), 8.02 (d, J = 7.6 Hz, 1H), 8.41 (d, J = 7.6 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 55.6, 83.9, 87.6, 97.6, 114.5, 115.6, 123.6, 123.8, 124.0, 125.1, 128.9, 130.8, 
131.5, 132.6, 133.0, 135.3, 145.6, 152.9, 157.1, 160.1; HRMS Calcd for C24H18NO2: 
352.1332 [M+H]+, Found: 352.1330. 
 
 
Imidate 9{13}. 1H NMR (400 MHz, CDCl3) δ 2.33 (s, 3H), 5.86 (s, 1H), 7.13 (d, J = 8.0 Hz, 
2H), 7.19 (t, J = 6.8 Hz, 1H), 7.36-7.42 (m, 4H), 7.55 (d, J = 8.0 Hz, 2H), 7.61 (t, J = 7.6 Hz, 
1H), 7.68 (t, J = 7.6 Hz, 1H), 8.03 (d, J = 7.6 Hz, 1H), 8.39 (d, J = 7.6 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 21.3, 85.2, 87.0, 96.5, 121.1, 122.1, 123.6, 123.8, 123.9, 125.2, 128.9, 
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131.0, 131.4, 132.66, 132.69, 135.1, 145.4, 150.8, 152.9, 157.6, 169.4; HRMS Calcd for 
C25H18NO3: 380.1281 [M+H]+, Found: 380.1300. 
 
O
N
N
H
 
Imidate 9{16}. 1H NMR (400 MHz, CDCl3) δ 5.87 (s, 1H), 7.19 (t, J = 6.8 Hz, 1H), 7.24-
7.27 (m, 1H), 7.36-7.42 (m, 4H), 7.51 (d, J = 7.6 Hz, 1H), 7.61 (t, J = 7.6 Hz, 1H), 7.67-7.72 
(m, 2H), 8.02 (d, J = 7.6 Hz, 1H), 8.54 (d, J = 8.0 Hz, 1H), 8.65 (d, J = 4.4 Hz, 1H); 13C 
NMR (125 MHz, CDCl3) δ 84.9, 86.1, 96.5, 122.9, 123.7, 123.9, 124.0, 125.2, 126.9, 128.9, 
131.2, 131.5, 132.8, 134.9, 136.3, 143.4, 145.3, 150.4, 152.5, 158.8; HRMS Calcd for 
C22H15N2O: 323.1179 [M+H]+, Found: 323.1202. 
 
 
Imidate 9{18}. 1H NMR (400 MHz, CDCl3) δ 0.95 (t, J = 7.6 Hz, 3H), 1.43-1.52 (m, 2H), 
2.62 (t, J = 7.6 Hz, 2H), 4.11 (s, 3H), 6.68 (d, J = 8.0 Hz, 1H), 7.18 (t, J = 7.2 Hz, 1H), 7.33 
(t, J = 7.6 Hz, 1H), 7.39-7.47 (m, 5H), 8.01 (d, J = 8.0 Hz, 1H), 8.50 (s, 2H); 13C NMR (125 
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MHz, CDCl3) δ 13.9, 20.9, 35.6, 55.4, 115.0, 122.0, 124.0, 124.3, 124.9, 125.8, 128.9, 129.7, 
131.7, 132.1, 135.2, 145.7, 147.3, 153.4, 159.8, 165.4; HRMS Calcd for C23H22N3O2: 
372.1707 [M+H]+, Found: 372.1690. 
 
 
Imidate 9{19}. 1H NMR (400 MHz, CDCl3) δ 0.97 (t, J = 7.2 Hz, 3H), 1.42-1.52 (m, 2H), 
2.70 (t, J = 7.6 Hz, 2H), 4.00 (s, 3H), 6.42 (d, J = 8.0 Hz, 1H), 7.18-7.26 (m, 2H), 7.40-7.49 
(m, 5H), 8.00 (d, J = 7.6 Hz, 1H), 8.36 (s, 1H), 8.40 (s, 1H), 8.93 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ 14.1, 21.2, 35.7, 53.2, 118.9, 121.8, 124.1, 124.2, 124.3, 125.1, 128.5, 128.9, 
129.9, 131.9, 132.1, 132.9, 134.9, 136.6, 141.2, 145.7, 147.1, 149.1, 153.2, 164.9; HRMS 
Calcd for C26H23N2O5: 443.1601 [M+H]+, Found: 443.1596.  
 
O
N
N
Me2N
 
Imidate 9{22}. 1H NMR (400 MHz, CDCl3) δ 0.92 (t, J = 7.2 Hz, 3H), 1.41-1.51 (m, 2H), 
2.60 (t, J = 7.6 Hz, 2H), 3.17 (s, 6H), 6.61 (d, J = 8.8 Hz, 1H), 6.86 (d, J = 8.0 Hz, 1H), 7.16 
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(t, J = 7.2 Hz, 1H), 7.29 (t, J = 7.6 Hz, 1H), 7.37-7.41 (m, 4H), 7.49 (d, J = 7.6 Hz, 2H), 7.96 
(d, J = 7.6 Hz, 1H), 8.13 (d, J = 2.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 21.1, 35.8, 
38.3, 105.8, 120.4, 121.2, 122.4, 123.6, 124.4, 124.6, 128.8, 128.9, 131.4, 131.9, 136.1, 
138.3, 146.1, 146.2, 148.3, 154.4, 158.9; HRMS Calcd for C25H26N3O: 384.2070 [M+H]+, 
Found: 384.2075. 
 
 
Imidate 9{23}. 1H NMR (400 MHz, CDCl3) δ 0.95 (t, J = 7.6 Hz, 3H), 1.45-1.54 (m, 2H), 
2.71 (t, J = 7.6 Hz, 2H), 6.46 (d, J = 8.0 Hz, 1H), 6.59 (s, 1H), 7.11-7.19 (m, 3H), 7.29-7.36 
(m, 2H), 7.41 (t, J = 8.0 Hz, 2H), 7.48 (d, J = 8.4 Hz, 1H), 7.53 (d, J = 7.6 Hz, 2H), 7.59 (s, 
1H), 7.95 (d, J = 7.6 Hz, 1H), 8.34 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ 14.2, 21.2, 
36.5, 103.2, 111.7, 121.5, 122.8, 123.4, 123.5, 124.47, 124.52, 124.6, 125.0, 128.5, 128.6, 
128.8, 129.8, 131.3, 131.7, 135.7, 136.4, 145.8, 146.4, 154.8; HRMS Calcd for C26H23N2O: 
379.1805 [M+H]+, Found: 379.1799. 
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Imidate 9{24}. 1H NMR (400 MHz, CDCl3) δ 0.97 (t, J = 7.6 Hz, 3H), 1.47-1.56 (m, 2H), 
2.64 (t, J = 7.6 Hz, 2H), 6.53 (s, 2H), 6.64 (d, J = 8.0 Hz, 1H), 7.17 (t, J = 7.2 Hz, 1H), 7.27 
(t, J = 7.6 Hz, 1H), 7.37-7.42 (m, 3H), 7.49 (d, J = 7.6 Hz, 2H), 7.96 (d, J = 7.6 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 14.2, 21.2, 35.8, 56.4, 61.3, 106.2, 122.7, 122.9, 123.5, 124.4, 
124.6, 128.8, 129.0, 131.4, 131.8, 133.9, 135.9, 137.9, 145.9, 146.1, 153.8, 154.2; HRMS 
Calcd for C27H28NO4: 430.2013 [M+H]+, Found: 430.2010.  
 
 
Imidate 9{32}. 1H NMR (400 MHz, CDCl3) δ 0.95 (t, J = 7.2 Hz, 3H), 1.44-1.53 (m, 2H), 
2.64 (t, J = 7.2 Hz, 2H), 3.86 (s, 3H), 3.96 (s, 3H), 6.60 (d, J = 8.0 Hz, 1H), 6.83 (s, 1H), 6.88 
(d, J = 8.0 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 7.16 (t, J = 7.2 Hz, 1H), 7.24 (t, J = 7.2 Hz, 
1H), 7.35-7.42 (m, 3H), 7.49 (d, J = 7.6 Hz, 2H), 7.96 (d, J = 7.6 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 14.2, 21.1, 35.9, 56.1, 56.2, 111.7, 112.4, 121.7, 122.6, 122.8, 123.5, 124.4, 
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124.6, 128.8, 128.9, 130.9, 131.4, 131.7, 136.0, 145.9, 146.2, 148.9, 149.5, 154.3; HRMS 
Calcd for C26H26NO3: 400.1907 [M+H]+, Found: 400.1902.  
 
 
Imidate 9{34}. 1H NMR (400 MHz, CDCl3) δ 0.93 (t, J = 7.6 Hz, 3H), 142-1.51 (m, 2H), 
1.67-1.76 (m, 3H), 191-1.92 (m, 2H), 2.00-2.07 (m, 1H), 2.61-2.64 (m, 2H), 3.65-3.68 (m, 
1H), 3.99 (t, J = 9.2 Hz, 1H), 5.48 (s, 1H), 6.61 (d, J = 7.6 Hz, 1H), 7.12-7.18 (m, 3H), 7.22-
7.26 (m, 3H), 7.35-7.41 (m, 3H), 7.48-7.50 (m, 2H), 7.95 (d, J = 7.6 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 14.1, 19.2, 21.1, 25.4, 30.7, 35.9, 62.6, 96.9, 117.0, 122.6, 122.9, 123.5, 
124.4, 124.6, 128.8, 130.2, 130.4, 131.4, 131.5, 131.7, 136.1, 145.8, 146.2, 154.4, 157.1; 
HRMS Calcd for C29H30NO3: 440.2220 [M+H]+, Found: 440.2229.  
 
 
Imidate 9{36}. 1H NMR (400 MHz, CDCl3) δ 3.37 (s, 3H), 3.56 (s, 3H), 3.91 (s, 3H), 4.30 
(s, 4H), 5.75 (s, 1H), 6.87 (d, J = 8.0 Hz, 1H), 6.91 (s, 1H), 7.01 (d, J = 8.0 Hz, 1H), 7.20 (s, 
1H), 7.23-7.25 (m, 1H), 7.36 (t, J = 7.6 Hz, 2H), 7.64 (d, J = 7.6 Hz, 2H); 13C NMR (100 
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MHz, CDCl3) δ 35.4, 55.7, 56.5, 64.6, 64.8, 103.5, 105.4, 117.0, 118.1, 120.4, 123.7, 124.7, 
127.2, 128.2, 129.7, 130.9, 131.6, 138.5, 143.7, 144.3, 146.1, 150.9, 151.8, 156.8; HRMS 
Calcd for C26H24NO5: 430.1649 [M+H]+, Found: 430.1643. 
 
 
Imidate 9{46}. 1H NMR (400 MHz, CDCl3) δ 4.09 (s, 3H), 6.45 (s, 1H), 7.17-7.20 (m, 1H), 
7.39-7.42 (m, 5H), 7.46 (t, J = 7.6 Hz, 1H), 7.56 (t, J = 7.6 Hz, 1H), 8.03 (d, J = 7.6 Hz, 1H), 
8.61 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 55.4, 100.7, 121.8, 122.1, 123.9, 124.3, 125.0, 
128.9, 130.9, 132.36, 132.41, 134.5, 145.7, 151.5, 153.1, 159.5, 165.1; HRMS Calcd for 
C20H16N3O2: 330.1237 [M+H]+, Found: 330.1234. 
 
 
Imidate 9{47}. 1H NMR (500 MHz, CDCl3) δ 4.01 (s, 3H), 6.68 (s, 1H), 7.19-7.22 (m, 1H), 
7.37 (d, J = 8.0 Hz, 1H), 7.41-7.47 (m, 5H), 7.58 (t, J = 8.5 Hz, 1H), 8.06 (d, J = 7.0 Hz, 1H), 
8.47 (s, 1H), 8.51 (d, J = 1.0 Hz, 1H), 8.83 (d, J = 1.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) 
231 
 
 
δ 53.2, 105.2, 122.1, 123.6, 123.9, 124.4, 125.2, 127.9, 129.0, 131.4, 132.4, 132.5, 132.6, 
134.1, 136.1, 136.5, 145.5, 148.8, 152.1, 152.9, 164.9; HRMS Calcd for C23H17N2O5: 
401.1132 [M+H]+, Found: 401.1145. 
 
 
Imidate 9{52}. 1H NMR (400 MHz, CDCl3) δ 3.85 (s, 6H), 3.92 (s, 3H), 6.67 (s, 3H), 7.15-
7.19 (m, 1H), 7.39-7.45 (m, 5H), 7.52 (t, J = 7.2 Hz, 1H), 7.60 (d, J = 8.0 Hz, 1H), 8.01 (d, J 
= 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 56.4, 61.3, 106.6, 109.1, 115.6, 122.9, 123.9, 
124.7, 128.9, 129.3, 130.4, 131.9, 132.2, 135.1, 138.1, 146.0, 150.2, 153.6, 153.8; HRMS 
Calcd for C24H22NO4: 388.1543 [M+H]+, Found: 388.1541. 
 
 
Imidate 9{55}. 1H NMR (400 MHz, CDCl3) δ 4.31 (s, 4H), 6.61 (s, 1H), 6.90-6.95 (m, 3H), 
7.15-7.18 (m, 1H), 7.38-7.39 (m, 4H), 7.43-7.45 (m, 1H), 7.50 (t, J = 7.6 Hz, 1H), 7.63 (d, J 
= 7.6 Hz, 1H), 8.00 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 64.6, 64.7, 108.9, 
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117.7, 118.2, 122.7, 123.8, 123.9, 124.7, 127.0, 128.9, 129.5, 130.2, 131.9, 132.1, 135.1, 
143.6, 143,8, 146.1, 149.8, 154.0; HRMS Calcd for C23H18NO3: 356.1281 [M+H]+, Found: 
356.1277. 
 
 
Imidate 9{56}. 1H NMR (400 MHz, CDCl3) δ 1.43 (t, J = 7.2 Hz, 3H), 4.43 (q, J = 7.2 Hz, 
2H), 6.62 (s, 1H), 7.17-7.20 (m, 1H), 7.22-7.25 (m, 1H), 7.31 (d, J = 8.4 Hz, 1H), 7.39-7.43 
(m, 4H), 7.46 (d, J = 7.2 Hz, 1H), 7.54-7.57 (m, 2H), 7.97-8.04 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 14.5, 61.6, 106.7, 117.6, 117.8, 118.2, 118.3, 122.7, 123.9, 124.1, 125.0, 
125.06, 125.08, 128.9, 131.0, 132.2, 132.4, 132.6, 134.4, 140.8, 140.9, 145.6, 151.4, 153.2, 
161.1, 163.2, 164.22, 164.25 (extra peaks due to C-F splitting); HRMS Calcd for 
C24H19FNO3: 388.1343 [M+H]+, Found: 388.1349. 
 
O
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Imidate 9{59}. 1H NMR (400 MHz, CDCl3) δ 5.12 (s, 2H), 6.66 (s, 1H), 7.03 (d, J = 8.8 Hz, 
2H), 7.14-7.18 (m, 1H), 7.35-7.43 (m, 10H), 7.46-7.49 (m, 3H), 7.52 (t, J = 7.6 Hz, 1H), 8.00 
(d, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 70.4, 109.0, 115.3, 122.6, 123.86, 
123.95, 124.7, 126.4, 127.7, 128.3, 128.8, 128.9, 130.1, 130.7, 131.9, 132.1, 135.2, 136.9, 
146.2, 149.7, 154.1, 158.7; HRMS Calcd for C28H22NO2: 404.1645 [M+H]+, Found: 
404.1643. 
 
Crystallographic Experimental Section 
 
Table 1. X-ray Crystallographic Data for Compounds 4{2}, 4{4}, and 9{24}. 
 
compd Structure ORTEP diagram 
4{2} 
 
 
234 
 
 
4{4} 
 
 
9{24} 
 
 
 
 
Data Collection for Imidate 4{2}. 
A good crystal could not be obtained for this compound, so the X-ray studies were 
performed using a relatively poor quality crystal. The crystal was covered with Paratone oil 
under ambient conditions and was mounted and centered in the X-ray beam by using a video 
camera. 
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The crystal evaluation and data collection were performed at 173 K on a Bruker 
CCD-1000 diffractometer with Mo Kα (λ = 0.71073 Å) radiation and a detector to crystal 
distance of 5.03 cm.  
The initial cell constants were obtained from three series of ω scans at different 
starting angles. Each series consisted of 30 frames collected at intervals of 0.3º in a 10º range 
about ω with the exposure time of 20 seconds per frame. The reflections obtained were 
successfully indexed by an automated indexing routine built into the SMART program. The 
final cell constants were calculated from a set of strong reflections from the actual data 
collection.  
The data were collected using a full sphere routine by collecting four sets of frames 
with 0.3º scans in ω with an exposure time of 20 sec per frame. This data set was corrected 
for Lorentz and polarization effects. The absorption correction was based on the fit of a 
spherical harmonic function to the empirical transmission surface as sampled by multiple 
equivalent measurements using SADABS software.19,20 
 
Structure Solution and Refinement 
The systematic absences in the diffraction data were consistent for the space group 
P21/c and yielded chemically reasonable and computationally stable results of refinement.20 
The position of almost all non-hydrogen atoms were found by direct methods. The remaining 
atoms were located in an alternating series of least-squares cycles and difference Fourier 
maps. The observed resolution of the data set was above 1 Å. Therefore, the refinement lead 
to R-factors significantly exceeding the values required for publication of X-ray structure 
analysis. The poor quality of X-ray data also leads to some NPD (non-positive definite) 
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atoms. Therefore, rigid body restraints were applied to the final stages of refinement. All 
non-hydrogen atoms were refined in full-matrix anisotropic approximation. All hydrogen 
atoms were placed in the structure factor calculation at idealized positions and were allowed 
to ride on the neighboring atoms with relative isotropic displacement coefficients.  
Two structurally non-equivalent molecules were found in an asymmetric unit of 
primitive monoclinic cell. The ORTEP diagram was drawn at a 50% probability level. H-
atoms were omitted for clarity. The resulting CIF file has been tested with PLATON 
software.21 The results and comments have been included in the output package 
(Platon_Lar32.doc).  
 
 Table 2. Crystal data and structure refinement for Imidate 4{2}. 
Empirical formula  C18H18INOSi 
Formula weight  419.32 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 6.793(3) Å α = 90° 
 b = 18.773(8) Å β = 93.443(7)° 
 c = 28.433(12) Å γ  = 90° 
Volume 3619(3) Å3 
Z 8 
Density (calculated) 1.539 Mg/m3 
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Absorption coefficient 1.837 mm-1 
F(000) 1664 
Crystal size 0.46 x 0.38 x 0.24 mm3 
Theta range for data collection 1.43 to 20.82°. 
Index ranges -6<=h<=6, -18<=k<=18, -28<=l<=28 
Reflections collected 17216 
Independent reflections 3784 [R(int) = 0.0752] 
Completeness to theta = 20.82° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6669 and 0.4854 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3784 / 262 / 404 
Goodness-of-fit on F2 1.247 
Final R indices [I>2sigma(I)] R1 = 0.1221, wR2 = 0.3340 
R indices (all data) R1 = 0.1387, wR2 = 0.3488 
Extinction coefficient 0.0065(8) 
Largest diff. peak and hole 3.726 and -1.441 e.Å-3 
----------------------------------------------------------------------------- 
R1  = Σ | |Fo| – |Fc| |  / Σ |Fo|  and  wR2  =  { Σ [ w(Fo2–Fc2)2 ]  / Σ [ w(Fo2)2 ]  }1/2 
 
Data Collection for Imidate 4{4}. 
A colorless weakly diffracted crystal was selected under ambient conditions. The 
crystal was mounted and centered in the X-ray beam by using a video camera. 
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The crystal evaluation and data collection were performed at room temperature on a 
Bruker CCD-1000 diffractometer with Mo Kα (λ = 0.71073 Å) radiation and a detector to 
crystal distance of 5.03 cm.  
The initial cell constants were obtained from three series of ω scans at different 
starting angles. Each series consisted of 30 frames collected at intervals of 0.3º in a 10º range 
about ω with an exposure time of 20 seconds per frame. The sample was twinned. Therefore, 
the obtained reflections were indexed by visually separating two crystallites using the 
RLATT program.20 The final cell constants were calculated from a set of strong reflections 
from the actual data collection.   
The data were collected using a full sphere routine by collecting four sets of frames 
with 0.3º scans in ω with an exposure time of 20 sec per frame. This data set was corrected 
for Lorentz and polarization effects. The absorption correction was based on a fit of a 
spherical harmonic function to the empirical transmission surface as sampled by multiple 
equivalent measurements using SADABS software.19,20  
 
Structure Solution and Refinement 
The systematic absences in the diffraction data were consistent for the space group 
P21/c and yielded chemically reasonable and computationally stable results of refinement.20 
The position of almost all non-hydrogen atoms were found by direct methods. The remaining 
atoms were located in an alternating series of least-squares cycles and difference Fourier 
maps. All non-hydrogen atoms were refined in full-matrix anisotropic approximation. The 
resolution of statistically relevant data was above 1Å. Therefore, rigid body restraints were 
applied to refine some C atoms anisotropically. All hydrogen atoms were placed in the 
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structure factor calculation at idealized positions and were allowed to ride on the neighboring 
atoms with relative isotropic displacement coefficients.  
One proposed molecule and one CHCl3 solvent molecule were found in the 
asymmetric unit of the primitive monoclinic cell. The ORTEP diagram was drawn at 50% 
probability level. H-atoms were omitted for clarity. The resulting CIF file has been tested 
with PLATON software.21 The results and comments have been included in the output 
package (Platon_Lar31.doc).  
 
Table 3. Crystal data and structure refinement for imidate 4{4}. 
Empirical formula  C19H17Cl3INO3 
Formula weight  540.59 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 14.655(9) Å α = 90° 
 b = 18.309(11) Å β = 95.567(10)° 
 c = 7.846(5) Å γ  = 90° 
Volume 2095(2) Å3 
Z 4 
Density (calculated) 1.714 Mg/m3 
Absorption coefficient 1.930 mm-1 
F(000) 1064 
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Crystal size 0.32 x 0.26 x 0.15 mm3 
Theta range for data collection 1.79 to 20.82°. 
Index ranges -14<=h<=14, -18<=k<=18, -7<=l<=7 
Reflections collected 9731 
Independent reflections 2183 [R(int) = 0.0987] 
Completeness to theta = 20.82° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.74 and 0.69 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2183 / 14 / 247 
Goodness-of-fit on F2 1.111 
Final R indices [I>2sigma(I)] R1 = 0.0655, wR2 = 0.1678 
R indices (all data) R1 = 0.0911, wR2 = 0.1859 
Largest diff. peak and hole 2.270 and -0.970 e.Å-3 
----------------------------------------------------------------------------- 
R1  = Σ | |Fo| – |Fc| |  / Σ |Fo|  and  wR2  =  { Σ [ w(Fo2–Fc2)2 ]  / Σ [ w(Fo2)2 ]  }1/2 
 
Data Collection for Imidate 9{24}. 
A yellow crystal was selected under ambient conditions and covered with Paratone 
oil. The crystal was mounted and centered in the X-ray beam by using a video camera. 
The crystal evaluation and data collection were performed at 173 K on a Bruker 
CCD-1000 diffractometer with Mo Kα (λ = 0.71073 Å) radiation and a detector to crystal 
distance of 5.03 cm.  
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The initial cell constants were obtained from three series of ω scans at different 
starting angles. Each series consisted of 30 frames collected at intervals of 0.3º in a 10º range 
about ω with an exposure time of 20 seconds per frame. The reflections obtained were 
successfully indexed by an automated indexing routine built into the SMART program. The 
final cell constants were calculated from a set of strong reflections from the actual data 
collection.  
The data were collected using a full sphere routine by collecting four sets of frames 
with 0.3º scans in ω with an exposure time of 10 sec per frame. This data set was corrected 
for Lorentz and polarization effects. The absorption correction was based on a fit of a 
spherical harmonic function to the empirical transmission surface as sampled by multiple 
equivalent measurements using SADABS software.19,20 
 
Structure Solution and Refinement 
The systematic absences in the diffraction data were consistent for the space group 
P21/c and yielded chemically reasonable and computationally stable results of refinement.20 
The position of almost all non-hydrogen atoms were found by direct methods. The remaining 
atoms were located in an alternating series of least-squares cycles and difference Fourier 
maps. All non-hydrogen atoms were refined in full-matrix anisotropic approximation. All 
hydrogen atoms were placed in the structure factor calculation at idealized positions and 
were allowed to ride on the neighboring atoms with relative isotropic displacement 
coefficients.  
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The ORTEP diagram was drawn at 50% probability level. H-atoms were omitted for 
clarity. The resulting CIF file has been tested with PLATON software.21 The results and 
comments have been included in the output package (Platon_Lar30.doc.).  
 
Table 4. Crystal data and structure refinement for imidate 9{24}. 
Empirical formula  C27H27NO4 
Formula weight  429.50 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 9.037(3) Å α =  90° 
 b = 19.075(5) Å β =  98.377(5)° 
 c = 13.320(4) Å γ  =  90° 
Volume 2271.6(11) Å3 
Z 4 
Density (calculated) 1.256 Mg/m3 
Absorption coefficient 0.084 mm-1 
F(000) 912 
Crystal size 0.60 x 0.34 x 0.32 mm3 
Theta range for data collection 2.14 to 23.26°. 
Index ranges -10<=h<=10, -21<=k<=21, -14<=l<=14 
Reflections collected 14509 
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Independent reflections 3254 [R(int) = 0.0520] 
Completeness to theta = 23.26° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9736 and 0.9513 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3254 / 0 / 293 
Goodness-of-fit on F2 1.086 
Final R indices [I>2sigma(I)] R1 = 0.0488, wR2 = 0.1141 
R indices (all data) R1 = 0.0741, wR2 = 0.1278 
Largest diff. peak and hole 0.191 and -0.232 e.Å-3 
----------------------------------------------------------------------------- 
R1  = Σ | |Fo| – |Fc| |  / Σ |Fo|  and  wR2  =  { Σ [ w(Fo2–Fc2)2 ]  / Σ [ w(Fo2)2 ]  }1/2 
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GENERAL CONCLUSIONS 
In this dissertation, new and synthetically useful approaches involving palladium 
catalysis and electrophilic cyclization have been described for the synthesis of potentially 
medicinally and industrially important heterocycles and carbocycles. The methods used are 
quite general and can be utilized to synthesize a wide variety of isochromenes, and cyclic 
imidates, as well as linear and fused polyheterocyclic compounds (PHCs) containing 
benzofurans, benzothiophenes,  indoles, and isocoumarin subunits.  
In Chapter 1, competition studies in alkyne electrophilic cyclization reactions have 
been performed. This has been accomplished by applying this electrophilic cyclization 
methodology to a variety of unsymmetrical functionally-substituted diarylalkynes using 
halogen and selenium electrophiles and the resulting products characterized in order to 
determine the relative reactivities of various functional groups towards electrophilic 
cyclization. The results suggest that a number of factors affect the cyclization. These include 
electronic (the relative nucleophilicity of the functional groups, and the cationic nature of the 
intermediate) and steric factors (hindrance and geometrical alignment of the functional 
groups), and the nature of the electrophile.  
In Chapter 2, several iodocyclization/palladium-catalyzed approaches have been 
described for the generation of linked and fused polyheterocyclic compounds. The general 
method to prepare linked polyheterocyclic compounds involves iterative cycles of palladium-
catalyzed Sonogashira coupling, followed by iodocyclization using I2 or ICl. Important 
heterocyclic units, like indole, benzofuran, benzothiophene etc., can be easily inserted at the 
desired location by just changing the order of the building blocks, easily accessible terminal 
alkynes. The reactions are very efficient, afford clean reactions, and tolerate almost all 
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important functional groups. Finally, this methodoogy is very flexible and can be quickly 
combined with other efficient transformations, like the palladium-catalyzed Ullmann reaction 
and alkyne annulation, to construct more complex fused heterocycles. These features 
enhance the synthetic utility and scope of the methodology, making this a very practical 
approach for PHC synthesis.  
In Chapter 3, a variety of iodo-substituted isochromenes, dihydroisobenzofurans, and 
pyranopyridines are prepared in good to excellent yields under mild conditions by the 
iodocyclization of readily available 2-(1-alkynyl)benzylic alcohols or 2-(1-alkynyl)-3-
(hydroxymethyl)pyridines. The nature of the substituents in the starting material governs the 
regiochemistry of the reaction products. The 5-membered ring products obtained, namely 1-
alkylidene-1,3-dihydroisobenzofurans, exhibit unexpected Z-stereochemistry, and are 
presumably derived from the initially formed less stable E-isomers through iodine-mediated 
isomerization. 
In Chapter 4, the solution-phase parallel synthesis of a 71-member library of multi-
substituted (with four diversity points) cyclic imidates is described. 3-Iodomethylene cyclic 
imidates are readily prepared by iodocyclization chemistry. Diversification of these 3-
iodomethylene cyclic imidates has been accomplished by using various commercially 
available building blocks, for example, boronic acids, terminal alkynes, styrenes, and carbon 
monoxide plus amines, through a variety of C-C and C-N bond forming reactions. The cyclic 
imidate library members are being evaluated for their biological potential by the National 
Institutes of Health Molecular Library Screening Center Network. 
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